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Body of Abstract

Background: Presbyphonia is an age-related voice disorder characterized by vocal fold atrophy,
and its effects on voice are potentially compounded by declines in respiratory function. We
assessed: 1) the relationships between respiratory and voice function; 2) the effect of adding
respiratory exercises to voice therapy; and 3) the impact of baseline respiratory function on the
response to therapy in patients with presbyphonia.
Methods: Twenty-one participants underwent respiratory and voice assessments, from which
relationships were drawn. Ten of these participants were blocked-randomized to receive either
voice exercises only, or voice exercises combined with inspiratory muscle strength training or
expiratory muscle strength training, for a duration of four weeks.
Results: FVC, FEV1, and MEP had an association with phonation physiology through their effect
on aerodynamic resistance and vocal fold pliability. Percent predicted values of FVC and FEV1
were strong predictors of perceived voice handicap. IMST induced the largest improvements in
perceived handicap, and a lower baseline respiratory function was associated with a greater
improvement, regardless of the intervention received.
Conclusion: Respiratory function associates with voice and the response to behavioral voice
therapy. Adding IMST to voice exercises improves self-reported outcomes even in patients with a
normal respiratory function.
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Chapter 1: Introduction

Background and Significance
Voice Disorders

Phonation is the coordinated activity of the respiratory, laryngeal and neurological systems that
creates a sound. When combined with the action of the articulatory system, phonation allows
individuals to communicate through the production of words and sentences and is thereby at the
center of most social interactions. As it is the case for all organs of the human body, those
involved in voicing are subject to injury, disease or degeneration, which may result in a voice
disorder, termed dysphonia. Voice disorders affect the quality, pitch and/or loudness of the voice
and can hinder communication activities to various degrees depending on the severity of the
disorder and the extent to which an individual relies on their voice.
Approximately one out of three individuals experience dysphonia throughout their life (Cohen,
Kim, Roy, Asche, & Courey, 2012a, 2012b; Roy, Merrill, Gray, & Smith, 2005), with a point
prevalence between 6.6% and 7.5% in the adult US population (Cohen, 2010; Roy et al., 2005).
Based on these prevalence rates and on the adult population of the United States for the year of
2017 (244,340,854 individuals aged over 20 years old), between 16,126,496 and 18,325,564
Americans are currently experiencing dysphonia. With a direct health care cost for evaluation and
management of voice disorders estimated at $577.18 per person over a period of one year
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(Cohen et al., 2012a), the potential burden on the health care system ranges between 9 billion
and 10.5 billion dollars. Cohen et al. (Cohen et al., 2012a) reported similar direct costs and
observed that they are comparable to major chronic illnesses such as asthma, diabetes and
chronic obstructive pulmonary disease (COPD). If not treated, voice disorders can impact quality
of life by hindering work abilities and by leading to social isolation, depression and increased work
absenteeism (Cohen et al., 2012b; Roy et al., 2005; Smith et al., 1996) Voice therapy with a speech
language pathologist (SLP) is often the primary approach used with dysphonic patients.
Depending on the etiology of the voice disorder, it can also be recommended along with surgery
and/or pharmacological treatment (Cohen, Dinan, Kim, & Roy, 2015). Voice therapy aims at
optimizing voice production and limiting maladaptive compensatory mechanisms. The SLP
recommends and teaches exercises targeting the laryngeal, resonance and/or respiratory system.
While the body of literature on voice therapy pertaining to the laryngeal and resonance systems
is existing and growing (Desjardins, Halstead, Cooke, & Bonilha, 2017), there is a lack of evidence
supporting the use of respiratory exercises with dysphonic patients.

Role of the Respiratory System in Voice Disorders

Pathophysiology
It is well established that the respiratory system plays a crucial role in the production of voice.
The driving pressure arising from the lungs overcomes the resistance of the vocal folds and pulls
them apart from each other and this sets off the vibratory process (Mathieson, 2006). The
pressures generated by the lung-thorax unit are also involved in loudness and pitch adjustments.
There are two ways of increasing pitch and loudness: 1) with fine-tuning of the tension, stiffness,
length and mass (thickness) of the vocal folds (Zhang, 2016b) and 2) by altering the driving
pressure generated by the lung-thorax unit (Zhang, 2016b). By increasing the air pressure coming
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from the lungs and adjusting the tension of the vocal folds, subglottal pressure is enhanced and
this leads to a larger amplitude of vibration and a faster and stronger return to the initial position
by the tensed vocal folds (Mathieson, 2006). This also has the effect of augmenting the pitch of
the sound because of the increased velocity of vibration. The respiratory muscles also play a role
in airflow management by counteracting the recoil pressures of the lungs to slow the expiratory
phase of speech, thereby allowing for the production of longer utterances and constant pressure.

While the normal physiology of respiration and phonation and the relationship between the two
have been extensively described in the literature, there is a scarcity of data pertaining to the
impact of a suboptimal respiratory system on voice production. Impaired respiratory function can
be induced by compromised pulmonary function because of weak respiratory muscles or
conditions such as asthma or COPD. An impaired respiratory function can influence spirometry
outcomes, but the extent to which it may influence voice outcomes remains unclear. The
respiratory and laryngeal systems are coupled and impairment in one of them may lead to
dysfunction of the other one (Zhang, 2016c). If the respiratory system is not strong enough to
generate sufficient air pressure, one has to rely mainly on laryngeal adjustments to build up
substantial subglottic pressure and to increase loudness by augmenting the duration of contact
and the medial compression of the vocal folds. Similarly, if the respiratory muscles are not strong
enough to control the expiratory airflow during speech, the airflow conservation role relies solely
on the vocal folds acting as a valve (Zhang, 2016c). Vaca et al. (Vaca, Mora, & Cobeta, 2015) found
that elderly patients presenting with a laryngeal deficit (glottal gap) in addition to respiratory
deficits (vital capacity or peak expiratory airflow below 80% of the reference value) had shorter
phonation times, increased jitter, worse auditory perceptual ratings and higher Voice Handicap
Index scores than the groups with deficits in only the laryngeal or respiratory system. The
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impaired respiratory system could not compensate for the poor laryngeal valving function,
thereby explaining the inferior voice outcomes in this subgroup.

Intervention
Exercises to increase breath support are commonly used by SLPs with a variety of voice patients,
although common practices pertaining to breathing exercises appear to differ between clinics and
clinicians (J. L. Gartner-Schmidt, Roth, Zullo, & Rosen, 2013; Sellars, Carding, Deary, MacKenzie, &
Wilson, 2006). One possible reason for this variability is the paucity of evidence related to
breathing exercises in the voice literature (Desjardins & Bonilha, 2019), despite the well
documented relationship between the respiratory and laryngeal systems. Exercises
recommended in certain voice therapy books include but are not limited to: diaphragmatic
breathing, increasing extent of thoracic expansion, increasing period of rib elevation, and
increasing period of expiratory airflow on phonemes /s, z, a, æ, i/(Boone, 2010; Mathieson, 2006).
These exercises have seldom been tested individually in clinical trials with voice patients and their
specific effects on respiratory and voice outcomes remains unclear (Desjardins & Bonilha, 2019).
It is likely that most of these exercises are not intensive enough to induce changes in the
respiratory system and impact voice parameters.
A more intensive intervention, respiratory muscle strength training (RMST) with a pressure
threshold loading device, has received more attention in the literature. This type of intervention
can be used to strengthen either the inspiratory muscles, the expiratory muscles, or both. The
effect of expiratory muscle strength training (EMST) has been studied mostly on patients with
important respiratory muscle weakness, as it is the case in patients with multiple sclerosis and
Parkinson’s disease (Chiara, Martin, & Sapienza, 2007; Silverman et al., 2006). Eight studies have
assessed the effect of EMST on various populations, and improvements were found for at least
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some participants in sound pressure level (SPL), subglottal pressure (Psub), words per minute,
utterance length, coefficient of variation of fundamental frequency (F0), Voice Handicap Index 10
(VHI-10) scores, pitch range, and /s,z/ durations (Cerny, Panzarella, & Stathopoulos, 1997; Chiara
et al., 2007; Darling-White & Huber, 2017; Johansson, 2012; Pereira, 2015; Ray, 2018; Tsai et al.,
2016). Moreover, improved self-assessment scores, subglottal pressure at loud intensity, dynamic
range, and vocal fold edges were found when combining voice therapy and EMST in professional
voice users with laryngeal irritation, edema, and/or benign vocal fold lesions (Wingate, Brown,
Shrivastav, Davenport, & Sapienza, 2007). Regarding inspiratory muscle strength training (IMST),
most studies in the literature are case series targeting patients with upper airway obstruction
diseases such as paradoxical vocal fold movement disorder, recurrent laryngeal papilloma and
bilateral abductor vocal fold paralysis (S. E. Baker, Sapienza, & Collins, 2003; Mathers-Schmidt &
Brilla, 2005; C. M. Sapienza, Brown, Martin, & Davenport, 1999). Only two studies have assessed
the effect of IMST with regards to vocal quality; however, one of them did not assess the
significance of pre-post intervention changes (Mueller, 2013). The other study, a single-subject
cross-over trial, did not find improvement during the IMST phase in the two voice outcomes
measured, SPL and pitch range (Ray, 2018).
Surprisingly, no studies on respiratory muscle training has been conducted on patients with an
age-related voice disorder, in whom both the laryngeal and respiratory systems undergo
significant changes affecting voice production.
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Voice Disorders in the Elderly
Prevalence
Elderly people are at risk of experiencing reduced laryngeal and respiratory efficiency because of
the changes that occur in the body with aging and that affect the systems involved in phonation.
They represent an ideal subgroup of patients to study the impact of the respiratory system on
voice outcomes because of the variability in the aging process and comorbid conditions impacting
the laryngeal and respiratory systems. As a consequence, individuals are likely to present with
various laryngeal and respiratory profiles, making it possible to assess their relative contribution
on the resulting voice disorder.
The prevalence of dysphonia increases with age and peaks in individuals of 70 years and older
(Cohen et al., 2012b). In a study using data from 54,600,465 individuals enrolled in a national
claims database, people over 60 years old represented 27.8% of the total dysphonic population
(Cohen et al., 2012b), corresponding to 149,270 individuals over a period of five years. The
number of elderly people actually suffering from dysphonia is thought to be much higher. In fact,
one out of five individuals over 65 years old experience difficulties with their voice (Golub, Chen,
Otto, Hapner, & Johns, 2006), but less than a quarter of them consult a physician or a voice
specialist (Turley & Cohen, 2009).
In a retrospective chart review of geriatric voice referrals at the Emory Voice Center, Davids et al.
(Davids, Klein, & Johns, 2012) found that the most common diagnostic was vocal fold atrophy,
accounting for a quarter of the voice diagnoses in this patient group. Another study using ICD-9CM codes revealed that the most common laryngeal/voice disorder among older patients was
"nonspecific hoarseness" (ICD-9-CM codes: 784.49, 784.42, 784.40, 784.41). Nonspecific causes
of dysphonia were observed to increase in a relatively linear fashion with age, representing
49.24% of the diagnoses in the 65-69 bracket and 57.14% of the diagnoses in the >95 years old
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bracket (Roy, Kim, Courey, & Cohen, 2015). The authors suggested that these nonspecific codes
were likely to be used in cases of presbyphonia since there exist no code for this condition (Roy
et al., 2015). Presbyphonia is a voice disorder that arises from age-related changes in the
laryngeal, respiratory and neurological systems. It is often diagnosed based on the presence of
atrophied and bowed vocal folds occasioning a glottal gap and prominent vocal processes.
Compensatory involvement of the false vocal folds to aide in glottal closure may also be observed
during videostroboscopy assessment. Patients with presbyphonia often complain of vocal fatigue,
hoarseness, breathiness and reduced loudness. Although the etiology of presbyphonia stems
from normal aging processes, elderly patients often present with comorbid conditions that can
further impact voice production. Woo et al. found that more than 50% of their sample of 151
older voice patients had at least one systemic condition, the most common being pulmonary
diseases (Woo, Casper, Colton, & Brewer, 1992). Moreover, Gregory et al. (Gregory, Chandran,
Lurie, & Sataloff, 2012) found that 91% of their sample of 159 geriatric voice patients presented
with laryngopharyngeal reflux (LPR).

Impacts of Presbyphonia
In elderly individuals, for whom health-related quality of life may already be declining due to
various chronic conditions, the presence of a voice disorder further participates in the decline
(Davids et al., 2012). Voice-related quality of life (V-RQOL) was measured in a sample of 107
individuals living in a senior independent living community in Atlanta, Georgia. Of those, more
than 50% presented V-RQOL scores indicative of an altered qualify of life due to voice problems
(Golub et al., 2006). Voice disorders in the elderly population can lead to social isolation and
psychological repercussions such as increased anxiety and depression and reduced self-esteem
(Davids et al., 2012; Gregory et al., 2012). Voice difficulties may prevent individuals from
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communicating their needs to caregivers and induce frustration for the patient, caregiver and
other communication partners (Davids et al., 2012). In the context where the individual and their
partner are often experiencing hearing loss, the presence of a voice disorder may further hinder
communication and negatively impact quality of life of both spouses (Cohen & Turley, 2009).

Why is it important to find a better intervention paradigm?
The number of patients seeking treatment for vocal fold atrophy has been gradually increasing in
the past years and this trend is expected to be maintained in the future (Takano et al., 2010). The
first reason for this upsurge is the rapid expansion of the elderly population in the United States.
Individuals of 65 years and older actually represent 15.6% of the total national population and
this percentage is anticipated to reach 20.6% in 2030, based on the predictions of the United
States Census Bureau.
The second factor is the increase in labor force participation rate of elderly individuals. For the
population 65 years and older, this rate has raised from 12.1% in 1990 to 16.1% in 2010, with a
more significant increase for women (Kromer & Howard, 2013). Different reasons can explain the
choice to continue working past the traditional working age. Motives may include financial
responsibilities and the desire and ability to remain active longer due to enhanced medical
technology and a resulting extended lifespan (Gregory et al., 2012). In a 7-year longitudinal study,
Takano et al. (Takano et al., 2010) found that 33% of patients diagnosed with vocal fold atrophy
were still active in the workforce and, therefore, were likely to rely on their voice for professional
matters.
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Problem Statement
Intervention: What We Know and What We Don’t Know

The growth in the elderly population combined with their increased labor force participation rate
is expected to increase the number of geriatric patients complaining of voice difficulties (Davids
et al., 2012). This is likely to burden the health care system and contribute to the "2030 challenge"
of ensuring necessary resources and effective services for the rising elderly population (Roy et al.,
2015). Surgery is one treatment option for vocal fold atrophy, but is not always recommended for
older people who are more at risk for complications. Moreover, a health care cost analysis of voice
and laryngeal disorder management revealed that surgery represents 34.37% of the total
procedure claims (Cohen et al., 2012a). In addition to being costly, surgery for vocal fold atrophy
often yields suboptimal outcomes with a success rate that has been evaluated at 56% in elderly
patients undergoing injection laryngoplasty, based on their voice handicap self-rated score (J.
Gartner-Schmidt & Rosen, 2011). On the other hand, there is a lack of evidence supporting voice
therapy for presbyphonia. Although some voice exercise programs present with growing evidence
stemming from well-designed clinical trials, such as Vocal Function Exercises and PhonationResistance Training Exercise (PhoRTE; adapted from the Lee Silverman Voice Treatment approach)
(Ziegler, 2014), discrepancies in the results, the lack of improvement in some of the outcome
measures and the scarcity of direct assessment of the larynx through videostroboscopy warrant
further studies to determine the most effective approach for presbyphonia. Because of their
deficits in both the laryngeal and respiratory systems, it is our hypothesis that the most effective
approach for these patients would be a combination of voice therapy and respiratory training.
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Impairment-Specific Interventions
Even when belonging to the same voice disorder category, patients present with various profiles
of laryngeal and respiratory mechanisms impairments. Consequently, there exist no specific
treatment approach that would yield optimal results for all patients and this explains why many
SLPs often combine techniques from different approaches to create a "hybrid therapy" (J. L.
Gartner-Schmidt et al., 2013). This individualized treatment plan should be based on specific
assessments and justified by evidence proving that the chosen technique will benefit the patient.
In the literature, most studies have focused on testing intervention approaches for broad
categories of voice disorders (J. L. Gartner-Schmidt et al., 2013) (e.g. LSVT for Parkinson’s disease
patients; resonant voice for muscle tension dysphonia patients, etc.) with little attention given to
inter-individual variability. It is likely that the effectiveness of voice therapy would be enhanced if
the treatment plan was tailored specifically for the patient’s profile (Vaca et al., 2015).
Following this reasoning, it is essential to identify which patients would benefit the most from a
respiratory training intervention. It is possible that patients with a well-preserved respiratory
system might gain more from therapy time allocated exclusively to voice exercises, while patients
with impairments in both systems may benefit from a combination of voice and respiratory
exercises. This is particularly relevant to patients with presbyphonia because of the important
variability in the aging process, resulting in various pathogenic profiles. In fact, Vaca et al. (Vaca
et al., 2015) categorized 105 elderly participants (mean age of 75 years old) based on their deficits,
which resulted into four laryngeal/respiratory profiles: glottal deficits only (21% of the
participants), altered spirometry and no glottal gap (37%), altered spirometry and glottal gap
(24%), and no deficit (18%).
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To be even more specific, initial assessments should provide sufficient information to determine
if a patient needing respiratory training should undergo EMST, IMST, or both. Most studies aiming
at improving voice outcomes have focused on EMST and have generated conflicting results. Roy
et al. (Roy et al., 2003) found that EMST resulted in increased maximum expiratory pressure (MEP)
in teachers with voice disorders, but this increase was not translated into improved voice
outcomes (self-perceived voice handicap or voice severity ratings). It is likely that these
participants didn’t have respiratory compromise and that voice improvements were not observed
because of a ceiling effect of the treatment outcomes. It is also possible that some of these
participants had weaknesses in their inspiratory muscles and were compensating with their larynx
to lengthen the expiratory phase of their speech and subsequently their utterance length. In such
cases, strengthening the expiratory muscles would not eradicate the hyperfunctional
compensatory mechanism and IMST would be more appropriate. A similar dilemma applies to
patients with presbyphonia: based on the patient’s individual profile and functional deficits (e.g.
decreased loudness, decreased utterance length, sensation of dyspnea during speech, etc.), what
respiratory intervention would be the most likely to generate functional improvements? This
question has not been answered to date in the voice literature.
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Research Questions
The voids in the literature pertaining to the impact of respiratory impairments and respiratory
training on voice outcomes, combined with the absence of an optimal treatment for presbyphonia
and a growing population of treatment-seeking patients presenting with vocal fold atrophy justify
the need for a study examining the effects of respiratory training on presbyphonic patients.

Three research questions arise:
1. Which outcome measures present with the strongest intra-subject reliability in a sample
of patients with presbyphonia?
2. What is the respiratory function of patients with presbyphonia and how is it correlated
with voice measures in this population?
3. a) What is the effect of RMST on respiratory and voice outcomes in patients with
presbyphonia and b) how do baseline measures of respiratory function influence the
response to the intervention?
To answer these questions, a clinical trial will be conducted on three groups of participants with
presbyphonia: one group will receive voice therapy and IMST, one group will receive voice therapy
and EMST, and one group will receive voice therapy only. The details of the methodology are
described in Chapter 3 of this document.

The next chapter presents a literature review pertaining to the following aspects: normal voice
anatomy and physiology; changes to voice anatomy and physiology occurring with aging; current
intervention approaches for presbyphonia; suggested interventions (IMST and EMST); and
outcome measures relevant to voice therapy research for patients with presbyphonia.

Chapter 2: Review of the Literature

Section 1: Normal Anatomy and Physiology of Voice Production
Voice production is the result of the coordinated activity of the respiratory, laryngeal, and
neurological systems (Larson, 2017). These represent the three main subsystems involved in voice
production. Their anatomy and physiology are described in the following section.

Respiratory System
Lung-Thorax Unit
The lungs are located in the rib cage, which consists of 12 pairs of ribs each made of a bony part
and a costal cartilage (J. Thomas, Fall 2016). The first pair is immobile and is attached to the
manubrium (superior part of the sternum) anteriorly and to the vertebrae posteriorly. The
following six pairs (the true ribs) are mobile; they also attach to the vertebrae posteriorly but
anteriorly they are connected to the body of the sternum via synovial (gliding) joints that allow
for anteroposterior expansion of the thorax (J. Thomas, Fall 2016). The eighth to twelfth pairs are
the false ribs and are not directly connected to the sternum; the first three pairs are attached to
adjacent ribs via cartilage and fibrous tissue and when they move they widen the thorax. The two
last pairs, the floating ribs, are connected to the abdominal wall via fascia and therefore they
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follow abdominal movements (Mathieson, 2006; Netter, 2014). The lungs are protected by the
thorax and they are connected to the ribs by the pleura, which consists of two layers of tissue:
the visceral pleura tightly covers the lungs and the parietal pleura is attached to the inner surface
of the thorax and superior part of the diaphragm (Netter, 2014). Between the two membranes is
a space called pleural cavity, which contains fluid that ensures lubrication and reduces friction
during breathing (J. T. Hansen, 2014; Netter, 2014). The pressure of the pleural fluid is always
negative, and this ensures the visceral and parietal pleurae to stay closely together, keeping the
lungs from collapsing. The result is an elastic system called lung-thorax unit, with a resting point
corresponding to a lung volume at which the forces of the lungs and the thorax balance each other
(Mada, n.d.). The transpulmonary pressure (the difference between the alveolar pressure in the
lungs and the pleural pressure) dictates the flow of air in and out of the lungs, allowing the lungs
to follow the movements of the rib cage (Mada, n.d.).

Inspiration
Inspiration occurs when the pressure inside the lung is negative, and exhalation occurs when the
pressure inside the lungs is positive. The negative pressure is created by activating the inspiratory
muscles, which leads to an increase in the thorax dimensions and consequently in lung volume.
The volume change decreases the pressure inside the lungs, which becomes negative (because
lower than the atmospheric pressure) and this allows for airflow to enter (Hall & Hall, 2020).
Inhalation is therefore considered an active phenomenon, because muscular activity is generated
to overcome the resistance of the lung-thorax unit which is being pulled away from its resting
point. The primary inspiratory muscle is the diaphragm, responsible for approximately 2/3 of the
vital capacity (VC) (Williams, Bannister, Berry, & al., 1995). It has the shape of a dome and its fibers
originate at the xiphoid process (lower part of the sternum), the costal cartilages of the six lower
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rib pairs, and the vertebrae L1-L3 (J. T. Hansen, 2014). They insert at the central tendon and pull
on each other when the diaphragm contracts, which flattens it and moves it slightly forward (J. T.
Hansen, 2014). This has the effect of increasing the vertical dimension of the thorax and
expanding the lungs (Mathieson, 2006). The second most important muscles for inspiration are
the external intercostal muscles, located between the ribs and attached to their lower borders.
Because they insert on the upper border of the rib below their origin, the external intercostal
muscle fibers have the effect of elevating the rib cage when they contract during inspiration
(Netter, 2014), and this increases the anteroposterior and oblique dimensions of the thorax
(Mathieson, 2006). Other accessory muscles participate in the inhalation process to support the
activity of the diaphragm and the external intercostal muscles (Table 1). In speech breathing, the
inspirations are quicker than in rest breathing, to avoid long interruptions between utterances.
For this reason, inhalations occur through the mouth instead of through the narrow nostril
openings (Mathieson, 2006).

Table 1. Accessory muscles of inspiration

Muscle

Action

Sternocleidomatoid

-Supports the head
-Raises the sternum and the clavicles during the
inspiration
-Elevates the 1st rib
-Bends neck
-Elevates 1st rib,
-Bends neck
-Elevates 2nd rib,
-Bends neck
-Stabilizes the spine and helps elevates the rib cage
-Elevates ribs

Scalene (anterior)
Scalene (middle)
Scalene (posterior)

Levatores costarum
Serratus posterior
superior
(Mathieson, 2006; Netter, 2014; J. Thomas, Fall 2016)
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A maximal inspiration raises the lung volume to the Total Lung Capacity (TLC), and this upper limit
is reached when the recoil force of the lung-thorax unit becomes so strong that it cannot be
further overcome by the muscular strength of the inspiratory muscles. This is explained by the
fact that, the further an elastic system is brought from its resting point, the stronger the pressure
exerted to go back to that point. This force is called relaxation pressure and it is null at the resting
end expiratory level (EEL)-or resting lung volume, when the elastic recoil of the lungs is perfectly
counterbalanced by the elastic recoil of the chest wall at the end of a passive expiration, which
corresponds to approximately 40% of the VC (Hixon & Hoit, 2005). Below this point, the system
will generate a negative pressure to trigger inspiration and return to its resting EEL at 40% of VC.

Expiration
Expiration is essential to phonation because it generates the airflow and pressure necessary to
trigger vocal fold vibration and to generate adequate loudness and pitch. The pressure generated
is a function of the trade-off between the natural pressures created by the volumes of air in the
lungs and the muscle activity. For speech at a comfortable conversation level, lung volumes
ranging from 35% to 60% of VC are required, which is more than during quiet breathing (Hixon,
1987). At approximately 60% of VC, the alveolar pressure generated by the lung-thorax unit recoil
forces is 8 cmH20, which is an ideal pressure for speech (Hixon & Hoit, 2005). An inhalation
reaching a higher percentage of the VC will generate stronger positive relaxation pressures and
will therefore create a subglottal pressure that is too elevated for conversational speech, leading
to an increased intensity. In order to counterbalance the relaxation pressures and to reduce the
subglottal pressure, a negative pressure has to be generated by voluntary muscular activity.
Inspiratory muscles are therefore activated to help maintain an adequate and constant subglottal
pressure throughout speech (Hixon & Hoit, 2005). Since the pulmonary volume is constantly
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changing during expiration, the muscles are continually working to maintain the subglottal
pressure constant or to adjust it depending on the demand. The end of a passive exhalation, when
breathing at rest, occurs when the lung-thorax unit reaches equilibrium, which is when the elastic
recoil of the lungs is perfectly counterbalanced by the elastic recoil of the chest wall at resting
EEL. However, during speech, the expiration phase might continue beyond this point and into the
expiratory reserve volume (ERV) in order to avoid interruptions in a middle of a sentence. Once
below the resting EEL, the expiratory muscles have to generate a positive pressure to
counterbalance the relaxation pressures that have become negative (Hixon & Hoit, 2005).
The primary expiratory muscles are the internal intercostal muscles. They lie deep to the external
intercostal muscles, originate on the lower border of the ribs and insert on the costal cartilage of
the ribs above their origin. This configuration allow them to close the intercostal spaces during
forced exhalation (J. Thomas, Fall 2016). These muscles also fix the spaces between the ribs during
inspiration and exhalation, preventing them from pushing out or drawing in (J. T. Hansen, 2014).
Another important muscle group that helps to fix the intercostal spaces is the innermost
intercostal muscles. They lie deep to the internal intercostal muscles and their fibers run in the
same direction. They also originate from the lower border of the ribs, but they insert on the upper
border of the ribs below their origin (Netter, 2014). The abdominal muscles play an important role
in forced exhalation, but they are also active during the normal expiratory phase of conversational
speech above resting EEL, with EMG amplitudes exceeding tidal breathing resting amplitudes
(Hoit, Plassman, Lansing, & Hixon, 1988). The abdomen activation during speech at a
conversational loudness level provides an opposing force against which the rib cage can rely to
induce volume compressions and effectively transmit expiratory pressures to the upper
respiratory tract, therefore improving its mechanical efficiency during voice production (Hoit et
al., 1988; Hixon & Hoit, 2005). In their study using EMG, Hoit and colleagues (1988) found that
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activation of the lateral abdominal muscles was higher than in the middle abdominal muscles
during conversation speech, which led them to hypothesize that the external oblique abdominis,
internal oblique abdominis, and/or transverse abdominis muscles were active whereas the rectus
abdominis muscles, located more towards the midline of the abdomen, was not. Moreover, they
noted that the lower lateral sections were more active than the upper lateral section, a
phenomenon that is also present during resting tidal breathing and that is explained by a response
to the pressure of the abdominal content when in standing position (Hoit et al., 1988). As a matter
of fact, the location and extent of abdominal muscle activity were shown to be influenced by
factors such as body position, but also lung volume and task. For example, when higher expiratory
muscular pressure was needed, such as when speaking at low lung volumes, middle EMG activity
in addition to the lateral EMG activity were observed, suggesting an activity of all abdominal
muscle groups (Hoit et al., 1988). Other accessory expiratory muscles include the transverse
thoracis, the serratus posterior inferior, and the subcostal muscles (Mathieson, 2006; Netter,
2014; J. Thomas, Fall 2016). These muscles are mostly active during forced exhalation (Mathieson,
2006; Netter, 2014; J. Thomas, Fall 2016).

Co-activation of Inspiratory and Expiratory Muscles
Even though they have been categorized as "inspiratory muscles" and "expiratory muscles", these
two groups of muscles each play a role during both the inspiratory and expiratory phases of
speech production. As it was mentioned in the previous section, the inspiratory muscles
(diaphragm and external intercostal muscles) are active during the expiratory phase of speech to
counterbalance the relaxation pressures and maintain a constant subglottal pressure. This is
accompanied by a co-contraction of the lateral abdominal wall which helps control the pressure
that is directed to the upper respiratory tract (Hixon & Hoit, 2005; McFarland, 2008). This co-
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activation results in more rapid adjustments of the subglottal pressure and fundamental
frequency, while avoiding undesirable pressure changes that could occur during speech
(McFarland, 2008). This co-activation of inspiratory and expiratory muscles is also present during
the inspiration phase of speech breathing. During speech, the inspirations have to be quick and
efficient in order to avoid unnecessary interruptions. The activation of the abdominal muscles in
synchrony with the diaphragm and external intercostal muscles moves the abdominal wall
inwards and induces more effective expansion of the rib cage by lengthening the diaphragm
muscle fibers and increasing its force (Hixon & Hoit, 2005; McFarland, 2008).

Laryngeal System
The laryngeal and respiratory systems are closely related and a healthy phonation relies on the
good coordination between the two. The vocal folds in adduction serve as a valve to modulate
the expiratory airflow that is generated by the lower respiratory system (Mathieson, 2006). The
vocal folds are located in the larynx, which is a structure made of cartilages, ligaments, muscles,
and membranes that extends from the base of the tongue to the trachea (from C3 to C6)
(Mathieson, 2006; J. Thomas, Fall 2016). It lies anterior to the esophagus and is suspended in the
neck by the hyoid bone. The larynx is part of the upper respiratory system, along with the
oropharynx, the mouth, and the nasal cavity (Mathieson, 2006). The anatomy and physiology of
the vocal folds as well as the function of the different muscles of the larynx will be described in
the following sections as the phonation process is dissected.

Onset of Vibration
Even before the onset of phonation, a close relationship between the larynx and the lower
respiratory system is witnessed: at the moment of inspiration, the vocal folds abduct rapidly
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during what has been named the "pre-phonatory inspiratory phase" (Wyke, 1983; cited in
Mathieson, 2006). There is also a lowering of the larynx simultaneously with the descent of the
diaphgragm, phenomenon known as the tracheal pull (Herbst, 2017). Abduction of the vocal folds
results from the contraction of the posterior cricoarytenoid (PCA) muscles, the only abductors of
the vocal folds. The PCA muscles originate on the posterior surface of the cricoid cartilage and
their fibers insert on the muscular process of the arytenoids (Netter, 2014). Their contraction pulls
the arytenoids away from each other and rotates them in a way that pulls the vocal processes
outwards, therefore abducting the vocal folds (Mathieson, 2006). After this short abduction
phase, the arytenoids are brought together by the interarytenoid muscles (IA) (composed of a
single transverse arytenoid muscle and a pair of oblique arytenoid muscles). This has for effect of
bringing the vocal folds closer to the midline before they are adducted by the lateral
cricoarytenoid (LCA) muscles (Mathieson, 2006). The LCA muscles originate on the lateralsuperior edges of the cricoid cartilage and insert on the muscular processes of the arytenoid
cartilages, which allows them to rotate the arytenoids anteriorly and to adduct the posterior
portion of the vocal folds (Boone, 2010; Mathieson, 2006; Zhang, 2016b). To achieve a complete
closure of the glottis, activation of the thyroarytenoid (TA) muscles is required. The TA muscles
constitute the body of the vocal folds. Their fibers originate from the interior surface of the thyroid
cartilage and insert on the anterolateral surface of the arytenoid cartilages (Yin & Zhang, 2014).
Their contraction induces a bulging of the muscle as well as a rotation on the horizontal plane
towards the midline, which allows for adduction of the anterior portion of the vocal folds (Chhetri,
Neubauer, & Berry, 2012; Yin & Zhang, 2014) Once the vocal folds are adducted, subglottal
pressure (generated by the alveolar pressure during the expiration phase of respiration) increases
until it reaches the phonation threshold pressure (Farley & Barlow, 1994; cited in Mathieson,
2006). The phonation threshold pressure corresponds to the pressure necessary to overcome the
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intertie of the vocal folds and put them into movement. The vocal folds’ resistance to the
subglottal pressure depends on their size, viscoelastic properties, and tension (Titze, 1994; cited
in Mathieson, 2006).

Self-Sustained Phonation
Once the subglottal pressure reaches the phonation threshold pressure, the vocal folds start to
separate from their inferior border up to their superior border. Once they are peeled apart, a
negative intraglottal pressure is induced in the glottis, created by the Bernouilli effect. The
Bernouilli effect occurs when air moves from a large space to another through a constricted space
(in this case the glottis), which leads to a high velocity and a low pressure at the site of constriction
(Maran, 1988; cited in Mathieson, 2006). The negative pressure creates a suction on the vocal
folds, which are pulled back towards the midline. This recoil to the midline is made possible due
to the elastic properties of the vocal folds (Berke & Gerratt, 1993). This theory explains part of the
vocal fold vibration but not its entirety. Newer models of phonation biomechanics suggest that
the main condition necessary to transfer the energy from airflow to the vocal folds and induce
vibration is the vertical phase difference engendered when the lower lips of the vocal folds shift
laterally before the air reaches the upper lips and pulls them away from each other (Krausert et
al., 2011). This phase difference creates a pressure asymmetry between the opening and closing
phases of the vibration, which is necessary to achieve an energy transfer from the airflow to the
vocal folds (Zhang, 2016b). The pressure changes in the subglottal and supraglottal vocal tracts,
caused by the opening and closing of the vocal folds and resulting airflow variations, further
participate in the push and pull action of the vocal folds during self-sustained vibration (Titze,
2001).
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Vocal Folds
During the opening phase of the vibratory cycle, the subglottal pressure deforms the vocal folds’
superficial layers, which results in the opening of the vocal folds from the lower lip to the upper
lip (Krausert et al., 2011). In other words, it is the structural properties of the vocal folds, which
have been described in the body-cover model, that allow the mucosal wave to take form and to
spread vertically and medially, resulting in the transformation of air into sound (Krausert et al.,
2011). The vocal fold is composed of the TA muscle and a mucous membrane. This mucous
membrane is divided into the epithelium (covered by a thin layer of mucus) and the lamina
propria, separated by the basement membrane. The epithelium acts as a physical barrier to
protect the lamina propria against injuries. It is composed of five to ten layers of stratified
squamous cells, which are divided in the most basal layers and move to the suprabasal layers to
replace old cells and ensure homeostasis (Levendoski, Leydon, & Thibeault, 2014). The epithelial
cells are separated by different types of junctions, which play three important roles: they seal
together adjacent cells, they stabilize the epithelium during vibration, and they provide pathways
for communication between cells (Levendoski et al., 2014). The mucus barrier that lies on the
epithelium also serves a protective function, as well as a lubricative one. Moreover, the viscosity
of the mucus has an impact on the vocal fold vibration, therefore changes in its quantity and
proprieties may affect phonation (Levendoski et al., 2014). The lamina propria is made of
connective tissue and is divided into three sections: 1) the superficial layer (also called Reinke’s
space), 2) the intermediate layer, and 3) the deep layer (Mathieson, 2006). In the body-cover
model, the structurally different parts of the vocal folds are reorganized into their functional roles:
the epithelium and Reinke’s space form the cover, the intermediate and deep layers of the lamina
propria form the vocal ligament, and the TA muscle constitutes the body (Mathieson, 2006). The
cover is loose and vibrates the most during phonation (Boone, 2010; Mathieson, 2006); deeper
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to the cover is the vocal ligament which is stiffer and provides a support to the vocal folds, and
underneath it is the muscle (Boone, 2010).
The different roles played by the mucous layers are explained by their composition, more
specifically by the components of their extracellular matrix (ECM). The ECM supports and
surrounds the cells and is composed of different molecules that are produced by fibroblast cells
(Thibeault, 2005) and released through exocytosis, resulting in fibers and ground substances
(Thibeault, 2005). In terms of fibers, the most omnipresent component of the ECM is collagen,
present throughout the three layers of the lamina propria, but more significantly in the deep layer
(Hammond, Gray, & Butler, 2000), which explains the increased stiffness of the vocal ligament
compared with the cover of the vocal fold. Collagen represents approximately 43% of the total
proteins in the lamina propria (Ishikawa & Thibeault, 2010) and is synthesized from procollagen,
its precursor produced by the fibroblasts (J. K. Hansen & Thibeault, 2006; Ishikawa & Thibeault,
2010). A specific type of collagen fibers, reticular fibers, are also present in the ECM around the
cells and are characterized by their small diameters (Ishikawa & Thibeault, 2010). The last type of
fibers are elastic fibers, which are made out of elastin protein and are present in the superficial
and deep layers of the vocal folds (J. K. Hansen & Thibeault, 2006). Elastin represents 8.5% of the
total proteins in the lamina propria and provides the elasticity to the tissues (Ishikawa & Thibeault,
2010). Ground substances of the ECM are made of large interstitial molecules named
glycosaminoglycans (GAGs), of which the main role is to preserve the viscoelastic characteristics
of the tissue (Ishikawa & Thibeault, 2010). GAGs attract water molecules and therefore allow the
tissue to remain hydrated. They also regulate the extracellular environment necessary for healthy
cellular activity. Increases or decreases in the ground substance materials have the potential to
significantly affect the viscosity of the tissue (Ishikawa & Thibeault, 2010). Interstitial molecules
include fibronectin, decorin, fibromodulin, cadherin, syndecan-1, syndecan-4, and hyaluronic acid
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(HA) (J. K. Hansen & Thibeault, 2006). HA has a substantial impact on the lamina propria’s stiffness
and viscosity. The stiffness of a tissue corresponds to its elastic restoring force in response to
deformation (Friedrich et al., 2013; Zhang, 2016b) and is different from tension or stress, which
correspond to the actual mechanic condition of the tissue (Zhang, 2016b). Viscosity is the
resistance to deformation (Zhang, 2016b). Studies have shown that a reduction in HA leads to a
decreased stiffness and an increased viscosity of the vocal folds and thus in suboptimal conditions
for vibration including a higher phonation threshold pressure (Friedrich et al., 2013; J. K. Hansen
& Thibeault, 2006). HA is also involved in scar formation and wound healing by playing a role in
cell migration and proliferation (Bless & Welham, 2010; Branski, Verdolini, Sandulache, Rosen, &
Hebda, 2006; Friedrich et al., 2013; J. K. Hansen & Thibeault, 2006). Its half-life is very short (0.5
to 4 days) and its concentration is higher in men’s vocal folds (J. K. Hansen & Thibeault, 2006).
Although no laryngeal glands are found on the free edges of the vocal fold, they are numerous in
the submucosa of the laryngeal saccule, which is the extension of the vestibule (space between
the true and the false vocal folds). The thyroepiglottic muscle (part of the TA muscle) lies next to
the saccule and separates it from the thyroid cartilage. When the muscle contracts, secretions
from the laryngeal glands are being released on the vocal folds to protect them from dryness and
friction during vibration. This lubrication is essential for a healthy phonation (Mathieson, 2006).

Laryngeal Adjustments
Once vibration is initiated and maintained due to adequate viscoelastic properties of the vocal
folds, different laryngeal adjustments can be performed to modify the sound, more specifically to
adjust the fundamental frequency and loudness.
The frequency of the sound is determined by the time taken by the vocal folds to complete one
vibratory cycle (its period) (Mathieson, 2006), and can be modified by changes in vocal fold
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posturing and properties. More specifically, it can be increased by shortening length, increasing
tension and stiffness, and reducing thickness (vibrating mass) of the vocal folds (Zhang, 2016b).
The length of the vocal folds can be decreased by contracting the TA muscle and can be increased
by activating the cricothyroid (CT) muscle (Zhang, 2016b). The CT muscle is made of two different
bundles, a vertical one (pars recta) and an oblique one (pars oblique), which both originate from
the anterolateral part of the cricoid cartilage and insert on the inferior border and inferior horn
of the thyroid cartilage (Netter, 2014). Activation of both bundles results in an elongation of the
vocal folds by bringing the two cartilages closer together through an anterior rotation about the
cricothyroid joint and by inducing a slight backward movement of the cricoid cartilage and
forward movement of the thyroid cartilage (Zhang, 2016b). Although contraction of the CT
increases the length of the vocal folds, it also increases their tension and stiffness. In the case of
the CT activation, the effect of stiffness and tension dominates the effect of the lengthening and
thus results in an increased F0 (Zhang, 2016b). Length and tension are often associated, which
could explain why an increased length of the vocal folds is often associated with an increased F0.
Activation of the LCA, IA, and PCA muscles simultaneously to the CT contraction help stabilize the
arytenoid cartilages and inhibits them from moving forward, further elongating and tensing the
vocal folds for production of very high pitches (Zhang, 2016b). Elongation of the vocal folds
through CT activation also decreases the thickness of the vibrating mass, which also has for effect
of increasing F0 (Zhang, 2016b). On the contrary, activation of the TA muscle increases the
thickness of the vocal folds. Although an increased thickness in theory reduces F0, it also enhances
the medial compression force, which leads to longer durations of vocal fold contact during
vibration, which increases the stiffness and consequently F0. The role of the TA muscle in
frequency modulation is thus very complex, as its activation can either increase or decrease F0,
depending on the activation of the other laryngeal muscles. Moreover, TA contraction increases
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the tension of the body of the vocal folds but it decreases the tension in the cover layers by
shortening the muscle but not the mucous membrane (Zhang, 2016b).
Different strategies can be used to increase amplitude of vocal fold vibration, and therefore sound
intensity. At the level of the larynx, increasing duration of contact and medial compression of the
vocal folds will have the effect of boosting the harmonics close to the first formant and therefore
will increase intensity (Zhang, 2016b). This enhanced approximation of the vocal folds can be done
by augmenting the thickness/contact surface and medial compression of the vocal folds by
contracting the TA (Zhang, 2016b). However, increases in intensity usually don’t merely rely on
laryngeal adjustments, but are the result of simultaneous increases in subglottal pressure and
laryngeal resistance (Stathopoulos & Sapienza, 1993), as explained in the following section.

Co-activation of Respiratory and Laryngeal Systems
The main strategy to enhance the intensity of the voice is to increase the subglottal pressure,
which induces a larger amplitude of vibration (Zhang, 2016b). This also has the effect of
augmenting the pitch of the sound because of the relationship between frequency and tension of
the vocal folds, as described above. At high intensities, laryngeal adjustments play a minor role in
controlling the intensity of the sound (Zhang, 2016b). However, some adjustments need to be
made by the laryngeal muscles in order to increase the resistance of the vocal folds to the high
subglottal pressure. Without a sufficient resistance, the vocal folds would get easily blown apart
(Zhang, 2011). Vocal fold resistance is a function of the vocal folds’ adduction and medial
compression, which relies on the activation of the LCA, IA, and TA muscles (Zhang, 2016b).
Moreover, increasing glottal resistance proportionally to subglottal pressures avoids changes in
mean airflow rates and allows for a longer and more controlled expiration phase during speech
(Zhang, 2016c). The airflow conservation role of the glottis is important to reduce the effort of
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the respiratory muscles (Zhang, 2016c). In fact, it has been reported that a weakness in one
system (i.e. laryngeal or respiratory) may lead to hyperfunction in the other system in an attempt
to compensate (Zhang, 2016c).

Source-Filter Model (Resonance System)
So far, it has been presented that loudness can be altered by the respiratory and laryngeal
systems. However, there is another mean through which loudness can be increased and reduced,
and it involves the articulatory system (supraglottic vocal tract) (Zhang, 2016b). The supraglottic
tract comprises the structures above the larynx and includes the different parts of the pharynx
(hypopharynx, oropharynx, and nasopharynx) as well as the oral and nasal cavities (Mathieson,
2006). The three sections of the pharynx are bordered by the superior, middle and inferior
pharyngeal constrictor muscles, which modify the circumference of the pharynx (Mathieson,
2006).
Modifications in the shape of the vocal tract not only affect loudness of the sound, but also its
pitch and quality. Although humans cannot change the length of their trachea and vocal tract,
they can adjust the height of their larynx (Titze, 2008), the shape of their epilarynx (including the
aryepiglottic folds and the superior portion of the epiglottis) and the shape of their vowels to
optimize the acoustic properties of the vocal tract (Titze & Worley, 2009). The position of the
larynx is altered by the extrinsic laryngeal muscles, which can be classified into two categories:
suprahyoid and infrahyoid. The suprahyoid muscles originate from above the larynx and insert on
the hyoid bone (Mathieson, 2006). When they contract they elevate the larynx (digastric,
stylohyoid, mylohyoid and geniohyoid muscles) (Mathieson, 2006; Netter, 2014). The infrahyoid
muscles originate from below the larynx and insert on the hyoid bone or thyroid cartilage (in the
case of the sternothyroid) (Mathieson, 2006). When they contract, they pull the larynx
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downwards (sternohyoid, sternothyroid, omohyoid and thyrohyoid) (Mathieson, 2006; Netter,
2014).
Acoustically, an interaction between the source (vocal folds) and the filter (vocal tract) results in
a good tuning between the harmonics that are being produced at the source and the formants
(range of frequencies enhanced by the vocal tract resonance) (Titze & Worley, 2009). Because the
source-filter model is nonlinear, certain vowels and voice qualities are more effective at certain
pitches and specific vocal tract shapes are more effective with particular vocal fold configurations.
A megaphone shape (narrow epilarynx and wide mouth) such as in the vowel /a/ or during a shout,
interacts well with a high glottal resistance and therefore with a pressed glottal adduction (Titze
& Worley, 2009). On the other hand, an inverted megaphone (wide epilarynx and narrow mouth)
or neutral vocal tract shape has a more effective interaction with a low glottal
resistance/moderate vocal fold adduction (Titze & Worley, 2009). Speakers can therefore adjust
their vocal tract shape and vocal fold adduction for an ideal source-filter interaction. The
supraglottic tract configuration can also affect the pitch of the voice without a change in the
fundamental frequency, the implication of which being that F0 is not always a precise predictor
of the pitch (Mathieson, 2006). As a matter of fact, the sound that is perceived by the listener is
not the same as the one produced at the source (the glottal signal), but is the result of the sound
after it has been filtered by the supraglottic tract (Mathieson, 2006). The glottal signal is made of
a series of harmonics and depending on the shape of the vocal tract and the different articulators,
some of them will resonate more than others. These zones of frequencies enhanced by the vocal
tract resonance are called formants (Titze & Worley, 2009). This allows for the production of the
different vowels and gives the "color" to the voice that is unique to every speaker (Mathieson,
2006).
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Hormonal Influence on the Larynx
The larynx is a hormone-sensitive organ (D'Haeseleer, Depypere, Claeys, Van Borsel, & Van Lierde,
2009). It is affected in a different way by each class of sexual hormone (Abitbol, Abitbol, & Abitbol,
1999). While estrogens have a proliferative effect on the laryngeal mucosa and reduces the
desquamation process in the superficial layers of the lamina propria, progesterone exerts the
opposite effect and hastens desquamation of the superficial layers (Abitbol et al., 1999). Estrogen
and progesterone also play contrasting roles with regards to glandular secretions and capillary
permeability, which tend to be increased by estrogens and decreased by progesterone. As a
result, progesterone has a dehydrating effect on the vocal fold mucosa. Androgens are also
associated with dehydration of the mucosa, as well as with its atrophy. Moreover, androgens are
thought to have an impact on skeletal muscles, causing hypertrophy and a decrease in fat cells
(Abitbol et al., 1999). Considering these effects, the levels and ratios of the different hormones
play a significant role on the maintenance of optimal conditions for voice production, which may
be disrupted during life events such as puberty and menopause (Awan, 2006).

Neurological System
Central Nervous System
Phonation is the result of the coordinate activity of laryngeal, respiratory, and articulatory
muscles, with motor fibers originating from different locations in the central nervous system. The
intrinsic laryngeal muscles are controlled through the vagus nerve by motoneurones located in
the nucleus ambiguus of the medulla, while the motoneurones controlling the external muscles
lie in the 2nd cervical segment and send signals through the ansa cervicalis (Jurgens, 2009). The
respiratory muscles are operated by neurones located in the ventral horn of the thoracic and
upper lumbar spinal cord and the articulatory muscles are regulated by many different groups of
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motoneurones, including those from the facial nucleus and the trigeminal motor nucleus (Jurgens,
2009). Since there is no evidence of a direct connection between these groups of motoneurones
(Jurgens, 2009; Thoms & Jurgens, 1987), how is it possible that the result of their co-activation is
this perfectly well coordinated activity that is phonation? The explanation lies in the existence of
a region in the brain that receives input from all the motoneurones involved in phonation and
that coordinates their activity. This region is located in the reticular formation of the lower
brainstem and plays a major role in the two pathways involved in vocalization, as described by
Jurgens (2009) in a model on the neural control of phonation: 1) the readiness to vocalize and 2)
the motor patterning of vocalizations.
1) Readiness to Vocalize
The voluntary control of phonation starts in the cortex of the medial frontal lobe, in a region called
anterior cingular cortex (ACC) (Jurgens, 2009; Jurgens & von Cramon, 1982; Rubens, 1975). The
confirmation of the ACC’s role in voluntary phonation has been provided by the observation of
communication behaviors of patients with a lesion in this part of the brain. These patients could
still vocalize, but they wouldn’t initiate phonation unless a question was directly asked to them
(Jurgens, 2009; Jurgens & von Cramon, 1982; Rubens, 1975). The ACC sends projection to the
periaqueductal gray (PAG), in the caudal half of the midbrain (upper part of the brainstem). The
PAG has been identified as an important area for voice production not only in humans, but in the
large family of mammalians (Davis, Zhang, Winkworth, & Bandler, 1996). It is responsible for
involuntary and emotional sounds in humans, such as a pain cries (Jurgens, 2009). It is also in
charge of the initiation and intensity of the sounds (Jurgens, 2009). The PAG projects its fibers to
the reticular formation of the lower brainstem (Mantyh, 1983).
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2) Motor Control
The second neural pathway of voluntary vocalization starts in the precentral gyrus of the primary
motor cortex of the right and left brain hemispheres (Jurgens, 2009; Mathieson, 2006). The
cortical homunculus, developed by Dr. Wilder Penfield (Penfield & Boldrey, 1937), is a map of the
different body part representations within the motor cortex. Brown and colleagues (Brown, Ngan,
& Liotti, 2008) identified a definite region within the primary motor cortex that specifically
controls the adduction/abduction as well as the tension/relaxation of the vocal folds, which is
located next to the lip region that was identified in the cortical homunculus. Moreover, Ramsay
and colleagues (1993) found an overlapping of the regions of the primary motor cortex that are
activated during phonation with those activated during controlled exhalation. Another group of
researchers (Loucks, Poletto, Simonyan, Reynolds, & Ludlow, 2007) had similar findings and
concluded to a "common volitional sensorimotor system" for phonation and voluntary
respiration, which might help facilitate the coordination of these systems during phonation
activities (Brown et al., 2008). Quiet breathing is a reflex activity and is coordinated in the
respiratory control center (West, 1976, cited in Mathieson, 2006) in the reticular formation of the
brain stem, more specifically in the pons and medulla (Mathieson, 2006). However, during speech
the breathing activity becomes voluntary and is regulated to some extent by the cortex
(Mathieson, 2006), as suggested by the results from Loucks and Ramsay and their colleagues
(Loucks et al., 2007; Ramsay et al., 1993). This voluntary control is gradually developed from a
young age when the child starts to vocalize and eventually starts talking. When individuals reach
adulthood, speech breathing is so well integrated that it has become automatic (Mathieson,
2006). Literature regarding the predominance of a certain hemisphere for vocalization control is
conflicting. Some studies found a left hemisphere predominance (Loucks et al., 2007; Ramsay et
al., 1993), whereas others found a right hemisphere predominance (Riecker, Ackermann,
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Wildgruber, Dogil, & Grodd, 2000) and some concluded to a symmetrical pattern of activation
(Ozdemir, Norton, & Schlaug, 2006). This could be explained by differences in the tasks
administered, generating diverse cognitive and motor responses (Loucks et al., 2007).
Based on Jurgens’ model (2009), fibers from the motor cortex project to the reticular formation
of the lower brainstem, where the two pathways of readiness to vocalize and motor patterning
converge and allow for phonation. The motor cortex also receives information from other brain
regions (Jurgens, 2009). The motor commands are sent from the motor cortex to the cerebellum
and the pallidum via the pontine gray and putamen respectively, and are pre-processed before
being sent back to the motor cortex through the ventrolateral thalamus (Jurgens, 2009).
Fibers from the laryngeal region of the motor cortex reach the medulla in the brainstem by
descending in the corticobulbar pathway (group of neurons that travel from the motor cortex to
the medulla). With the corticospinal tract, the corticobulbar tract is part of the pyramidal system,
which refers to the upper motor neurons. Once the corticobulbar tract reaches the medulla, part
of its fibers decussate to the contralateral side while the rest of the fibers remain in the ipsilateral
side (Mathieson, 2006). Fibers sending motor signals to the different parts of the larynx therefore
synapse with either the contralateral or ipsilateral nuclei of the 10th cranial nerve (vagus nerve),
located in the nucleus ambiguus of the medulla (J. T. Hansen, 2014). The fibers stemming from
the vagal nuclei are part of the peripheral nervous system and form the lower motor neuron
pathway (Mathieson, 2006).

Peripheral Nervous System
Efferent fibers of the vagal nerve descend down the neck (within the carotid sheath) through a
hole in the skull called the jugular foramen. Just below the jugular foramen, a part of the vagus
nerve branches into the superior laryngeal nerve (SLN), which itself branches into an internal and
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an external branch (J. Thomas, Fall 2016). The external SLN provides motor innervation to only
one muscle of the larynx, the cricothyroid muscle. The internal SLN contains sensory and
parasympathetic fibers and innervates the tissues of the larynx above the vocal folds (Mathieson,
2006). On both the right and the left sides, the main trunks of the vagus nerve maintain their
course downward. On the right side, it branches into the right recurrent laryngeal nerve (RLN)
once it reaches the subclavian artery (J. Thomas, Fall 2016). The right RLN curves under the right
subclavian artery and ascend to reach the larynx by traveling between the trachea and the
esophagus (Mathieson, 2006). On the left side, the vagus nerve branches into the left RLN at the
level of the aortic arch. Because of its location, and because of its extensive pathway under the
arch of the aorta and upwards, the left RLN is more susceptible of being affected by pressure from
intrathoracic masses and by iatrogenic injuries (Mathieson, 2006). Once they have reached the
larynx, the right and left RLN split into an anterior and a posterior branch before they enter the
larynx and supply motor innervation to all the intrinsic muscles of the larynx, with the exception
of the cricothyroid muscle, which is innervated by the external branch of the SLN as
abovementioned.
The peripheral nerves such as the SLN and the RLN are responsible for transmitting information
between the central nervous system and the muscles or organs. The contact between the motor
neuron and the muscle fiber is called the neuromuscular junction (J. Thomas, Fall 2016). When
the neurons synapse, through the action of neurotransmitters, the resting membrane potential is
disrupted and this leads to the creation of an action potential. The action potential is an impulse
that travels in the neuron’s axon, which is covered with segments of myelin sheath made of
Schwann cells. The myelin provides the insulation necessary for an effective impulse transmission:
the action potential jumps along the Nodes of Ranvier, the depolarized regions between the
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myelin sheaths. The result of this "saltatory conduction" is a conservation of energy and an
enhanced conduction velocity (J. Thomas, Fall 2016).

Feedback System
Most peripheral nerves are mixed, which means that they contain both efferent and afferent
fibers. While efferent fibers send commands from the central nervous system to the muscles,
afferent fibers send information from the muscles to the central nervous system. This feedback
allows the brain to constantly adjust the motor commands to obtain the desired movements. For
the intrinsic laryngeal muscles, this is made possible by the mechanoreceptors contained in the
mucosa of the larynx, which are sensitive to stretch, touch and pressure and therefore respond
to vibration and airflow (Hammer & Krueger, 2014). These mechanoreceptors travel via the
afferent fibers of the vagus nerve and reach the lateral part of the medulla, from which projections
are sent to the primary somatosensory cortex (Hammer & Krueger, 2014). Along with
somatosensory feedback, auditory feedback plays a primordial role in phonation. An important
brain region for auditory feedback is the superior temporal gyrus (STG). As it was mentioned in
the previous section, the primary motor cortex regions activated by phonation are similar to those
activated by controlled exhalation because of their close relationship. However, a stronger
response is found in the auditory region, more precisely the superior temporal gyrus (STG), during
phonation when compared with controlled exhalation (Loucks et al., 2007). This confirms the
involvement of the STG in the phonation feedforward system (Larson, Altman, Liu, & Hain, 2008).
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Section 2: Age-Related Changes in Voice Anatomy and Physiology
This section describes the anatomical and physiological changes in the different systems involved
in voice production: the respiratory, laryngeal, and neurological system.
The impact of these changes on the different voice outcomes will be discussed in the last section,
along with the associated outcome measures that are relevant for assessing pre- post-treatment
changes in patients with presbyphonia.

Changes in the Respiratory System
Respiratory Muscle Strength
Respiratory muscles are mainly composed of skeletal muscles, which are subject to muscle fiber
atrophy with aging. In this process named sarcopenia, the proportion of type II fibers (fast-twitch
fibers) is decreased and this leads to a reduction in muscle mass, which in turn induces a decrease
in muscle strength and power (Kim & Sapienza, 2005). The extent and progression of the
sarcopenia process varies among the population and depends on different factors (such as
nutrition, physical activity, neuromuscular, molecular and hormonal status, age, body mass index)
(Melton, Khosla, & Riggs, 2000; Reychler, Delacroix, Dresse, Pieters, & Liistro, 2016), but can result
in a 50% decrease in total muscle mass by age 80 (Lexell, Taylor, & Sjostrom, 1988). The
physiological process that leads to muscle atrophy involves the neurological changes that take
place with aging (described in a subsequent section), but can also result from a direct decrease in
muscle protein synthesis (Tolep & Kelsen, 1993). More specifically, the cross sectional areas of
intercostal muscles decrease with age, with an onset around 50 years old and a greater reduction
in internal intercostal muscles (expiratory muscles) than in external intercostal muscles (Lalley,
2013). Atrophy of the diaphragm has also been noted, with a decrease in fast twitch (type II) fibers
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(Lalley, 2013). Structural changes in respiratory muscles are reflected in declined maximum
expiratory pressure (MEP) and maximum inspiratory pressure (MIP) (Lalley, 2013).

Lungs and Chest Wall Compliance
Respiratory function is not only affected by alterations in muscle strength. Structural changes
occurring in the lungs and in the thorax greatly affect respiratory function in elderly individuals.
With age, changes with regards to the number and organization of the elastic fibers surrounding
the alveolar ducts take place in the connective tissue of the lungs. In addition to inducing the
collapsing of small airways and increasing resistance in the airway at low long volume (Enright,
Kronmal, Manolio, Schenker, & Hyatt, 1994), these changes increase the compliance ("change in
volume per unit change in pressure"(Mada, n.d.)) of the lungs, which become more distensible
and lose some of their elastic recoil (Janssens, Pache, & Nicod, 1999).
The aging effect on lung elasticity has been noted to be more marked in men, who lose more
elastic recoil than women over time. Because men’s elastic recoil are higher than women at a
young age, the recoil forces of both sexes becomes similar with aging (Bode, Dosman, Martin,
Ghezzo, & Macklem, 1976). While lung compliance is increased with aging, chest wall compliance
is decreased due to a narrowing of the intervertebral disk spaces and a calcification of the
articulations between the ribs and the spine (Janssens et al., 1999). Moreover, the shape of the
thorax is subjected to changes caused by age-related osteoporosis, in some cases leading to a
kyphotic spine and impacting the curvature and functioning of the diaphragm (Janssens et al.,
1999). Structural alterations in the thorax increase the stiffness (resistance to deformation) of the
chest wall and explain its reduced compliance and an increased elastic recoil (Janssens et al.,
1999).
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Changes in the lungs and chest walls as well as changes in respiratory muscle strength have an
impact on pulmonary function (Lalley, 2013). Firstly, they lead to a greater residual volume in
older individuals (Janssens et al., 1999). Janssens et al. mention that residual volume increases by
approximately 50% between the ages of 20 and 70 years old, and this leads to a reduced vital
capacity in these individuals. The functional residual capacity (FRC) is increased with age, which
means that older individuals have a smaller functional reserve and that they breathe at higher
lung volumes than younger people (Janssens et al., 1999; Kim & Sapienza, 2005; Tolep & Kelsen,
1993). In spirometry testing, changes in the respiratory system translate into a reduced forced
vital capacity (FVC) and a reduced force expiratory volume (FEV1) (Janssens et al., 1999; Kim &
Sapienza, 2005). However, the total lung capacity is not affected by aging (Janssens et al., 1999).

Impact on Phonation Physiology
Combined, the aforementioned changes related to the respiratory system have a substantial
impact on voice production. Confronted with an altered respiratory mechanism, elderly people
use compensatory mechanisms for voice production. While young adults initiate speech at midlung volume (35-60% of their vital capacity) (Hixon, 1973), older adults use a higher lung volume
and the difference is more important in men (Huber & Spruill, 2008). By filling their lungs at midvolume, adults are relying on the natural recoil pressure of the system to produce the required
air pressure for voice production without having to use much muscle activity (Hixon, 1973).
However, because of the loss of elasticity in the lungs, the recoil pressure is not as effective in
older individuals and this explains why they need to initiate speech at higher lung volumes (Huber,
2008). Another way of increasing the subglottal pressure would be to use the expiratory muscles.
However, this is not the mechanism that is primarily adapted by elderly individuals when speaking
at a comfortable loudness, for three reasons: 1) with age, the decline in expiratory muscle
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strength is more important than the decline in inspiratory muscle strength, as may be reflected
by values of MEP and MIP. Starting at 65 years old, there is a decline of 2-3 cmH20/year in MEP
and of 1 cmH20/year in MIP (Enright, Kronmal, Manolio, et al., 1994). Since the inspiratory muscles
are better preserved, using them to increase lung volume prior to initiating speech might be a
more effective mechanism for elderly individuals than to rely on expiratory muscles (Huber,
2008). 2) Considering that older people have a reduced functional reserve, they are susceptible
of reaching their expiratory reserve volume (ERV) more rapidly than younger adults (Huber, 2008;
Tolep & Kelsen, 1993). Once ERV is reached, one has to generate pressure using the expiratory
muscles in order to overcome the negative pressure created by the lung-thorax unit (Huber,
2008). Therefore, by using a higher lung volume the chances of speaking below the resting point
are reduced. 3) The third reason is related to the changes in the vocal folds and the resulting poor
laryngeal valving (Hoit & Hixon, 1987). Because of the reduced laryngeal resistance, more air is
likely to escape during the closed phase of the vocal folds vibration and consequently a larger
volume of air is spent during speech (Hoit & Hixon, 1987; Huber & Spruill, 2008). By using a higher
lung volume, individuals can speak for longer durations before taking a pause for breathing
(Huber, 2008). However, despite the use of this strategy, it has been found that older adults
produce shorter utterances when compare to a younger group, regardless of the voice loudness
(Huber, 2008). Moreover, Huber and Spruill (Huber & Spruill, 2008) found that, when talking loud
over background noise, older individuals tend to use their abdomen significantly more than when
talking at a comfortable level, whereas younger people tend to rely more on passive recoil forces
to increase loudness (Huber & Spruill, 2008). The authors explain this result with the hypothesis
that, since older adults are already initiating phonation at high lung volumes for comfortable
sound level, increasing the volume even more might be too demanding for the inspiratory muscle
strength available (Huber, 2008). Nonetheless, by using their expiratory muscles to increase
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loudness, elderly individuals need to take more pauses for breath intake because they are
expending air at an increased flow rate (Huber & Spruill, 2008).
In summary, changes in the vocal folds affect laryngeal resistance and create a need for an
increased subglottal pressure. However, changes in respiratory muscle strength and in the lungthorax unit compliance reduce the ability of older individuals to generate and maintain a sufficient
subglottal pressure (Huber & Spruill, 2008). The consequences of these changes are more obvious
in challenging situations in which more muscular force is needed, i.e. during production of longer
utterances and during loud speech (Huber, 2008).

Changes in the Laryngeal System
Some of the key clinical findings of presbyphonia are a bowing of the vocal folds, prominence of
the vocal processes, and the presence of a glottal gap. This section will discuss the etiology of
these observed laryngeal changes as well as other age-related alternations that occur in the
laryngeal system.
Epithelium and Lamina Propria
Numerous changes in the mucous membranes of the vocal folds (epithelium and lamina propria)
have been reported in older individuals, affecting both the structure and function of these tissues.
Comparisons between old and young vocal folds revealed increased cell desquamation and
reduced quantity of cells (2-3 cells instead of 5-7 cells of thickness) in the epithelium of aged vocal
folds (Goncalves, Dos Santos, Pessin, & Martins, 2016; Hammond et al., 2000). Moreover, in some
of the elderly specimens, cell junctions in the epithelium were characterized by deep sulci, which
were not present in younger vocal folds (Goncalves et al., 2016). Age-related changes have also
been found in the lamina propria, with an impact on the shape and viscoelastic properties of the
vocal folds (Hammond et al., 2000). In the superficial layer of the lamina propria, collagen fibers
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are more abundant and distributed irregularly and elastic fibers are reduced in number and
disorganized (M. Hirano, 1974; Martins et al., 2015). In the deep layer, the collagen network tends
to be denser than in younger vocal folds (Goncalves et al., 2016). Changes in the aged larynx
should not only be considered from a quantitative standpoint, but also from a qualitative one:
collagen fibers, although increased in number, are not fulfilling their role as well as in younger
vocal folds, therefore leading to a decreased tissue resistance (Hammond et al., 2000). Moreover,
their augmented presence does not reflect an increased collagen production, but rather a
decrease in the turnover process (Hammond et al., 2000): because of an impaired expression in
the enzyme collagenase, the mature collagen fibers do not degrade and instead become distorted
and rearrange in clusters and disorganized layouts, thereby affecting the flexibility of the tissue
(Goncalves et al., 2016). Regarding elastic fibers, they have been found to undergo significant
morphologic and metabolic changes with aging: they vary in size, contain less microfibrils and
their surface is less uniform (K. Sato & Hirano, 1997). They authors conclude that these changes
are important enough to play a role in the perceptual changes associated with the aging voice (K.
Sato & Hirano, 1997).
Although the structural changes in the fibroblast cells of aged larynges have received little
attention, some authors have stressed their potential role in the protein alterations in the elderly
vocal folds. For example, fibroblasts in the macula flava (MF) of the vocal folds were found to be
less active in the geriatric group when compared to the adult group and fibroblasts in Reinke space
(RS) were found to be more active in the geriatric group, as shown by the degree of development
of their rough endoplasmic reticulum (rER) and Golgi apparatus (GA) (M. Hirano, Sato, &
Nakashima, 2000). These results are important given that fibroblasts in the MF are responsible
for producing collagen and elastic fibers for the vocal ligament, whereas those in the RS produce
intercellular material such as fibronectin and HA and participate in wound repair. As a matter of
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fact, the concentration of HA has been found to be reduced in older vocal folds (S. Hirano, Tateya,
Kishimoto, Kanemaru, & Ito, 2012; K. Sato, Hirano, & Nakashima, 2002). According to Hirano et
al. and other authors (Roberts, Morton, & Al-Ali, 2011), the reduced activity of the fibroblasts in
the aged vocal folds are partly responsible for the changes observed in the lamina propria and
epithelium of elderly people.

Laryngeal Muscles
Age-related atrophy of the TA muscle and consequential reduction in force, speed of contraction
and endurance (McMullen & Andrade, 2009) have been reported by many authors, but the
findings regarding patterns of fiber loss vary across studies. The speed of contraction of a muscle
fiber depends on the myosin heavy chain (MHC) isoform, which is the main protein in skeletal
muscles (Suzuki et al., 2002). Five MCH isoforms have been identified in animal and human
intrinsic laryngeal muscles: I (slow), IIA, IIB, IIX and IID (fast to different degrees) and IIL (superfast) (Suzuki et al., 2002). One study found a loss of type I fibers (Kersing & Jennekens, 2004),
while another study reported only a loss of type II fibers (Malmgren, Fisher, Bookman, & Uno,
1999) and a third study reported a loss of both types of fibers in aged TAs (T. Sato & Tauchi, 1982).
Despite the reduced number of muscle fibers, a recent experiment (Ziade, Semaan, Ghulmiyyah,
Kasti, & Hamdan, 2016) using magnetic resonance imaging (MRI) found no significant differences
in dimensions (length, width, height) and volume between the TA muscles of aged (65 and older)
and younger larynges. The unchanged volume and dimensions could be explained by a
compensation hypertrophy in the remaining muscle fibers (Malmgren et al., 1999). Other
explanations could lie in the alterations occurring in the connective tissue of the TA muscle: an
increase in ragged red fibers (resulting from the increased mitochondrial activity) (Kersing &
Jennekens, 2004) and in collagen fibers (Kersing & Jennekens, 2004; Rodeno, Sanchez-Fernandez,
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& Rivera-Pomar, 1993) could partly account for the unchanged muscle dimensions and volume
despite the loss of muscle fibers.
The degeneration process is not limited to the TA muscle but also affects the other intrinsic
laryngeal muscles as confirmed by observed changes in proportions and diameters of type I and
type II fibers and reduced EMG amplitudes (K. K. Baker, Ramig, Sapir, Luschei, & Smith, 2001) in
other laryngeal muscles. Interestingly, Suzuki et al. (2002) found alterations in MHC isoform
profiles only in adductory muscles and not in the PCA, suggesting that the function of respiration
might be better preserve than those of phonation and airway protection (Suzuki et al., 2002). In
the TA and the LCA, a decrease in type IIB isoforms was found along with an increase in a slower
fiber type, IIX. In the LCA muscle, an increase in the type IIA isoform was noted. The authors
concluded to a replacement of fast contracting fibers to slower contracting fibers, a phenomenon
similarly observed in denervated muscles (Suzuki et al., 2002).
One of the underlying mechanisms that could be partly responsible for the loss of certain muscle
fibers is the decrease in blood flow (hypoperfusion) that has been observed in the intrinsic
laryngeal muscles. A study by Lyon & Malmgren (Lyon & Malmgren, 2010) showed a significant
blood flow reduction of 60% in the TA muscles, of 50% in the CT muscles and of 42% in the PCA
muscles in older rat larynges versus younger ones. In humans, while no change in capillary length
have been found with aging, alterations related to the arrangement of the capillary contacts have
been noted in intrinsic laryngeal muscles and are likely to impact blood flow (Lyon, Steer, &
Malmgren, 2007). Decreased blood flow has a direct effect on muscular fatigue resistance as it
affects the oxygen and nutrient supply to the muscle and reduces cellular waste elimination,
leading to an altered muscle function (Lyon & Malmgren, 2010; L. B. Thomas, Harrison, & Stemple,
2008). Moreover, chronic hypoperfusion can induce an enhanced production of reactive oxygen
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species (ROS) by the mitochondria and cause damage to the cells, thereby inducing a loss of
muscle fibers (Lyon & Malmgren, 2010).

Cartilages, Bones and Joints
Mineralization (calcification) and ossification processes are observed in the cartilages of the larynx
with aging as a response to mechanical stress induced by the laryngeal muscles on the tissues
over time (von Glass & Pesch, 1983). These changes are observed only in the hyaline cartilages
(thyroid, cricoid and arytenoid cartilages) since ossification does not occur in elastic cartilages
(epiglottis, corniculate and cuneiform cartilages) (Turkmen et al., 2012). The process starts as soon
as during the second decade of life, with an increased progress in the fifth decade for the thyroid
cartilage and in the third decade for the cricoid cartilage (Turkmen et al., 2012). Along with the
progressive ossification of the arytenoid and cricoid cartilages, changes in the cricoarytenoid
joints have been reported and affect the range of movement of the articulation (Casiano, Ruiz, &
Goldstein, 1994). These include a disorganization of collagen fibers, irregularity and thinning of
the articular surface, and fibrosis of the periarticular region (Casiano et al., 1994; Ramig et al.,
2001). Tissue changes in the insertion zones of the vocal ligament have also been observed in the
anterior commissure, where fibrocartilage is slowly replaced by bone with advancing age
(Paulsen, Kimpel, Lockemann, & Tillmann, 2000). The stiffening caused by ossification of the
cricoarytenoid joint and vocal ligament insertion zone is thought to limit the extent of
approximation of the vocal folds, further hindering their adduction in older speakers (Paulsen et
al., 2000; Ramig et al., 2001).
Ossification of the laryngeal cartilages has an impact on the resonance of the sound, which is
further altered by the lowering of the larynx and by the changes in the length and volume of the
vocal tract (Linville & Fisher, 1985; Xue & Hao, 2003). A large part of the dimension changes in the
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vocal tract is thought to be attributable to the increment in oral cavity volume and these
alterations impact the formant frequencies of the different vowels (Xue & Hao, 2003). More
research is needed regarding the effects of craniofacial skeleton enlargement and facial muscle
atrophy on voice and more specifically on resonance (Xue & Hao, 2003).

Mucosal Glands
The concentration of laryngeal glands decreases with aging as the glandular tissues are either
atrophied or replaced by adipose tissue (Tomita, Nakashima, Maeda, Umeno, & Sato, 2006). In
addition, serous and mucous glands undergo age-related morphologic changes affecting the
cytoplasm of the cells and these changes impact the quantity and properties of the secretions,
which become thicker (Johns, Arviso, & Ramadan, 2011; K. Sato & Hirano, 1998). These alterations
hinder the lubrication process of the vocal folds and this is thought to play a role in impeding vocal
function (K. Sato & Hirano, 1998).

Impact on Phonation Physiology
The abovementioned physiological changes in the larynx have significant repercussions on vocal
function. Because of the changes occurring in the epithelium, lamina propria and TA muscle, the
vocal folds become thinner and weaker (Ximenes Filho, Tsuji, do Nascimento, & Sennes, 2003).
This vocal fold atrophy leads to an incomplete glottal closure and shorter closed phase during
vibration, particularly in men. In fact, age-related changes in the vocal fold tissue and laryngeal
cartilages have been found to be more extensive in men than women, with 67% of older men
presenting with vocal fold atrophy versus 26% of older women in a study by Honjo and Isshiki
(Honjo & Isshiki, 1980). The glottal gap caused by the atrophy is further increased by changes in
the joints and insertion zones of the vocal ligaments as well as in the other adductory muscles. To
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compensate for this lack of closure, speakers tend to increase muscular adduction force (Higgins
& Saxman, 1991) which can involve medialization of the false vocal folds towards the midline.
The result of this compression is the need for a greater subglottal pressure to overcome the
phonation threshold pressure and initiate or maintain vocal fold vibration (Higgins & Saxman,
1991). The need for a greater subglottal pressure is further induced by the changes in the
structural properties of the vocal fold epithelium and lamina propria and laryngeal mucosal
glands. By increasing the stiffness of the vocal folds and reducing its lubrication, these alterations
hinder the vertical and medial propagation of the mucosal wave and the vertical height difference
indispensable for a healthy vibration (Zhang, 2016b).
Even when compensatory mechanisms are used to promote vocal fold adduction, an increased
airflow and a shorter closed phase often persist in older subjects and are indicative of the
persistence of poor laryngeal valving (Higgins & Saxman, 1991; Hoit & Hixon, 1987). This adds on
to the limitations of the respiratory muscles and participates in decreasing utterance length and
vocal quality in this population.

Changes in the Neurological System
Central Nervous System and Feedback
Although it has been suggested that the CNS loses fine motor control with aging and that this may
affect voice production (Johns et al., 2011), research that correlates age-related changes in upper
neurons with vocal function are sparse. Liu and colleagues (2011) examined the effect of age of
the pitch-shift reflex (Larson, 1998) and found that the magnitude of the vocal response to a shift
in the artificially fed back F0 changed as a function of age (Liu, Chen, Jones, Huang, & Liu, 2011)
examined. The magnitude of the response increases up to the age of 51-60 years old, after which
it starts to gradually decrease (Liu et al., 2011). Statistical analyses confirmed that the changes in
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voice F0 observed with aging were not correlated with the alterations in pitch-shift responses.
The authors explain their results by a decrease vocal motor control induced by physiological
changes in the laryngeal muscles, but also by alterations in the CNS. In fact, aging has been
associated with a decrease in the number of synapses and a subsequent reduction in grey matter
volume (Sowell et al., 2003). The decrease in inhibitory synapses may reduce the capacity of the
cortical and subcortical systems to inhibit the vocal response to a F0 shift, therefore resulting in
altered response magnitudes (Amenedo & Diaz, 1998; Liu et al., 2011). Elderly people also present
with different neural representations of sounds than younger individuals, as demonstrated by
distinctive responses in the temporal lobes (Bellis, Nicol, & Kraus, 2000). The effect that these
changes, as well as hearing impairment, could have on voice production has not been studied yet.
Changes in proprioception related to the laryngeal respiratory system are also mentioned in the
literature. In fact, older people have a reduced ability to integrate information provided by
sensors via the afferent somatosensory route (Janssens et al., 1999). Regarding the respiratory
system, they are also thought to rely more on feedback from the respiratory muscles in opposition
to younger people who rely more on lung proprioception to gauge lung volume for phonation.

Peripheral Nervous System
As it has been previously detailed, aging brings about remodeling in the respiratory and laryngeal
muscles, including changes in the proportion of slow and fast fiber types. Part of the reason for
this remodeling lies in the interdependent relationship between the muscles and the motor
neurons. With age, morphological changes occur in the superior and recurrent laryngeal nerves
including a reduction in Schwann cells and myelinated fibers as well as a loss of large axons and a
decrease in their diameter (Nakai, Goto, Moriyama, Shiraishi, & Nonaka, 2000; Tiago, Pontes, &
Brasil Ode, 2008). Mortelliti et al. found a 31% decrease in myelinated nerve fibers in the superior
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laryngeal nerves from the older group when compared with the younger group (Mortelliti,
Malmgren, & Gacek, 1990). Similar findings have been reported affecting the myelinated fibers of
the phrenic nerve (innervating the diaphragm) and resulting in reduced action potential
amplitudes of this important inspiratory muscle (Imai et al., 2005; cited in Laller 2013) (Lalley,
2013). As a result of these changes, the nerves lose conduction velocity. Since the nerves are
responsible for transmitting the neural input to the muscle and are therefore essential for the
muscles’ survival, this loss in conduction effectiveness leads to partial denervation of the muscle
fibers and explains manifestations such as fiber loss and muscle atrophy (L. B. Thomas et al.,
2008).

Neuromuscular Junction
As a result of the spontaneous axonal degeneration described above, changes happen at the level
of the neuromuscular junction (Perie, St Guily, Callard, & Sebille, 1997), which are similar to
alterations observed in denervated muscles (Connor, Suzuki, Lee, Sewall, & Heisey, 2002). Firstly,
the percentage of motor fibers that are innervated through multiple branches of a same axon is
significantly reduced in intrinsic laryngeal muscles (TA, PCA, IA, CT) (Perie et al., 1997). Secondly,
the mean lengths of the neuromuscular junctions are decreased with age. These changes in
innervation reduce the ability to sustain synaptic transmission and therefore participate in the
sarcopenia process of the laryngeal muscles (Connor et al., 2002). In order to limit the impact on
muscle function, a reorganization of the neuromuscular junctions takes place, during which the
muscle fibers that were denervated are re-innervated by sprouts of axons belonging to adjacent
fibers, otherwise known as the denervation/re-innervation process (Perie et al., 1997).
A similar phenomenon is observed in respiratory muscles innervation. The loss of motor neurons
in the spinal cord leads to denervation of type II fibers in the respiratory muscles, which are then
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re-innervated by adjacent slow-twitch motor neurons (type I) through axonal branching (Tolep &
Kelsen, 1993). This process results in alterations in respiratory muscle structure and function.
Moreover, changes in the neuromuscular junctions at the level of the diaphragm and of the
intercostal muscles have been observed in aged rats and in humans, including a decrease in
acetylcholine receptors and acetylcholine release, as well as a reduce number of end plates (Smith
et al., 1990; Jan and Van Remmen, 2011; cited in (Lalley, 2013)).

Coordination Between Systems
Changes in the respiratory, laryngeal and neurological systems result in a decreased sensorimotor
function, affecting the coordination between the subsystems. In fact, studies on animals have
shown alterations in the temporal relationship between laryngeal and respiratory movements
during quiet breathing, with older animals often initiating inspiration during the closed phase of
the vocal folds (Nagai, 2005; cited in Johns et al., 2011)(Johns et al., 2011). Regarding phonation
in humans, the lack of coordination between the laryngeal and respiratory systems adds up to the
decreased rapidity of movements and can translate into timing deficiencies (Mathieson, 2006).
These include the production of sounds on voiceless phonemes and on pauses during speech (the
vocal fold abduction is too slow) as well as in increased voice-onset time (the vocal fold adduction
is not well coordinated with the exhalation) (Mathieson, 2006).

Changes in the Endocrinal System
While the fundamental frequency of men tends to increase with aging, that of women tends to
decrease. Many authors have explained this contrast by hormonal changes occuring with
menopause in women around 50 years old, bringing about various biological changes throughout
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the body, including the larynx (D'Haeseleer et al., 2009). With menopause, the ratio of estrogenprogesterone to androgens is altered and results in an enhanced influence of androgens on the
organs (D'Haeseleer et al., 2009). The increased ratio of testosterone to estrogens has also been
reported as having an effect on voice, possibly involved in the decrease in F0 (Lindholm, Vilkman,
Raudaskoski, Suvanto-Luukkonen, & Kauppila, 1997). Visual examinations of the larynx in
menopaused women revealed edema of the free edges of the vocal folds, a loss of the white
appearance of the mucosa, and the presence of microvarices (Abitbol et al., 1999; Schneider, van
Trotsenburg, Hanke, Bigenzahn, & Huber, 2004). Edema in the vocal folds causes an increase in
the vibrating mass and a subsequent decrease in F0 and vocal range (Abitbol et al., 1999;
Schneider et al., 2004). Reduced flexibility and stability of the voice have also been reported by
menopaused singers, along with a loss of their higher register (Boulet & Oddens, 1996).
Even though the abovementioned changes in the larynx are thought to be the result of hormonal
changes in menopaused women, it remains challenging to differentiate some of the menopausal
symptoms from other age-related changes in the larynx (D'Haeseleer et al., 2009). Moreover,
there is a lack of scientific studies to support the mechanisms through which hormonal changes
may induce laryngeal manifestations. In fact, studies have reported conflicting results regarding
the mediation process of hormonal influence and the presence of sex hormone receptors in the
larynx (D'Haeseleer et al., 2009; L. B. Thomas et al., 2008). For these reasons, some authors have
suggested that menopause might affect the larynx indirectly. One example of that is the high
prevalence of gastroesophageal reflux symptoms that are associated with menopause and that
are known to induce edema of the vocal folds (D'Haeseleer et al., 2009).
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Section 3: Current Treatment Approaches for Presbyphonia

Behavioral Therapy
Different exercise programs have been applied to the treatment of presbyphonia, but the
biological rationale for this type of intervention has not been thoroughly studied (Johnson, Ciucci,
& Connor, 2013), often because of feasibility issues (Johnson et al., 2013). Although strengthening
exercises have been shown to reverse the sarcopenia process in limb muscles, their physiological
effect on laryngeal age-related alterations still remains unclear (L. B. Thomas et al., 2008). To
address this question, Johnson and colleagues (Johnson et al., 2013) used an animal model to
study the impact of exercise on neuromuscular plasticity. The results suggest that vocal training
can mitigate some of the age-related differences in the neuromuscular junction of the TA muscle
by reducing motor endplate dispersion in the muscle. This is likely to improve synaptic
transmission, which is dependent on the synapse spatial arrangement, and therefore to increase
muscle strength and allow for a reliable muscle contraction (Johnson et al., 2013).
In the current intervention paradigm, the first line of treatment for presbyphonia is voice therapy
with a speech and language pathologist before suggesting a medical or surgical approach to
improve glottal closure (Lu, Presley, & Lammers, 2013). However, the literature supporting
behavioral approaches for presbyphonic patients is still sparse. Few research papers have been
published in relation to behavioral voice therapy for the aging voice, and most of them have a low
level of evidence (J. M. Oates, 2014). Nonetheless, these studies have generated data on the
effect of different exercise protocols on the presbylarynx and have painted the picture of
treatment approaches that are currently used in clinics by SLPs.
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Vocal Function Exercises
Stemple’s program of Vocal Function Exercises (VFE) is the treatment approach that has received
most attention in presybyphonia studies to date. Its impact on the aging voice was examined in
seven studies (E. E. Berg, Hapner, Klein, & Johns, 2008; Gorman, Weinrich, Lee, & Stemple, 2008;
Kaneko et al., 2015; Sauder, Roy, Tanner, Houtz, & Smith, 2010; Tanner, Sauder, Thibeault,
Dromey, & Smith, 2010; Tay, Phyland, & Oates, 2012; Ziegler, 2014), although sometimes
combined with other approaches such as resonant voice therapy (E. E. Berg et al., 2008) or
unsuccessful injection laryngoplasty (Tanner et al., 2010).
The program consists of a series of four specific exercises that were designed to improve the
strength, endurance, flexibility and stability of the laryngeal and respiratory systems and to build
up the balance between muscular effort and airflow (Stemple, Lee, D'Amico, & Pickup, 1994; Tay
et al., 2012). The exercises are as followed: 1) sustain the vowel /i/ on the musical note F (above
middle C for women; below middle C for men) for as long as possible; 2) glide from the lowest
note to the highest note on the word "knoll"; 3) glide from the highest note to the lowest note of
the word "knoll"; 4) sustain the notes C-D-E-F-G (starting from middle C for women and an octave
below middle C for men) on the word "oll", for as long as possible. The placement of the voice is
forward-focused for all the exercises (the rationale of a forward-focused voice will be detailed in
the section on resonant voice). The protocol is usually practiced once a week with a SLP and the
participants complete practices of five minutes twice daily for the duration of the therapy, which
varies from four (Ziegler, 2014) to 12 (Gorman et al., 2008) weeks in the literature.
The VFE program is thought to induce a positive effect on the vocal fold vibration by promoting
its regularity (Stemple et al., 1994), which in turns decreases acoustic measures of jitter and
shimmer as well as the perceptual correlate of roughness (Tay et al., 2012). As a matter of fact,

52
roughness and jitter have been associated with the periodicity of vibration (Gorham-Rowan &
Laures-Gore, 2006). This reduced roughness as well as decreased acoustic measures of
perturbation have been observed in a study by Tay et al. (2012), who examined the effects of six
weeks of VFE on a group of 22 aging choral singers randomized to a treatment or no treatment
group. In this study, significant improvements in maximum phonation time (MPT) have also been
observed in the VFE group but not in the control group. The authors explained these
improvements by the enhanced coordination between the phonatory and respiratory systems, as
well as by the increased strength and endurance of the laryngeal and respiratory muscles. The
investigators didn’t find improvements in auditory perception of breathiness and strain and they
explained that finding by a lack of sensitivity of the auditory-perceptual instrument – the
Perceptual Voice Profile (J. Oates & Russel, 1997) – when used with non-impaired voices, as it was
the case in those healthy choir singers. On the other hand, Sauder and colleagues (2010) applied
six weeks of VFE on nine participants with diagnosed presbyphonia and found significant
reductions in breathiness and strain during reading tasks as judged by blinded listeners. In this
study, the exercises also led to a lessened score on the Voice Handicap Index (VHI) and decreased
self-assessed severity and phonatory efforts but no significant difference was found in MPT and
in acoustic and stroboscopy measures (Sauder et al., 2010). Even so, the authors concluded that
improvements in perceptual measures for functional reading tasks and reductions in perceived
handicap, severity and vocal effort are sufficient to demonstrate the clinical validity of VFE for
patients with presbyphonia (Sauder et al., 2010). They suggested that the absence of change in
glottal gap, which is one of the hallmarks of presbyphonia, might be due to a lack of sensitivity of
the laryngeal imaging technique used (videostroboscopy). They also proposed the alternative
hypothesis that functional and perceptual improvements might have occurred even in the
absence of an improvement in glottal closure because of combined alterations in the three
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subsystems of phonation leading to enhanced vocal efficiency (Sauder et al., 2010). Gorman and
colleagues (2008) found statistically significant improvements in MPT and in some aerodynamic
measures (including subglottal pressure and measures of glottal airflow) after a 12-week VFE
intervention in 19 elderly male participants. The authors hypothesized that the exercises may
have helped compensate for the decreased neural control of the laryngeal muscles by permitting
more motor unit recruitment. This may have increased the muscle function in the larynx and
helped counteract the age-induced atrophy, therefore leading to an improved medial
compression of the vocal folds (Gorman et al., 2008). Even though no visual examination of the
larynx was conducted as part of the outcome measures, the authors mentioned that the
significantly improved aerodynamic measures were related to improved glottal closure, since an
enhanced vocal fold adduction would lead to a better airflow management (Gorman et al., 2008).
Only two studies found improvements in glottal closure. One is a case study of two twin
participants (Tanner et al., 2010), therefore providing low evidence that VFE leads to an improved
glottal closure in patients with presbyphonia. The other one is a retrospective study with historical
controls, which revealed improvements in GRBAS, MPT, jitter, normalized mucosal wave
amplitude, normalized glottal gap, and VHI-10 (Kaneko et al., 2015). No improvements were
found in shimmer, intensity, mean flow rate and bowing index. It is possible that vocal fold
atrophy is resistant to intervention, because it is not only originating from the muscle atrophy,
but also from changes in the connective tissue of the lamina propria and those might not be
reversible with exercise, thus explaining the lack of change in bowing index (Kaneko et al., 2015).
Even though vocal exercises might be effective in improving function of the TA muscle and
therefore its vibratory status (Kaneko et al., 2015), in some cases this might not be sufficient to
close the glottal gap observed in this population. This further stresses the importance of
addressing the three systems involved in phonation and not only vocal fold adduction. The lack of
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improvement on certain outcome measures could be partly explained by the fact that VFE don’t
directly address the strengthening of the respiratory system and therefore overlook a key
component of presbyphonia. However, statements regarding the mechanisms of action of VFE in
patients with presbyphonia remain assumptions since the underlying physiological effects of the
treatment have not been confirmed (Sauder et al., 2010). The available data stems from
assessment of the clinical manifestations of the voice disorder before and after the intervention.
Some limitations that could explain the discrepancies in study results include: differences in
treatment durations, inclusion and exclusion criteria chosen to recruit participants, small sample
sizes, and sensitivity and reliability issues of the different assessment instruments (see section on
outcome measures). It is also noteworthy that, of the abovementioned studies, only two (Tay et
al., 2012; Ziegler, 2014) included a concurrent control group. One of them, by Ziegler and
colleagues (Ziegler, 2014), is the only one to have directly compared four weeks of VFE with
another intervention approach as well as with a no intervention control group, in a prospective
randomized controlled trial (level II evidence) (see Table 2). They found that VFE lead to positive
changes in voice-related quality of life (V-RQOL) but not in perceived phonatory effort contrarily
to the other intervention, phonation-resistance training exercise (PhoRTE). The details of the
PhoRTE approach, as well as possible reasons that could explain its slight superiority over VFE, are
presented in the following section.
Table 2. Levels of Evidence based on the National Health and Medical Research Council (NHMRC)

Evidence Level
I
II
IIIa
IIIb

Study Design
Systematic reviews of randomized controlled trials
Randomized controlled trials
Pseudorandomised controlled trials
Studies with concurrent controls (e.g., cohort studies, non-randomised
trials)
IIIc
Studies without concurrent controls (e.g., with historical controls)
IV
Case studies
(https://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/developers/nhmrc_levels_grades_evidenc
e_120423.pdf)

55
PhoRTE and LSVT Interventions
The PhoRTE program, adapted from the Lee Silverman Voice Treatment (LSVT) approach, consists
of four exercises: 1) loud maximum sustained phonation on the vowel /a/; 2) loud ascending and
descending pitch glides over the entire pitch range on the vowel /a/; 3) functional phrases using
a loud and high voice; and 4) phrases from exercise #3 in a loud and low voice.
The rationale behind this approach, which was designed specifically for patients with
presbyphonia based on the LSVT program, is that an effective intervention should target the
underlying causes of the disorder and thus in the case of presbyphonic patients should load both
the laryngeal and the respiratory systems (Ziegler, 2014). The authors of the PhoRTE intervention
support that this approach allows to target the phonatory biomechanics directly but also
indirectly, via improved respiratory biomechanics. The load on the two targeted systems is
achieved by asking the participants to produce a loud/strong voice. They are encouraged to use a
low abdominal breathing pattern, however the only feedback offered during the execution of the
exercises is to maintain a "strong voice". More precisely, the targeted intensity is 80-90 dB and
this goal is monitored via a microphone placed in front of the participant (Ziegler, 2014) (it is not
clear from the article if the participant has access to the visual feedback of the produced and
expected sound pressure levels). Producing a loud voice is a high intensity task as it requires
sustained effort from the laryngeal and respiratory muscles. This effort, or overload, is what is
thought to induce the neuromuscular changes necessary to improve strength and to reduce
perceived effort during voice production (Ziegler, 2014).
Reduced phonatory effort can also be explained by source-filter interactions (Titze, 2008). When
performing the exercises on the vowel /a/, participants have a wide-open mouth and a narrowed
pharynx, therefore making the form of megaphone with their vocal tract. The megaphone shape
has the effect of raising the frequency of the first formant and amplifying the fundamental and
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second harmonics of the sound at the source (Ziegler, 2014). It is also an optimal configuration to
promote vocal fold adduction and to transfer the sound from the source to the lips, thus providing
maximal intensity (Ziegler, 2014). This source-filter interaction might explain the significant
improvements in perceived phonatory effort in the PhoRTE group and the lack of improvement in
the VFE group. VFE are produced on the rounded vowel /o/, stimulating an inverted megaphone
shape in the vocal tract (a wide pharynx and a narrowing at the lips), which is thought to decrease
vocal fold adduction (Ziegler, 2014). In the PhoRTE group, the assumed increased vocal fold
adduction and resulting reduction in glottal gap could have lowered the respiratory effort
necessary to maintain a sufficient subglottal pressure and this may have led to a reduced
perceived phonation effort. The intervention also led to significant increases in voice-related
quality of life, although this result was found in both the VFE and the PhoRTE groups (Ziegler,
2014).
The PhoRTE intervention is based on the same principles as LSVT. LSVT was initially intended for
patients with Parkinson disease (PD) with the goal of improving their respiratory drive and vocal
fold adduction and consequently increase their voice loudness and quality (Lu et al., 2013). The
program, which can only be conducted by a LSVT-certified SLP, consists of 16 60-minute sessions
over a four-week period. The first half of each session is allocated to exercises designed to
increase pitch range and maximum phonation time (maximum F0 range and sustained vowels at
loud intensity (Ramig et al., 2001)), followed by the production of functional sentences at loud
intensity (Lu et al., 2013). During the second half of the sessions, participants practice their loud
and strong voice in different speech tasks including reading, question answering, word
production, and conversation (Lu et al., 2013; Ramig et al., 2001). Participants are also given
exercises to practice at home to promote carryover of the treatment effects (Lu et al., 2013; Ramig
et al., 2001). The LSVT protocol was conceived following motor learning and skill acquisition
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principles: it is intensive, it involves numerous repetitions (minimum of 12 to 15), it requires high
effort from the participants and the instructions are simple and targeted ("loud voice")(Ramig et
al., 2001). The rigorous vocal exercises combined with a focus on pitch and intensity are expected
to minimize vocal fold bowing and promote vocal fold adduction (Lu et al., 2013).
In patients with PD, LSVT has been shown to increase subglottal pressure, SPL, and F0 variations,
and to improve glottic closure and functional speech production (Dromey, Ramig, & Johnson,
1995; Ramig, Countryman, O'Brien, Hoehn, & Thompson, 1996; Ramig, Countryman, Thompson,
& Horii, 1995; Ramig & Dromey, 1996). Deeming that these improvements would be beneficial
for patients with presbyphonia, Ramig colleagues (2001) were the first ones to apply LSVT to this
patient population. Their study included three participants and demonstrated an increased SPL in
the three of them, an improved voice quality in two of them, and a better vocal fold adduction in
one of them. All patients reported a positive change in voice production. Another case series study
evaluated the effect of LSVT on two patients with presbyphonia and included quantitative
measurements of glottal gap size (GGS) (Lu et al., 2013). The GGS was significantly reduced in both
participants, who also demonstrated a higher frequency of complete closure per vibratory cycle.
Significant improvements in SPL and pitch range were also found in both subjects, and MPT
improved in one subject. Although subjects didn’t experience any laryngeal trauma during the
four-week program, the level of supraglottic activity remained the same following treatment and
no follow-up assessment beyond two weeks after the end of the program was conducted to
ensure that the level of hyperfunction would not increase over time. As a matter of fact, the
shortcoming in the PhoRTE and LSVT approaches is the likeliness that participants will rely on
compensatory strategies to produce high intensity utterances, both at the laryngeal and
respiratory levels. At the laryngeal level, medial compression of the false vocal folds could be
enhanced to promote more adduction force of the vocal folds, along with a general increase in
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muscle tension. At the respiratory level, participants might rapidly reach their expiratory reserve
and this could also promote a strained phonation (hyperfunctional laryngeal configuration). Since
very limited feedback is provided in those intervention methods, participants do not have tools
to modify their laryngeal and respiratory behaviors. The impact of these compensatory
mechanisms might have detrimental effects on the voice in the long term, even though a higher
vocal loudness is achieved at a short-term level. The long-term effects of these therapies have not
been studied on patients with presbyphonia.
An aspect of the LSVT intervention that could represent an impediment to its implementation is
the intensity component. It might be unrealistic for elderly patients to attend four therapies per
week for four weeks, because of possible mobility or geographical barriers (Lu et al., 2013).
Various alternatives have been studied with PD patients, such as an online delivery program
(Constantinescu, 2011), an assistive computer system (Halpern, 2012), or an extended version of
the program (16 sessions over two months)(Spielman, Ramig, Mahler, Halpern, & Gavin, 2007).
Although these options have been proven to be non-inferior to the original LSVT protocol, they
have not yet been tested with the presbyphonic population.
Studies on LSVT for patients with presbyphonia are limited to case series and therefore have a
low level of evidence (IV). The study on PhoRTE is a well-designed randomized controlled trial,
associated with a high level of evidence (II). However, the study by Ziegler and colleagues (2014)
is the only one to have tested these exercises on patients with presbyphonia and contains
limitations such as small sample size and limited set of outcome measures. More studies that
would evaluate the effects of PhoRTE on the aged larynx are warranted.

59
Resonant Voice and Semi-Occluded Vocal Tract Exercises
VFE are thought to promote a semi-occluded vocal tract and a resonant voice, which help
recalibrate vocal fold adduction while promoting vocal efficiency (Gorman et al., 2008; Titze,
2006). In the case of patients with a glottal gap and possibly false vocal fold hyperfunction, this
would have for effect of recalibrating adduction while reducing false vocal folds involvement. For
this reason, resonant voice therapy and semi-occluded vocal tract exercises are both employed
by SLPs when working with patients with presbyphonia, although no study to date has specifically
examined the effect of these treatment approaches on elderly patients (J. Gartner-Schmidt &
Rosen, 2011; Mau, Jacobson, & Garrett, 2010).

Semi-occluded vocal tract exercises (SOVTE) include tasks such as lip trills and tongue trills, flow
resistance straws or tubes and nasal consonants. The principles underlying the use of these
exercises stem from the source-filter model of voice production (Titze & Worley, 2009), which
supports that the vocal tract plays an active role in converting aerodynamic energy into acoustic
energy. The semi-occlusion in the vocal tract enhances the interaction between the source
(vibrating vocal folds) and the filter (the supraglottal tract), which allows for an optimal vocal
efficiency and economy (Titze, 2006). SOVTE increase the inertance of the vocal tract ("acoustic
property of an air mass [usually a column of air in a tube] being accelerated or decelerated by
pressure")(Titze, 2001) (p. 520). Back pressures are generated in the vocal tract which, when
reaching the glottis, create a slightly abducted/adducted vocal fold arrangement, a reduced
vibration amplitude, and a decreased phonation threshold pressure (Titze, 2006). The vocal folds,
instead of being tightly adducted at the vocal processes through the action of the LCA, are
uniformly adducted/abducted over their whole length through more TA involvement (Titze,
2006). In summary, SOVTE amplify the sound by optimizing the source-filter interaction instead
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of relying on an increased vibration amplitude, therefore protecting the vocal folds from collision
impact (Titze, 2006).
The most effective semi-occluded configuration for vocal economy and efficiency has been found
to be a narrow epilarynx and a wide mouth (in this case the semi-occlusion is located in the back
of the vocal tract, in the epilarynx) (Titze, 2006). However, exercises with a wide epilarynx and a
narrow mouth opening (such as in lip trills, tongue trills, straw phonation, humming, and VFE) are
a safer start for voice therapy because the inverted megaphone shape generates lower vibration
amplitudes at the level of the vocal folds, and lower acoustic pressures (Titze, 2006). Moreover,
it allows for easier control and more sensation of the occlusion, which is located at the front of
the vocal tract (lips) (Titze, 2006). The pressure created behind the occlusion is translated into
vibrations that allow speakers to associate a healthy vocal fold configuration with proprioceptive
sensations (Titze, 2006). Nevertheless, since the inverted megaphone shape doesn’t produce the
highest vocal loudness, SLPs should eventually bring patients to a more open mouth
configuration, in which case the epilarynx might naturally narrow in order to preserve the vocal
efficiency gained through SOVTE (Titze, 2006). This is particularly relevant for patients with
presbyphonia since one of the main therapeutic goal with this population is to increase voice
intensity. Relying on the source-filter interaction to do so is a promising alternative for them
because it allows for an increased intensity without solely depending on an increased vibration
amplitude, which would inevitably tax the respiratory system.
Once an efficient vocal production is reached, the resulting intensified acoustic pressures in the
oral cavity lead to another kinesthetic sensation: tissue vibrations in the face (alveolar ridge and
maxillary bones)(Titze, 2006; Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 1995). This
proprioceptive feedback is the basis of resonant voice therapy, in which patient learn to recognize
these sensations and use them to maintain an adequate vocal fold configuration (Titze, 2006;
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Verdolini, Druker, Palmer, & Samawi, 1998). Resonant voice therefore results from the same
acoustic phenomenon than in SOVTE and has the same goal: to maximize vocal production while
decreasing collision impact on the vocal folds by inducing a slightly adducted/abducted
configuration (Verdolini-Marston et al., 1995; E. M. Yiu, Lo, & Barrett, 2017). Exercises are graded
in a hierarchy from sounds (usually starting with humming) to words, sentences, reading, and
lastly natural conversation (E. M. Yiu et al., 2017). Specific voice therapy programs based on
resonance voice have been developed, such as Verdonlini’s Lessac-Madsen Resonant Voice
Therapy (LMRVT) and Stemple’s resonance therapy program (E. M. Yiu et al., 2017). Resonant
voice therapy has been studied mostly in patients with muscle tension dysphonia/hyperfunctional
dysphonia (Ogawa et al., 2014; Ogawa et al., 2013; Edwin ML Yiu & Ho, 2002) and in professional
voice users (Barrichelo & Behlau, 2007; Roy et al., 2003; Verdolini et al., 1998). A review of nine
resonant voice studies (Barrichelo & Behlau, 2007; F. C. Chen, Ma, & Yiu, 2014; S. H. Chen, Hsiao,
Hsiao, Chung, & Chiang, 2007; Ogawa et al., 2014; Ogawa et al., 2013; Roy et al., 2003; Verdolini
et al., 1998; Verdolini-Marston et al., 1995; Edwin ML Yiu & Ho, 2002) revealed positive outcomes
in perceptual voice quality, acoustic and aerodynamic measures, self-reported measures and
phonatory effort measures following two to nine therapy sessions. One study found
improvements in vocal fold closure after eight weeks of therapy (S. H. Chen et al., 2007) and one
study found significant reduction in medial and antero-posterior compression immediately
following humming exercises (Ogawa et al., 2013).
While these results seem promising for patients with presbyphonia, who often present with
glottal insufficiency and compensating hyperfunction, it is unclear what the impact of resonant
voice and SOVTE would be on laryngeal features for this patient population. As a matter of fact,
the level of evidence supporting the use of SOVTE and resonant voice therapy with patients with
presbyphonia is very low. Only two retrospective studies (J. Gartner-Schmidt & Rosen, 2011; Mau
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et al., 2010) have reported treatment outcomes following these approaches. Although a
retrospective cohort study would usually be associated with a level of evidence of III-2, in both
cases the voice therapy was described as an amalgam of direct techniques tailored to the patients
and included LMRVT, flow phonation, SOVTE, resonant voice, and/or LSVT, making it impossible
to isolate the treatment approach and to compare it to another treatment or no treatment.

(Stretch) and Flow Phonation
Flow phonation was also included in the direct voice technique approaches used by SLPs in the
two retrospective reviews on treatment for presbyphonia (J. Gartner-Schmidt & Rosen, 2011;
Mau et al., 2010). This approach, also known as "stretch and flow" (SnF), was first described by
Stone and Casteel (1982; cited in Watts et al., 2015) and since then has been commonly used by
SLPs to treat patients with hyperfunctional dysphonia. The approach consists of a hierarchy of
vocal tasks that aim to develop a balance between the respiratory, phonatory and resonatory
systems by producing an effortless voice. The program starts with a prolonged exhaled, followed
by slow whispering, slow breathy voice, breathy speech at a faster rate and lastly production of a
normal voice with minimal effort (C. R. Watts et al., 2015). The general level of evidence to support
SnF was very low until recently, when Watts and colleagues (C. R. H. Watts, Amy; Toles, Laura;
Childs, Lesley; Mau, Ted, 2015) conducted a randomized controlled trial on patients with muscle
tension dysphonia. However, no study has examined the effect of this treatment approach on
patients with presbyphonia or any other type of hypofunctional voice disorder, and the rationale
for using flow phonation with patients with glottal insufficiency is unclear. The results of Watts’
clinical trial revealed significant improvements in VHI, MPT and cepstral peak prominence (CPP)
measures, indicating that flow phonation is effective in improving hyperfunctional voices (C. R. H.
Watts, Amy; Toles, Laura; Childs, Lesley; Mau, Ted, 2015). This could be beneficial for patients
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with presbyphonia who present with secondary hyperfunction; however it might also be
counterproductive regarding glottal insufficiency. Clinical trials assessing the impact of SnF on
patients with presbyphonia would be needed to answer these questions.

Symptomatic Approaches and Breathing Exercises
The treatment approaches described so far are categorized as "physiological approaches"
because they are designed to modify physiology and aim at a more efficient voice production.
They don’t target a specific voice symptom but rather phonation as a whole. Some SLPs choose
to follow these programs, while others use an amalgam of different techniques depending on the
symptoms of the patient, thus following a "symptomatic approach". Voice techniques suggested
in speech therapy books for patients with presbyphonia include the following:
Glottal attacks: using words and sentences starting with a vowel and use a gentle glottal attack
to promote vocal fold adduction. This strategy targets the laryngeal features of glottal gap and
vocal fold atrophy/bowing (Mathieson, 2006).
Vocal glides and arpeggios: glides and arpeggios executed on vowels are suggested to increase
vocal pitch range, which is often decreased in older people. Glides are usually started at mid-range
and gradually extended to higher and lower pitches (Mathieson, 2006). Vocal glides are similar to
the second and third exercises of the VFE program and target muscle flexibility and contractile
function.
Focused voice: Focused voice is another term for resonant voice and is often suggested as a
voice technique in speech therapy book, for various voice disorders including presbyphonia
(Mathieson, 2006).
Phrases of increasing loudness: some books suggest to gradually increase the patient’s vocal
loudness using short sentences (Mathieson, 2006). The issue with this strategy is that the patients
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might not have the muscular/pulmonary resources to increase loudness and might not succeed
or might produce an unhealthy phonation. It is therefore important that the patient be
encouraged to integrate other voice techniques while increasing vocal loudness, such as a focused
voice.
Glottal fry: glottal fry is usually employed with patients who have hyperfunctional voices although
it has been suggested for patients with presbyphonia, who may present with compensatory
hyperfunction. The rationale is that during glottal fry, the vocal folds are very relaxed and the
airflow and subglottal pressure are reduced (Boone, 2010).
Auditory and visual feedback and masking: auditory feedback plays an important role in speech
therapy. It can be provided by the therapist (modeling), or it can consist of a playback from the
patient’s voice. For patients who have an impaired auditory feedback, as it may be the case in
older patients, other strategies are also suggested. Visual feedback can help the patient reach a
targeted F0, loudness or air volumes in the lungs (Boone, 2010). This may be relevant for
presbyphonic patients because older individuals also tend to have a decreased ability to integrate
information from proprioceptive sensors in the respiratory system (Janssens et al., 1999). Lastly,
masking is proposed for patients with an impaired auditory feedback. The rationale behind this
strategy is that a compromised auditory monitoring may lead to a suboptimal voice production
and that masking it with white noise could result in clearer voice production (Boone, 2010). While
this is appealing for patients with presbyphonia, there is no rationale to date that support the use
of this technique with this population.
Counseling on vocal hygiene: vocal hygiene counseling (indirect voice therapy) is recommended
in mostly all books of speech therapy, for all types of voice disorder. While it is important to limit
vocal abuses and stay hydrated, indirect voice therapy should always be combined with direct
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voice therapy, because there is no evidence that vocal hygiene by itself leads to improvements in
voice outcomes (Ruotsalainen, 2007).
Breathing exercises: Presbyphonic patients have less air volume and less respiratory muscle
strength available for speech production because of age-related changes in the respiratory
system. Therefore, breathing exercises that aim to lengthen maximum phonation time are
frequently used by SLP when working with patients with presbyphonia. The most common
techniques, and those described (very briefly) in speech therapy books are: diaphragmatic
breathing, increasing extent of thoracic expansion, increasing period of rib elevation, increasing
period of expiratory airflow on phonemes /s, z, a, æ, i/. Emphasis is placed on feeling the abdomen
and ribcage expand and retract with the hands and on maintaining a straight posture (Boone,
2010). The concern with these exercises is that they do not load the respiratory system and
therefore it is likely that they won’t result in increased respiratory muscle strength. Simply
modifying the breathing pattern by encouraging abdominal breathing will not result in an
enhanced support for phonation if the chest wall is rapidly collapsing due to inspiratory muscle
weakness. Moreover, there is very low evidence in the literature supporting the use of these
techniques to improve respiratory and/or voice outcomes (Desjardins & Bonilha, 2019).
This lack of evidence is an issue with most of the abovementioned symptomatic approaches, with
the exception of the focused voice techniques, which has been extensively studied. When
employed in voice studies, these approaches are usually combined with various other techniques,
which makes it challenging to draw causal relationships between the treatment and the
outcomes. A good example of this issue is the Cognitive Vocal Program (CVP) (Nemr et al., 2014).
The CVP is a therapy program that was conceived for patients with a presbylarynx. It consists of
stretching, breathing, and voice techniques, including ascending and descending glissandos,
repetitions of syllables with /p/ and /b/ and humming. Breathing exercises involved
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"costodiaphragmatic breathing pattern" with prolongation of air on the sounds /f, v, s, z, i, e/. The
authors reported improvements in loudness, jitter, HNR, vocal quality, MPT, F0, glottal closure,
and mucosal wave. However, the study comprised only three participants and did not include a
control group nor statistical analyses, in addition to testing the efficacy of numerous techniques
simultaneously.

Neuromuscular electrical stimulation
One study evaluated the impact of neuromuscular electric stimulation (NMES) on bowed vocal
folds (Lagorio, Carnaby-Mann, & Crary, 2010). The hypothesis was that the positive effects of
voice therapy would be enhanced by the simultaneous administration of NMES. To test this
hypothesis, Lagorio and colleagues (Lagorio et al., 2010) conducted a prospective case series with
seven participants exhibiting glottal insufficiency caused by bilateral vocal fold bowing. The NMES
was delivered through a VitalSim NMES device (Empi Corporation, St Paul, Minnesota), which
releases a biphasic pulsed current through electrodes that are strategically placed on the neck of
the participants. In Lagorio’s study, one pair of electrodes was placed above and below the
cricothyroid membrane to target the cricothyroid muscle. Another pair of electrodes was placed
inferiorly to the horns of the hyoid bone, targeting the SLNs. The intensity of the current was
regulated during the initial stroboscopy evaluation: the electrical stimulation was gradually
increased until the vocal folds reached an improved glottal closure. The vocal exercises, a
hierarchy of different vocalizations, were produced while the NMES was being administered.
Treatment outcomes were assessed after three weeks of treatment, five days a week for one
hour. Results indicate increased MPT and glottal closure as well as decreased supraglottic
compression and improvements in VHI scores (Lagorio et al., 2010). These improvements were
maintained up to three months following the end of the treatment. Although these results may
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seem promising, this study holds the significant limitation of not containing a voice exercises- only
control group. For this reason, the individual contribution of NMES is yet to be known and the
underlying mechanism that led to the observed improvements remains unknown. The authors
hypothesized that the increased glottal closure may have been stimulated by an enhanced
contraction of the CT muscle leading to more elongation and tension in the vocal folds (Lagorio et
al., 2010).
A clinical trial compared voice therapy alone with voice therapy combined with NMES in patients
with unilateral vocal fold paralysis (Ptok & Strack, 2008). The results showed a stronger
improvement in vocal fold vibration irregularity in the combined group, but no significant
improvement in MPT for either group. Moreover, the vocal exercises that were used in the study
are not described, which further hinders the interpretation of the results. In summary, there is
not sufficient evidence to support the addition of NMES to voice exercises in patients with agerelated vocal fold atrophy and more research is needed before suggesting a change in clinical
practice.

Surgical Options
Surgery is rarely the first line option for patients with presbyphonia. Their enhanced vulnerability
to stressors due to a decline in physiologic reserves (frailty) (Johns et al., 2011) makes them more
at risk for postoperative complications and longer hospital lengths of stay (Johns et al., 2011).
However, when voice therapy does not yield satisfying results or if the patient presents with
severe vocal fold atrophy and glottal insufficiency, surgical options are considered, with the two
main options being injection augmentation and type I thyroplasty (Mau et al., 2010). A
retrospective cohort review by Gartner-Schmidt and Rosen (J. Gartner-Schmidt & Rosen, 2011)
was conducted on 275 patients with a primary diagnosis of vocal fold atrophy who presented at
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the University of Pittsburgh’s Voice Center. Eighty-six of them had follow-up information in their
file and of those, 15% had surgery alone while 44% had voice therapy alone, and 9% had surgery
after unsuccessful voice therapy. In another retrospective cohort study, by Mau and colleagues
(Mau et al., 2010), 67 patients with presbyphonia were examined. Of those, 48 received voice
therapy only, six received voice therapy combined with injection augmentation, nine received
injection only, and four received a thyroplasty type I intervention (with or without an injection
augmentation).

Injection Augmentation (Injection Laryngoplasty)
During injection augmentation, a biomaterial is injected with a needle deep to the lamina propria
into the paraglottic space to medialize the atrophied vocal fold (Johns et al., 2011; Seino & Allen,
2014). The procedure can be done in the operating room, but office-based procedures in which
the patient is awake and under topical anesthesia are more common (Johns et al., 2011). Because
they are often performed percutaneously, office-based injection augmentations present some
risks for elderly patients who are likely to be on anticoagulation medication (Johns et al., 2011).
Various biomaterials can be used and have been tested in the literature, with the most common
ones being Cymetra (collagen-based), autologous fat, calcium hydroxylapatite (CaHA)
microspheres (Radiesse Voice) or CaHA gel (Radiess Gel) (Cantillo-Banos, Jurado-Ramos,
Gutierrez-Jodas, & Ariza-Vargas, 2013). These biomaterials are gradually degraded and therefore
their effects are only temporary (Seino & Allen, 2014). CaHA injections have been found to have
the longest duration with follow-up studies indicating an average benefit period of at least one
year with improved MPT, perceptual ratings of voice quality and closed quotients, and no major
complications (Carroll & Rosen, 2011; Kwon, An, Ahn, Kim, & Sung, 2010; Rosen et al., 2009). In
the retrospective chart review by Gartner-Schmidt and Rosen (2011), including injections of
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Cymetra and CaHA, success of treatment was defined by a change of at least five points on a total
of 40 points on the VHI-10, a cut-off chosen by the authors based on clinical experience. Based on
this criterion, the rate of success was 56% for patients who received injection augmentation only
and 17% for patients who received injection augmentation following voice therapy. These low
success rates highlight the limitations of surgery management for patients with presbyphonia and
reveal that reducing the glottal gap by augmenting the bulk of the TA muscle may not be sufficient
to improve functional voice outcomes, contrarily to in patients with vocal fold paralysis who
demonstrated greater improvements (J. Gartner-Schmidt & Rosen, 2011; Seino & Allen, 2014).
This can be explained by the fact that the injection augmentation does not restore the altered
microarchitecture of the lamina propria, affected by age-related alterations (J. Gartner-Schmidt
& Rosen, 2011). Therefore, even though glottal closure is improved by the intervention with
subsequent increase in the closed phase of vibration and in loudness, the flaccidity of the vocal
folds may remain (J. Gartner-Schmidt & Rosen, 2011). The lack of tone and the difference in tone
between the two vocal folds have a negative impact on vibration regularity, and thus perceived
roughness is likely to persist even after the injection (J. Gartner-Schmidt & Rosen, 2011). The
patients’ expectations with regards to the effects of surgery on their voice might explain the lack
of improvement in VHI scores.
Moreover, it is noteworthy that biomaterials such as Radiesse can lead to undesirable results if
the amount of injected material and location of the injection are not adequate. An over-injection
or superficial injection would increase the rigidity of the tissue and hinder the mucosal wave and
vibratory properties of the vocal folds (Seino & Allen, 2014). On the other hand, insufficient
injection would not sufficiently improve glottal closure and in this case a complementary type I
thyroplasty might be necessary (Seino & Allen, 2014), which will be described in the following
section.
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Type I Thyroplasty (Medialization Thyroplasty)
While injection augmentations are mostly used for mild glottal gaps, type I thyroplasties have
been recommended for patients with severe glottal insufficiency (gap>3 mm, VHI≥90) (CantilloBanos et al., 2013; Seino & Allen, 2014). However, some authors suggest that both methods are
equally valid in mild and moderate cases and that clear criteria to determine one or the other
technique are not provided in the literature (Cantillo-Banos et al., 2013). Type I thyroplasty, also
designated as laryngeal framework surgery or medialization thyroplasty, is a permanent solution
to glottal insufficiency because the vocal folds are medialized using implants that are not intended
to be absorbed, with materials such as silastic (Montgomery Thyroplasty Implant system), GoreTex ribbon, hydroxyapatite, or titanium (TVFMI) (Johns et al., 2011; Seino & Allen, 2014). Through
an opening in the neck, a small window is removed from the lamina of the thyroid cartilage and
the implant is inserted in the paraglottal space to medialize the vocal fold (Johns et al., 2011;
Seino & Allen, 2014). The procedure can be done while the patient is awake and phonating, which
helps indicate to the laryngologist when an adequate glottal closure is achieved (Johns et al.,
2011). Type I thyroplasty has been found to be an effective intervention for patients with
presbyphonia (Netterville, Stone, Luken, Civantos, & Ossoff, 1993; Shah, Deal, & Buckmire, 2013),
yielding improvements in perceptual ratings of voice quality and voice-related quality of life (Shah
et al., 2013). However, in a retrospective chart review (Shah et al., 2013), improvements in glottal
function index (GFI), a self-reported measure specifically for glottal dysfunction (Bach, Belafsky,
Wasylik, Postma, & Koufman, 2005), were not statistically significant for patients with vocal fold
atrophy and were in fact smaller than for the other groups of participants (vocal fold paresis and
scarring). In another retrospective study (Buckmire, Bryson, & Patel, 2011), significant changes
were found for voice-related quality of life, GRBAS composite score, and GFI after an average of
almost eight months post-intervention. However, sub-analyses revealed that the subgroup of
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patients with vocal fold atrophy showed the least improvement when compared to patients with
vocal fold paralysis, hypomobility, or scarring (Buckmire et al., 2011). Other authors (Lu, Casiano,
Lundy, & Xue, 1998) compared the effect of thyroplasty between patients with vocal fold bowing
or scarring and patients with unilateral vocal fold paralysis (UVFP). The results revealed better
outcomes in the group with UVFP, once again indicating that the evidence for medialization
thyroplasty for vocal fold paralysis cannot necessarily be generalized to presbyphonic patients.
Because the implants are not being absorbed by the tissue, there is a risk of inflammation and
foreign body reaction (Zeitels, Mauri, & Dailey, 2003). Moreover, just like it is the case with
injection augmentations, there is a risk of under-correction which would result in persistence of
the glottal insufficiency, and a risk of over-correction, which would affect the vibration of the
vocal folds (Johns et al., 2011) .
Most of the articles on the current surgical options for presbyphonia are retrospective chart
reviews, without concurrent controls (level III-3) or without controls (level IV). Moreover, the
main inclusion criteria is usually often vocal fold atrophy or glottal insufficiency, which can include
other diagnoses such as vocal fold paralysis. Therefore, although the literature reveals positive
voice outcomes that justify the use of these approaches in clinics, the overall level of evidence for
patients with age-related vocal fold atrophy remains moderate.

Novel Approaches
The current surgical approaches constitute mechanical compensatory strategies to the glottal
insufficiency in presbylarynges but they don’t address the underlying physiological causes of the
gap and therefore only offer a partial solution. This may explain why the improvements in voice
outcomes and related quality of life are lesser in presbyphonic patients when compared with
other subgroups of patients with glottal insufficiency such as those with vocal fold paralysis (Seino

72
& Allen, 2014). Novel approaches that directly address the cellular changes in the lamina propria
are currently being developed in animal models and translated into early phase clinical trials
(Ohno & Hirano, 2014). These approaches stem from both regenerative medicine and tissue
engineering and are based on the premise that age-related manifestations in the larynx (e.g.
bowing, glottal incompetence and reduced mucosal wave amplitude) are mainly caused by the
imbalance between synthesis and degradation of the ECM components such as hyaluronic acid
(HA) and collagen (Ding & Gray, 2001). As it was described in a previous section, HA synthesis is
decreased in aged vocal folds and collagen deposition tends to increase significantly (Ohno &
Hirano, 2014). HA is indispensable to the maintenance of optimal viscoelastic properties for vocal
fold vibration. Collagen is important because it provides structural support and malleable strength
to the tissue, but a disruption in its synthesis and degradation cycle leads to an excessive
accumulation in the lamina propria, which reduces the mucosal wave amplitude and therefore
affects the vibration of the vocal folds (Ohno & Hirano, 2014). Researchers gained interest in
molecules that could potentially restore the synthesis and degradation process of these ECM
components: growth factors. Growth factors are peptides that present with various biological
functions involved in cellular growth, proliferation and migration (Ohno & Hirano, 2014).

Basic Fibroblast Growth Factor
Basic Fibroblast Growth Factor (bFGF) has been found to promote the growth of fibroblasts and
to stimulate HA production in aged vocal folds during in vitro experiments (S. Hirano, Bless, del
Rio, Connor, & Ford, 2004). Studies on rats also revealed increased HA production in aged vocal
folds (S. Hirano et al., 2005; Ohno et al., 2009b). These promising results of in vitro studies and
animal models led to in vivo experiments on humans, with the first case study published in 2008
(S. Hirano, Kishimoto, Suehiro, Kanemaru, & Ito, 2008). In 2012, Hirano and colleagues (2012)
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conducted a clinical trial on 10 patients with vocal fold atrophy due to aging. The participants’
vocal folds were transorally injected with bFGF dissolved in saline via a curved needle. Seven days
after the intervention, results indicated complete glottal closure and improved mucosal wave in
the participants. Moreover, improvements in MPT, mean flow rate and acoustic parameters
(jitter, shimmer, noise-to-harmonic ratio) were also reported and lasted for at least one year after
treatment (S. Hirano et al., 2012). This study by Hirano, which contained no control group, is the
only clinical trial of a bFGF intervention to have been conducted on patients with presbyphonia.
Current evidence for bFGF intervention for vocal fold atrophy is therefore limited to a level IV.
However, more research on bFGF is being conducted and yielding encouraging results, mostly on
vocal fold scarring. One of the shortcomings of bFGF is its rapid absorption in vitro (Hiwatashi et
al., 2017) leading to a short working time and in some cases the need for multiple injections
(Kobayashi et al., 2017). Most recent research has focused on the development of a drug delivery
system that would allow for gradual release of bFGF into the vocal folds. Studies testing collagengelatin sponges (Hiwatashi et al., 2017) as well as gelatin hydrogels (Kobayashi et al., 2017) to
deliver the growth factor into scarred vocal folds have been conducted on animals (in rat and
canine models). Results indicate higher mucosal wave and vibratory amplitudes in the groups
using a sustained delivery system, therefore indicating that a solution to the rapid bFGF
absorption in vivo is currently coming to fruition (Hiwatashi et al., 2017; Kobayashi et al., 2017).
However, studies are still largely at the basic science stage and concentrating on scarred vocal
folds. There is no evidence to date that these gradual release strategies would yield significant
improvements in patients with vocal atrophy associated with presbyphonia.
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Hepatocyte Growth Factor
Hepatocyte growth factor (HGF) is another molecule to have received attention in the voice field,
because of its antifibrotic properties (Matsumoto & Nakamura, 2001). As a matter of fact, HGF
strongly induces the expression of matrix metalloproteinases (MMPs), which play an important
role in the degradation of various ECM components including collagen. It was suggested that the
decreased procollagen expression and increased collagen deposition in aged vocal folds are
associated with a downregulation in MMPs expression (Ding & Gray, 2001) and that HGF could
have the potential of restoring the balance in collagen synthesis and degradation (Ohno et al.,
2009a). This hypothesis was tested by Ohno and colleagues (2009a), who administered HGF in
aged rat vocal folds. They found that the gene expression of MMPs (MMP-2 and MMP-9) was
significantly increased in the HGF-treated group when compared to the sham-treatment group
(Ohno et al., 2009a). The expression of hyaluronan synthase-3 was also significantly increased,
with a resulting increase in hyaluronan density in the lamina propria (Ohno et al., 2009a). Basic
science studies are still ongoing in animal models and human vocal folds in vitro to find the optimal
dosage, administration route and drug delivery system for HGF interventions (Ohno & Hirano,
2014). Moreover, clinical trials are ongoing for vocal fold scarring and sulcus (Ohno & Hirano,
2014). However, there are no clinical trial available in the literature to support the injection of
HGF in patients with presbyphonia.
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Section 4: Possible Future Treatment for Presbyphonia - Respiratory
Muscle Strength training

Clinical Feasibility
The body of literature on respiratory muscle strength training (RMST) has been growing in the last
years. The objective of RMST is to strengthen either the inspiratory muscles or the expiratory
muscles, which can be done via different modalities: voluntary isocapnic hyperpnea, flow resistive
loading, incentive spirometry, or pressure threshold loading (McConnell & Romer, 2004). The first
method, in which the resistance depends on the user’s airflow rate (C. M. Sapienza, 2008), is
physically demanding and time consuming, as it requires the maintenance of a high level of
ventilation (up to 50 breaths per minute) for 30 minutes (McConnell & Romer, 2004), and is
therefore not adequate for the elderly population. Flow resistive loading, in which the individual
breathes through an orifice of variable diameter, is also dependent on the airflow and therefore
this variable needs to be controlled, which adds complexity to the intervention. Incentive
spirometers are also influenced by airflow rate, in addition to offering a low resistance (C. M.
Sapienza, 2008). Pressure threshold loading consists of using a mouthpiece with a spring-loaded
valve (C. M. Sapienza et al., 1999). The valve blocks the airflow until the threshold pressure is
reached. Once the threshold is met, the valve allows the airflow to pass through as long as a
sufficient pressure is maintained. With a threshold valve, the resistance to inspiration or
expiration is independent of the airflow produced by the participants (McConnell & Romer, 2004),
which makes it more reliable than the other methods. It is also portable and easy to use, cost
effective (McConnell & Romer, 2004), and can be easily performed with a limited amount of
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instruction (C. M. Sapienza et al., 1999), which makes it clinically feasible and ideal for the elderly
population.

Mechanism of Action
Respiratory muscles, similarly to other striated skeletal muscles, respond to conditioning and can
be strengthened with exercises that involve overloading (S. E. Baker, Sapienza, Martin, et al.,
2003; C. M. Sapienza et al., 1999). As recommended by the American College of Sports Medicine
(cited in Baker et al., 2003) the optimal effect on strengthening is obtained with a near maximal
load, which is defined by intensity, duration, and frequency of training. When the load is sufficient
to activate the neuromuscular system beyond its normal level of activity, the system is forced to
adapt and this results in changes in muscle function (Daniilidou, 2007). In order for the benefits
to be optimal, the exercise has to induce a functional reorganization in the cortex (increased
neuronal excitability and synaptic response), a phenomenon that has been associated with
specific skilled-tasks (C. M. Sapienza & Wheeler, 2006). Although RMST does not involve
phonation, Sapienza argues that since it requires the integration and coordination of many muscle
groups, it is thought to be complex and specific enough to lead to neuroplasticity and threshold
changes affecting respiratory function (C. M. Sapienza & Wheeler, 2006). Nonetheless, the
carryover of the effects of RMST to specific voicing tasks remains a crucial aspect of the therapy
to reach the best possible voice and functional outcomes.

Previous Studies and Impact on Voice
Inspiratory muscle training with a pressure threshold device has been studied mostly in cases of
airway obstruction disorders, such as COPD (Lotters, van Tol, Kwakkel, & Gosselink, 2002), asthma
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(Silva et al., 2013), and upper airway diseases including congenital juvenile laryngeal papilloma
(scarring and laryngeal web, case study)(C. M. Sapienza et al., 1999), exercise-induced vocal fold
dysfunction (Mathers-Schmidt & Brilla, 2005; Sandnes et al., 2013), as well as congenital and
acquired bilateral abductor vocal fold paralysis (case studies)(S. E. Baker, Sapienza, & Collins,
2003; S. E. Baker, Sapienza, Martin, et al., 2003). Results from the IMST literature are promising,
as they confirm that the intervention induces morphologic changes in the respiratory muscles and
leads to improvements in clinical measures. In a study by Ramirez-Sarmiento et al. (2002), a group
of patients with COPD underwent five weeks of IMST and a control group received a sham IMST
treatment. Following the intervention, biopsies were taken from the external intercostal muscles
and the results revealed a 38% increase in the proportion of type I fibers and a 21% increase in
the size of type II fibers (Ramirez-Sarmiento et al., 2002). Clinically, these changes were translated
into improvements in strength and endurance of the inspiratory muscles (Ramirez-Sarmiento et
al., 2002). A study by Souza et al. (2014) explored the effects of eight weeks of IMST on women
aged 60 to 80 years old in a well-designed double-blinded randomized controlled trial. Results
revealed significant improvements in MIP and MEP as well as in diaphragm thickness (when
contracted) and mobility. These changes were not found in the sham control group. The authors
suggested that the improvements detected in respiratory function might have been caused by a
combination of muscle hypertrophy (as shown by enhanced diaphragm thickness) and
neuromuscular adaptations induced by the training (Souza et al., 2014). The literature regarding
changes in pulmonary function following inspiratory training is conflicting, as some studies have
reported improvements in pulmonary function measures (forced vital capacity, forced expiratory
volume, vital capacity) and others did not (Mills, Johnson, Barnett, Smith, & Sharpe, 2015; Reyes,
Cruickshank, Nosaka, & Ziman, 2015). This could be explained by the different patient populations
and differences in training protocols.
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Surprisingly, the impact of IMST on voice outcomes has not been studied in patients with
respiratory muscle weakness as it is the case with presbyphonia. Studies on elderly individuals
and on patients with Parkinson’s disease and multiple sclerosis, who also present with suboptimal
respiratory function, have either used IMST to improve ventilatory functions (mostly to reduce
the sensation of dyspnea)(Kim & Sapienza, 2005) or have focused on expiratory muscle strength
training (C. M. Sapienza, 2008) to improve nonventilatory functions (coughing, swallowing, and
speaking). Eight studies have assessed the effect of EMST on voice outcomes in various patient
populations and found improvements in some outcome measures (SPL, Psub, words per minute,
utterance length, coefficient of variation of fundamental frequency [F0], VHI-10 scores, pitch
range, and /s,z/ durations), while some outcomes remained unchanged (Cerny et al., 1997; Chiara
et al., 2007; Darling-White & Huber, 2017; Johansson, 2012; Pereira, 2015; Ray, 2018; Tsai et al.,
2016). It is noteworthy that in those studies, the EMST protocol was applied by itself and was not
combined with voice exercises, which may have hindered the generalization to voice production.
One study combined voice exercises with EMST during a 5-week intervention protocol and found
significant improvements in MEP as well as in subglottal pressure (produced at loud intensity),
Voice Handicap Index and Voice Rating Scare scores, and dynamic range. The improvements were
greater than those obtained with voice therapy alone (Wingate et al., 2007).
The suggested rationale for choosing EMST to improve voice outcomes is that since elastic recoil
force of the lungs is reduced, active expiratory muscles should be activated to compress the chest
wall and therefore the lungs to a smaller volume and generate the required airway pressure for
the task (Kim & Sapienza, 2005; Silverman et al., 2006). There are two possible pathways to
increase respiratory driving pressure: by recruiting the expiratory muscles, as suggested in
previous research, or by intensifying the passive recoil pressures by increasing inspiratory lung
volume. During normal voice production, respiratory pressure is mostly generated from the lungs’
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passive recoil forces, with occasional activation of expiratory muscles in cases of very loud or long
duration speech (C. M. Sapienza & Wheeler, 2006). The activation of inspiratory muscles during
the active expiratory phase results in better control of the airflow, which allows for longer and
louder speech without using the expiratory reserve volume and without activating the expiratory
muscles. The strategy of initiating phonation at higher lung volumes is already naturally adopted
by older individuals, given that the inspiratory pressure is better preserved than the expiratory
pressure (Hoit & Hixon, 1987; Huber & Spruill, 2008). It is also thought to be an optimal strategy
because at lower lung volumes, speakers have to use more expiratory effort to maintain an
adequate subglottal pressure while at the same time physiological expiratory pressures decrease
(Zhang, 2016c). This is counterproductive and therefore it is recommended to maintain the lung
volume well above residual volume (Zhang, 2016c).
Patients with presbyphonia need even more strengthening of their inspiratory muscles to
compensate for their impaired laryngeal valving that restrains them from using glottal resistance
to decrease the rate of lung volume decline and conserve airflow. Moreover, since it has been
found that older adults produce shorter utterances when compare to younger adults (Huber,
2008), inspiratory muscle training would allow for a better control of the expiration during speech
which would lead to longer utterances and less pauses. Frequent breath pauses reduce the
linguistic cues in the message and affect the listener’s experience, who tend to perceive the
speaker as less competent (Huber, 2008). Despite these arguments, IMST might not be the best
approach for all patients with presbyphonia. Some individuals may have a well-preserved MIP and
may already be initiating phonation at very high lung volume. Because of their reduced ribcage
compliance and lung recoil forces, some patients may still have difficulties generating adequate
subglottal pressure for phonation and the early activation of expiratory muscles might be an
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effective strategy for them. Because of a lack of research, it is not known which approach, IMST
or EMST, would yield the best possible outcomes for patients with an age-related voice disorder.

Future Studies
Both IMST and EMST represents promising rehabilitation paradigms for patients with
presbyphonia who present with rises in expiratory reserve volume (Gibson, Pride, O'Cain, &
Quagliato, 1976) in addition to reduced respiratory muscle strength. Respiratory training is not
intended to replace voice therapy, but rather to complement it in order to generate the best
possible outcomes. Current standard of care consists of voice therapy, with or without breathing
exercises. The hypothesis is that current breathing exercises and voice therapy programs are not
specific and intensive (in terms of loading) enough to induce the neuromuscular and hypertrophic
changes necessary for improving respiratory outcomes. IMST and EMST have been proven to be
effective in engendering those changes in elderly individuals (Kim, Davenport, & Sapienza, 2009;
Souza et al., 2014), leading to significant improvements in clinical measures of respiratory
pressures. However, this is not enough to support their use with presbyphonic patients, because
the impact of these changes on voice outcomes have not yet been established.
In order to demonstrate that RMST should be integrated to current standard of care, a study
should be conducted comparing the voice and respiratory outcomes of patients receiving voice
therapy and RMST with those of patients receiving voice therapy only. This will allow for the
testing of two hypotheses: 1) that respiratory training combined with voice therapy leads to
significantly greater respiratory improvements than voice therapy only; and 2) that respiratory
improvements induced by RMST result in significantly greater improvements in voice outcomes
than those obtained solely with voice therapy.
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Section 5: Clinical Manifestations of Presbyphonia and Outcome
Measures for Presbyphonia Research

It is important that the outcome measures used to assess changes following treatment be strongly
associated with the vocal manifestations of the voice disorder. These manifestations, such as
breathiness, decreased loudness and incomplete glottal closure, are by themselves
manifestations of the underlying physiological processes of aging including atrophy of the TA and
respiratory muscles and degeneration of the lamina propria of the vocal folds. Therefore, to assess
if a treatment was specific enough to target the relevant physiological mechanisms of
presbyphonia, outcome measures should be chosen carefully. Moreover, while each outcome
measure has its own weight/significance, the importance of a multidimensional assessment of the
treatment outcomes should be taken into consideration to draw a complete representation of
the voice and its changes following treatment and to allow for future comparison with other
relevant studies.

Laryngeal Features
Laryngeal endoscopy with stroboscopy (LES) is used in voice clinics to diagnose patients, plan
therapeutic goals and assess changes following treatment and has been described as the most
valuable method for evaluating laryngeal function in presbyphonic patients (Bloch & Behrman,
2001; Vaca, Cobeta, Mora, & Reyes, 2017). In research, LES is used to choose participants based
on specific inclusion criteria, such as vocal fold bowing, presence of a glottal gap and/or vocal fold
processes prominence in the case of presbyphonia. Visual examination of the larynx would allow
for direct observation of laryngeal changes following treatment, however LES is rarely used as an
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outcome measure in the studies of voice therapy for presbyphonia. While many authors
hypothesized that their intervention yielded changes in vocal fold vibration and vocal fold
adduction, in many cases these assumptions were not verified. Only few studies, mostly case
series, have confirmed an improved glottal closure after behavioral voice therapy (Lu et al., 2013;
Tanner et al., 2010).
Although glottal insufficiency is thought to be one of the main pathogenic features of the
presbylarynx (Pontes, Yamasaki, & Behlau, 2006; Vaca et al., 2017), additional age-related
changes in laryngeal function and morphology are also at the basis of changes in elderly voices
and should therefore be considered as relevant/clinically meaningful outcome measures. An
observational study by Pontes et al. (2006) revealed that elderly larynges differ significantly from
young ones on different parameters including: vocal fold edges (bowing), glottal gap
configuration, supraglottic hyperfunction, and phase and amplitude symmetry of vocal fold
vibration. Although the difference was not always significant, aged vocal folds have also been
found to exhibit a decreased regularity in vocal fold vibration, an increased vibration amplitude,
a decreased mucosal wave symmetry (Pontes et al., 2006) and a dominant open phase (Murty,
Carding, & Kelly, 1991). While correlated, these parameters provide complementary information
on the laryngeal function and should therefore all be taken into consideration when assessing the
impact of an intervention on the presbylarynx.
Bowing of the vocal folds, thought to be caused by atrophy of the TA muscle and changes in the
ECM components of the lamina propria, has been related to glottal insufficiency (Bloch &
Behrman, 2001; Pontes et al., 2006) and provides a high sensitivity for the diagnosis of an
incomplete glottal closure. However, some patients will exhibit vocal fold bowing during rest
breathing but will achieve a complete glottal closure during phonation by medially compressing
the vocal folds with the ventricular folds (Vaca et al., 2017). A particular attention should be given
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to the configuration/location of the glottal gap as a stroboscopic parameter. In fact, no significant
difference was found in glottal gap occurrence between young and old subjects, whereas a
significant difference has been found regarding the shape of the glottal gap, with a spindle shaped
gap more frequently associated with aged larynges and a triangular posterior chink more
frequently found in young larynges (particularly in women)(Linville, 1996; Pontes et al., 2006).
Vocal fold bowing and glottal gap are also related to the parameter of phase closure which has
been found to be predominantly open in patients with presbyphonia, but which could also be
influenced by the degree of supraglottic hyperfunction.
A literature review on the use of LES as an outcome measure in voice treatment studies has
examined the sensitivity to change of different laryngeal parameters. The results revealed that
some of the abovementioned parameters present a good sensitivity to change: phase symmetry
showed a rate of improvement of 85% and location/shape of glottal gap had a rate of
improvement of 80% (Bonilha H, 2017). This signifies that these parameters were sensitive
enough to detect a statistically significant change following the administered treatment. The
features of vocal fold edges and of supraglottic hyperfunction were not assessed often enough
regarding their statistical significance in order to provide data on their sensitivity to change.
However, other parameters that demonstrated a good sensitivity to change and that are relevant
for presbyphonia research include regularity of vibration (88%), amplitude of vibration (83%),
mucosal wave quality (83%), mucosal wave amplitude (75%), and magnitude of glottal gap
(72%) (Bonilha H, 2017).
No study to date has established the magnitude of change in these parameters that would
correlate with a functionally meaningful improvement for presbyphonic patients. Such thresholds
are challenging to establish because they might differ from one patient to another but also
because few research studies to date have employed standardized rating forms for stroboscopic
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assessment of laryngeal anatomy and physiology (Bonilha H, 2017). The lack of a widely used
standardized form for stroboscopy ratings of laryngeal parameters, combined with the use of
ambiguous terms to name these parameters and the use of various scales to measure them, has
led to intra- and inter-rater reliability issues in LES assessment. Parameters that have been
identified to be the less reliable are those involving a movement pattern (functional/temporallydependent), such as amplitude of vibration, mucosal wave, phase symmetry, and regularity of
vibration (Bonilha, Focht, & Martin-Harris, 2015; Poburka & Bless, 1998). The implementation of
a standardized rating form such as the Vibratory Assessment With Laryngeal Imaging
(VALI)(Poburka, Patel, & Bless, 2016), with definitions, graphics, and rating instructions for each
parameter as well as video samples for training has been shown to improve the reliability of these
parameters and should therefore be used for voice research.

Aerodynamic Measures and Phonation Duration Measures
Aerodynamic measures and phonation duration measures are the result of laryngeal function,
pulmonary function and respiratory strength (Vaca et al., 2017). They can also be influenced by
the resonance system because of the acoustic pressures created by the source-filter interaction.
Because they encompass several components of voice production, it is challenging to make
assumption on physiological mechanisms underlying aerodynamic measures, unless other
outcome measures are being used to individually assess laryngeal function and respiratory
function. However, aerodynamic measures have the advantage of providing information on the
combined activity of these systems and therefore offer functional and clinically meaningful data.
This is particularly pertinent in the case of presbyphonia because of its known alterations in both
phonatory and respiratory mechanisms. Aerodynamic and phonation duration measures that are
relevant for presbyphonia research and that have been shown to demonstrate good outcome
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measures properties include laryngeal resistance (RLaw), mean airflow, estimated subglottal
pressure (Psub), and maximum phonation time (MPT).
Mean airflow rate has been shown to increase in older subjects, which can be explained by an
incomplete glottal closure (Higgins & Saxman, 1991). Higgins & Saxman (1991) found subglottal
pressure to be increased in older men when compared to younger men and explained this result
by the increased stiffness of the vocal folds, which may require a higher Psub. These findings are
different from those of Baker et al. (2001), who found similar absolute and normalized Psub values
for older and younger subjects across three loudness conditions (soft, comfortable and loud). The
variability in age-related changes and in compensation mechanisms could partly account for these
discrepancies: some patients compensate for their glottal insufficiency by increasing vocal fold
adduction while others may increase respiratory effort (K. K. Baker et al., 2001). Moreover,
variations in pulmonary and respiratory function can influence the available subglottal pressure.
Laryngeal resistance is computed by dividing Psub by mean airflow and provides information of
the valving function of the vocal folds. RLaw has been shown to be reduced in older individuals
and this is thought to be correlated with their reduced adductory function (Melcon, Hoit, & Hixon,
1989). MPT is influenced by both the laryngeal and respiratory function, and has consistently been
found to be reduced with aging (J. Gartner-Schmidt & Rosen, 2011). MPT is rapid and easy to
administer and is often used as an outcome measure in voice treatment studies (Desjardins et al.,
2017).
Authors have examined the expected variations in aerodynamic measures in healthy subjects and
have found that some parameters present with good intra-subject reliability when assessed on
different days or at different moments within one day. Laryngeal resistance, mean airflow,
estimated Psub, and maximum phonation time (MPT) showed no significant difference when
assessed on the same speaker at different time points, demonstrating a good reliability (Garrison,
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2009; L. Lee, J. C. Stemple, & M. Kizer, 1999; Linda Lee, Joseph C Stemple, & Marla Kizer, 1999;
Leeper & Graves, 1984). It was also found that standard deviations were smaller and reliability
was better when parameters of intensity and fundamental were controlled (Garrison, 2009; Linda
Lee et al., 1999; Leeper & Graves, 1984). Awan et al. (Awan, Novaleski, & Yingling, 2013)
calculated intraclass correlation coefficients (ICCs) for various aerodynamic measures to gather
information on relative reliability, which is the extent to which subjects maintain their respective
ranks in the sample (Weir, 2005) . The study revealed strong ICCs for MPT, Psub, and laryngeal
resistance. For these three outcome measures, ICCs were greater than 0.75, which has been
associated with excellent reproducibility (Marx, Menezes, Horovitz, Jones, & Warren, 2003). The
ICC for mean airflow was strong for males but weaker in females (ICC=0.67), which remains
acceptable for test-retest reliability (Awan et al., 2013). In this study, the intensity and
fundamental frequency were not controlled. The authors state that, even though stronger testretest reliability values may be obtained when controlling for these variables, it may negatively
impact the validity of the measurements by masking the true phonatory behaviors (Awan et al.,
2013; Higgins, Netsell, & Schulte, 1994). For this reason, they suggest that the measurements be
made while allowing subjects to use comfortable loudness and pitch.
A systematic review on voice therapy effectiveness studies revealed that this category of outcome
measures (including MPT, mean airflow, laryngeal resistance and Psub) were used in a third of the
15 reviewed studies and that they improved significantly in half of those (Desjardins et al., 2017).
A lack of improvement in these measures should not necessarily be interpreted as an absence of
treatment effect. Because these measures are a result of many physiologic components (including
respiratory muscle activity, integrity of vocal fold tissue, glottal competence and phonatory style
(Desjardins et al., 2017; Zraick, Smith-Olinde, & Shotts, 2012)), it is possible that improvement in
one of these components was present but not sufficient to impact the resulting aerodynamic

87
measure. This reveals the lower sensitivity to change of aerodynamic measures, but it also
highlights their clinical meaningfulness as functional measures since they integrate many aspects
of voice production. It is hard to determine if the 50% rate of significant improvement found in
the systematic review (Desjardins et al., 2017) was also caused by a high inter-subject variability.
In discussions on this topic, Higgins et al. (1994) suggest that their high inter-subject variability
does not discredit aerodynamic measures as outcome measures for voice research. The authors
calculated coefficients of variation in 21 subjects and concluded that a change of more than 15%
in subglottal pressure and of more than 25% in mean phonatory airflow should represent a true
physiological change, not caused by intra-subject variability. The use of cut-off values such as
those suggested by Higgins et al. (1994) should greatly help with the interpretation of
aerodynamic measures. Whether or not this change correlates with clinically meaningful voice
remains to be determined.
Laryngeal resistance, Psub and mean airflow can be measured with the voice efficiency protocol
of the KayPENTAX PAS 6600. Although it is possible that a certain amount of measurement error
be attributable to the system or to the user’s oversight, the PAS system has been shown to have
a strong calibration accuracy and a good validity of the built-in flowhead and pressure transducer
(Garrison, 2009; Zraick et al., 2012).

Auditory-Perceptual Judgement of Voice Quality
Auditory-perceptual judgements of voice quality are a common part of voice assessment both in
the clinical and research fields. They are the auditory perceptual consequence of the underlying
voice physiology and therefore are affected by the age-related changes in the respiratory,
laryngeal and neurological systems. A study on 72 elderly subjects revealed that the most
common vocal alterations observed in this population are: general dysphonia grade, followed by

88
roughness, and breathiness (Pessin, Tavares, Gramuglia, de Carvalho, & Martins, 2017). The same
study revealed that vocal alterations of different severities were present in 90% of subjects aged
60-75 years old and in 96% of subjects over 75 years old. Other auditory perceptual traits have
been reported in the literature as being characteristic of presbyphonia, including altered pitch
(lower in women and higher in men), decreased pitch range, increased strain and
unsteadiness/instability, occasional vocal tremor and decreased loudness (Lu et al., 2013; Tay et
al., 2012).
Two main standardized assessment forms are widely used in the voice field to rate perceptual
judgments of voice quality: the Grade Roughness Breathiness Asthenia Strain (GRBAS, or GRBASIincluding the parameter of instability) and the Consensus Auditory Perceptual Evaluation of
Voice (CAPE-V-including overall severity, breathiness, roughness, strain, pitch and
loudness)(Nemr et al., 2012). The CAPE-V seems like the most appropriate outcome measure
instrument for presbyphonia research because it includes the parameters of pitch and loudness,
which are typically affected in this patient population. The CAPE-V instrument also includes a
classification of the resonance parameter and allows for the description additional features (Nemr
et al., 2012). As study comparing the reliability of the GRBAS and the CAPE-V showed that both
instruments present with strong ICCs for intra-judge reliability, ranging from 0.923 to 0.985 (Nemr
et al., 2012). Strong correlations were also found for inter-judge reliability for both instruments
(Nemr et al., 2012). The CAPE-V and GRBAS have also been found to be highly correlated regarding
the general severity grade parameters, thus supporting their concurrent validity (Nemr et al.,
2012). The CAPE-V’s concurrent validity was also confirmed in a study that compared raters’
judgments of overall severity (using the CAPE-V scale) to a consensus of severity judgments that
had been a priori established on 59 voices (22 normal and 37 disordered) (Zraick et al., 2011).
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The CAPE-V has been found to be sensitive for detecting even subtle changes in voice quality,
more so than the GRBAS (Nemr et al., 2012; Wuyts, De Bodt, & Van de Heyning, 1999). This could
be explained by the different types of scales that are used in the two instruments. While the
GRBAS employs an ordinal scale that offers only three choices to the rater (mild, moderate,
severe), the CAPE-V uses a visual analog scale that allows for more nuances and might be helpful
for rating small changes in voice (Nemr et al., 2012). In a literature review on voice therapy
effectiveness studies, all studies that used the overall severity parameter from the CAPE-V, except
one, found a statistically significant improvement following behavioral voice therapy. This
confirms the strong sensitivity to change of the CAPE-V and its relevance as an outcome measure,
particularly in presbyphonia research since changes following treatment have been shown to be
minimal and/or harder to detect for this patient population (Gillespie, Dastolfo, Magid, & GartnerSchmidt, 2014).

Acoustic Measures
Although perceptual judgments of voice quality present with good reliability profiles, they remain
subjective measures and should be complemented by objective auditory measures in the context
of multidimensional voice assessments. Quantifying the severity and characteristics of a
disordered voice offers a precise way to assess treatment effectiveness and patient improvement
following an intervention. Acoustic assessments are therefore recommended by ASHA in their
guidelines for instrumental assessment of voice (Awan et al., 2005), as they are the correlates of
the perceptual parameters of pitch, loudness and voice quality. The recommended parameters
include:
1) Measures of sound level in decibels (dB):
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a. Habitual sound pressure level (SPL): mean SPL during connected speech, which
correlated with vocal loudness.
b. Maximal and minimal SPL: softest and loudest sustained sounds that can be
produced by the subject.
2)

Measures of vocal frequency in Hertz (Hz):
a. Mean fundamental frequency (F0): the number of vibratory cycles per
second(Pessin et al., 2017); correlates with the vocal pitch.
b. F0 standard deviation: provides information on the stability of the F0.
c. Minimal and maximal F0: these values can be used to compute the F0 range,
expressed in semitones.

3) Measures of vocal quality:
a. Jitter (%): cycle-to-cycle perturbation of the period.
b. Pitch perturbation quotient (PPQ)
c. Shimmer (%): cycle-to-cycle perturbation of the period amplitude.
d. Amplitude perturbation quotient (APQ)
e. NHR (dB): measures the degree of noise (aperiodicity) in the voice signal.
f.

Voice turbulence index (VTI)

g. Soft phonation index (SPI)
h. Smoothed cepstral peak prominence (CPP) (dB): measure of voice quality
derived from the cepstrum. It is the ratio of the observed amplitude of the
cepstral peak to the expected amplitude based on linear regression (Peterson et
al., 2013). A periodic signal will display a more prominent cepstral peak when
compared to an aperiodic signal because the fundamental frequency and the
harmonics are well defines (Peterson et al., 2013).
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With computer software for cepstral measure analyses becoming more accessible, ASHA
advocates for the inclusion of a cepstral measure such as CPP in the acoustic analysis of voice
quality. They justify this recommendation with the growing body of evidence that claims that
cepstral measures (frequency-based) are more appropriate than traditional acoustic measures
(time-based) for analyzing connected speech, which makes them more ecologically valid (Maryn,
Roy, De Bodt, Van Cauwenberge, & Corthals, 2009). In addition, time-based measures rely on the
periodic signal and thus their accuracy for severely dysphonic voices is not optimal (Gillespie et
al., 2014). On the other hand, frequency-based measures examine the dominance of the F0 over
superfluous noise in the signal and do not depend on the periodicity of the waveform (Gillespie
et al., 2014). CPP has been shown to be reliable in men and moderately reliable in women when
tested on vocally healthy volunteers (Leong et al., 2013).
Despite these considerations, traditionally-used time-based measures such as F0, jitter, shimmer
and HNR provide clinicians and researchers with valuable information regarding the impact of a
treatment on specific acoustic characteristics. Moreover, these measures are sensitive enough to
differentiate voices of young and elderly subjects and therefore to depict the acoustic
consequences of the age-related physiological changes occurring in the larynx. Acoustic analyses
in older subjects have consistently revealed a lower F0 in women and a higher F0 in men (Pessin
et al., 2017). While the higher F0 in men can be explained by a reduced mass of the vocal folds
caused by the muscle atrophy, the lower F0 found in women is thought to be related to postmenopausal hormonal changes (Awan, 2006). Other acoustic characteristics have been observed
in elderly subjects, including increased in amplitude variations (shimmer) and reduced HNR
(Deliyski, 2001; Ferrand, 2002; Gorham-Rowan & Laures-Gore, 2006). Observations regarding
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frequency variations values (such as jitter) for presbyphonic voices are conflicting in the current
literature (Tay et al., 2012), and this might be related to the data acquisition procedures.
As a matter of fact, attention should be given to the context in which acoustic measures are being
recorded in order to ensure their validity and reliability and therefore their ability to detect
changes following a treatment. Acoustic measures have indeed been criticized by some authors
on the basis of a lack of reliability and sensitivity to change (Carding, Wilson, MacKenzie, & Deary,
2009; Leong et al., 2013). However, in the abovementioned literature review on voice therapy
effectiveness (Desjardins et al., 2017), acoustic measurements showed significant improvements
between 85% and 90% of the time and yet most of the parameters used were time-based (cepstral
measures were included in only one of the 15 reviewed articles). In their guidelines, ASHA has
provided detailed information on how to conduct acoustic recordings and analyses in order to
limit measurement error. The strict following of these guidelines should greatly improve the
reliability of acoustic measures and consequently enhance their value as relevant outcome
measures for voice treatment studies.

Self-Assessment Measures
Self-assessment measures represent a unique and indispensable category of outcome measures
because they assess the functional impact of a voice disorder on the patient’s life. Self-reported
measures don’t necessarily correlate with other outcome measures and this is not because of a
lack of validity: it is because they assess a different construct, namely the concept of handicap.
The impact of a voice disorder on the patient is of course influenced by the voice disorder itself
(and therefore the stroboscopic, aerodynamic, auditory perceptual and acoustic findings), but
other factors come into play. These factors include the level of activity and participation of the
patient and the degree to which their vocal demands can be met despite the voice disorder. This
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type of information is particularly relevant for patients with presbyphonia who might present with
diverse profiles of activity and participation. This could partly explain why, even though agerelated changes in the subsystems related to voice production are universal, only a certain
proportion of elderly people are considered to have a voice disorder (although this number is also
affected by the number of people who seek treatment and by the inter-subject variability in the
physiological aging process).
The Voice Handicap Index (VHI) is one of the most broadly used self-reported questionnaire in
the voice field. It evaluates the degree of voice-related handicap experienced by the patients in
their day to day life. The questionnaire contains 30 items, which are divided into three categories:
functional, emotional and physical (Jacobson et al., 1997). For each item, the degree of perceived
handicap is rated on a 5-point scale, from 0 (no problem) to 4 (always a problem), for a total of
120 points (Jacobson et al., 1997). The test has a strong test-retest reliability for the three
subcategories as well as for the total score, and a strong internal consistency (Jacobson et al.,
1997). Moreover, the correlation between the patients’ perception of their voice disorder severity
and the scores on the VHI were moderately strong in the validation study, indicating an adequate
construct validity (Jacobson et al., 1997). The original version is lengthy and this could represent
an issue for the older population. For this reason, the use of the validated abridged version, the
VHI-10, seems more appropriate for presbyphonia research. This version contains 10 questions
which were specifically chosen based on their clinical relevance, through expert consensus but
also through item analysis by comparing a dysphonic and a control group as well as a pre- and
post-treatment conditions (Rosen, Lee, Osborne, Zullo, & Murry, 2004). The concurrent validity of
the VHI-10 was confirmed by comparing its results with those obtained with the original VHI,
which yielded a correlation exceeding 0.90. The results suggest that the VHI-10 is valid and might
even represent a more robust and sensitive instrument than the VHI to assess voice-related
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handicap in patients with voice disorders in addition to being faster to administer (Rosen et al.,
2004). In order to facilitate the interpretation of the results in terms of clinical meaningfulness a
group of researchers (Arffa, Krishna, Gartner-Schmidt, & Rosen, 2012) calculated normative
values for the VHI-10 and came to the conclusion that a score above 11 is indicative of a voicerelated handicap.
Although the VHI is useful in assessing the level of handicap caused by the voice disorder and the
level of improvement following treatment, it is not specific to the manifestations of presbyphonia.
The Glottal Function Index (GFI) (Bach et al., 2005) was conceived specifically to assess the
symptoms related to glottal insufficiency and therefore applies directly to presbyphonic patients,
considering that the presence of a glottal gap is one of the main hallmarks of this voice disorder.
The advantage of a disease specific impairment instrument such as the GFI is that it provides
information on the level of handicap and symptoms directly associated with the condition and
evaluates how the treatment was successful in targeting its underlying mechanisms (Bach et al.,
2005). Because it is targeted, the GFI is very short and can be easily administered at each therapy
session, allowing for interim data collection. The instrument comprises four items, each rated on
an ordinal scale from 0 (no problem) to 5 (severe problem), for a total of 20. The GFI presents
with an excellent test-retest reliability and with good criterion and construct validity (Bach et al.,
2005). Its criterion validity and sensitivity to change were confirmed based on its consistent and
significant decrease in scores following established surgical treatment for glottal insufficiency. Its
construct validity was confirmed by a good correlation with the VHI results. A GFI score higher
than 4 (mean + 2SD) was determined as the cut-off value to differentiate normal and abnormal
voices (Bach et al., 2005).
Perceived Phonatory Effort (PPE) is another easy-to-administer outcome measure relevant for
patients with presbyphonia. It was used in a clinical trial for presbyphonic patients by Ziegler et
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al. (Ziegler, 2014), in which participants were asked to rate their perceived effort during phonation
on a scale where 100 represents comfortable effort, 200 represents twice as much as
comfortable, 50 represents half the comfortable effort, etc. (Ziegler, 2014) This outcome measure
detected a significant reduction in perceived effort in one of the intervention groups.
Laryngopharyngeal reflux (LPR) is a widespread chronic condition that can have a significant
impact on the larynx and the voice, including edema of the vocal folds and perceived hoarseness
and vocal fatigue (Belafsky, Postma, & Koufman, 2001, 2002). Most voice studies on treatment
effectiveness don’t incorporate the presence of LPR in their exclusion criteria because of its scope
(it could be present in up to 50% of voice patients (Koufman, Amin, & Panetti, 2000)) and also
because many people are affected by reflux without being aware of it. Including subjects with LPR
in voice studies enhances the generalizability of the results to a wider patient population.
However, it remains important to document the presence and symptoms of reflux as it may
impact the response to voice therapy. The Reflux Symptom Index (RSI) (Belafsky et al., 2002) is a
self-reported measure that is commonly administered as part of voice evaluations to assess the
symptoms related to LPR. It contains nine items and it can be administered in less than one minute
(Belafsky et al., 2002). Each item is scored on an ordinal scale with values from 0 (no problem) to
5 (severe problem), for a total of 45 points. Similarly to the GFI, the RSI has been compared to the
VHI to confirm its construct validity, which has been shown to be good. Its criterion-based validity
is also good since the RSI can correctly detect improvements of LPR symptoms following
treatment (Belafsky et al., 2002). The instrument has also be proven to be reliable (Belafsky et al.,
2002). Lastly, the cut-off value to differentiate a LPR related problematic is a RSI score higher than
13. The authors mention that a certain amount of reflux can occur in most people and thus this
cut-off value helps interpret the results in a clinically meaningful way (Belafsky et al., 2002).
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Lastly, the Communicative Participation Item Bank (CPIB) (Baylor et al., 2013) is a 10-item
instrument designed to assess the construct of communicative participation across various
communication disorders and situations. The items are score from 0 (the condition interferes very
much with the situation) to 3 (the condition does not interfere at all). The total score ranges from
0 to 30, with a higher score being more favorable.

Pulmonary Function and Respiratory Muscle Strength Measures
In the context of presbyphonia research, it is clinically relevant to determine if patients who
present with voice complaints also have reduced pulmonary function and/or decreased
respiratory muscle strength when compared to norms for healthy elderly individuals. This data
could help understand why some elderly subjects present with poorer voice outcomes than others
and could partly explain why some patients who undergo voice therapy don’t improve as much
as others. It could also provide data on the effects of respiratory and voice therapies on these
measures and the resulting impact on voice outcomes.
The two main pulmonary function parameters obtained with spirometry are forced vital capacity
(FVC) and force expiratory volume in one second (FEV1). FVC is a measure of the lungs’ vital
capacity performed during a complete and forced exhalation from full inspiration to the end of
the expiratory reserve volume (Miller et al., 2005). FEV1 is the volume forcefully exhaled during
the first second of the FVC task (Miller et al., 2005). Both tasks are measured in liters at body
temperature and ambient pressure saturated with water vapour (BTPS) and can be altered in both
obstructive and non-obstructive lung disorders (Pellegrino et al., 2005) as well as in normal aging.
As a matter of fact, both FVC and FEV1 have been shown to decrease with age in a linear fashion
(Loth et al., 2013). When tested on sample of 3528 subjects, those spirometry measure have been
found to have an excellent reliability (Detels, Coulson, Tashkin, & Rokaw, 1975). Moreover, FEV1
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is thought to be the most repeatable measure of pulmonary function (Pellegrino et al., 2005). The
sensitivity to change of these measures following IMST is unclear from the data in the literature
and this could partly be explained by the differences in patient populations. Moreover, the lack
of change following a treatment with patients who have a rapidly progressive disease should be
interpreted carefully, as it does not imply that the treatment was ineffective or that the measure
has a poor sensitivity to change, but rather that the intervention may be maintaining the patient
at a certain level and avoiding decline (Pellegrino et al., 2005).
Measures of vital capacity do not only reflect the integrity of the lungs since they are also
influenced by the strength of the respiratory muscles. In fact, a low vital capacity or an increased
residual volume can either be a sign of disease of the lungs or they can be indicative of respiratory
muscle weakness (Evans & Whitelaw, 2009). Weak inspiratory muscles won’t allow to expand the
lungs to their full capacity, whereas weak expiratory muscles won’t allow to compress the lungs
completely to a normal residual volume (Evans & Whitelaw, 2009). Many conditions, such as
aging, comprise changes in both lung structure and respiratory muscle strength. Complementing
spirometry measures with outcome measures that provide direct information on the inspiratory
and expiratory muscle strength will offer a more precise picture of the respiratory system status
before and after the intervention.
To directly measure the number and the size of the respiratory muscle fibers before and after an
intervention would be invasive and wouldn’t provide clinically meaningful information. This is why
indexes such as Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP)
are useful, because they indirectly measure respiratory muscle strength (Kim & Sapienza, 2005;
C. M. Sapienza et al., 1999) by appraising the pressures at the mouth (Romer & McConnell, 2004).
This can be done by using a hand-held pressure meter or a manometer. Values obtained with a
hand-held device have been shown to be reliable and valid when compared to those obtained
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with a manometer (Hamnegard et al., 1994; Romer & McConnell, 2004). A reliability study by
(Romer & McConnell, 2004) revealed lowest intra-subject variability than previously published
findings, with excellent agreement ratios for MIP, MEP and FVC. The authors explain these results
by the fact that subjects in their experiment were thoroughly familiarised with the procedure a
priori and that the measurements were all taken by the same investigator, therefore reducing
secondary variance. Reducing bias is also likely to increase sensitivity to change of these
measures, which is already strong. In fact, many studies testing inspiratory and expiratory muscle
strength training have included MIP and MEP in their outcome measures and have obtained
statistically significant differences (Souza et al., 2014).
In summary, presbyphonia is a complex and multi-variable phenomenon. Its features and their
underlying physiological basis need to be thoroughly understood to develop the best possible
intervention and to adequately measure the efficacy of the newly developed treatment paradigm.

Chapter 3: Methodology
Research Questions
1. Which outcome measures present with the strongest intra-subject reliability in a sample
of patients with presbyphonia?
2. What is the respiratory function of patients with presbyphonia and how is it correlated
with voice measures in this population?
3. a) What is the effect of RMST on respiratory and voice outcomes in patients with
presbyphonia and b) how do baseline measures of respiratory function influence the
response to the intervention?

Specific Aims
Specific Aim 1: To determine which outcomes present with the strongest intra-subject
reliability in a sample of patients with presbyphonia. Hypothesis: Respiratory muscle strength
measure (MIP and MEP), cepstral peak prominence smooth (CPPS), mean F0, mean SPL, and
self-reported measures will be the most reliable outcomes.

Specific Aim 2: To assess respiratory function and its correlation with voice outcomes in
patients with presbyphonia. Hypothesis 1: Patients with presbyphonia will present with a
reduced respiratory function when compared to predicted values.
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Hypothesis 2: Participants with a lower respiratory function will present with poorer voice
outcomes than participants with a higher respiratory function when controlling for baseline
atrophy.

Specific Aim 3: To acquire pilot data on the effects of RMST on respiratory and voice outcomes
in patients with presbyphonia.
Aim 3a: To determine what effect sizes are to be expected within and between
participants following a RMST intervention. Hypothesis 1: Small effect sizes will be found within
participants for respiratory muscle strength measures (MIP and MEP), smoothed cepstral peak
prominence (CPPS), self-reported outcomes, and aerodynamic measures. Hypothesis 2: The
RMST groups (IMST and/or EMST) will demonstrate greater improvement in respiratory
outcomes, and in voice-related outcomes than the VFE-only group.
Aim 3b [exploratory]: To determine how baseline measures of respiratory function and
atrophy influence the effects of RMST. Hypothesis 1: IMST will have maximal effect on patients
with decreased maximum inspiratory pressure (MIP). Hypothesis 2: EMST will have maximal
effect on patients with decreased maximum expiratory pressure (MEP). Hypothesis 3:
Participants with more severe atrophy will be less responsive to non-surgical approaches, RMST
and VFE, than participants with milder atrophy.
This is an initial feasibility and mechanistic study that has the potential to reveal that RMST
(IMST/EMST) can significantly improve outcomes from voice therapy by acting in synergy with
VFE. Currently, much time is spent in voice therapy on subthreshold ‘breathing exercises’ that lack
evidence. This project will provide guidance for evidence-based and theory driven approaches to
leverage respiratory function to improve voice therapy. Conversely, negative findings from this
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study would indicate that respiratory function is ineffective and not a viable target for therapy in
this patient population.

Overview
After being enrolled in the study (inclusion and exclusion criteria are described below), treatmentseeking patients with a diagnosis of presbyphonia underwent baseline assessments including:
voice (videostroboscopy, acoustics, aerodynamics, self-assessments) and respiratory (pulmonary
function and respiratory muscle strength) measures. Participants were then blocked-randomized
(based on their respiratory muscle strength) to one of three groups using a 3-parallel arm design:
IMST+VFE (I+VFE), EMST+VFE (E+VFE) and VFE (interventions described below). Participants
attended four 1-hour therapy sessions with a SLP and a research team member. Each session
consisted of 15 minutes of pre-session measures; followed by 10 minutes of IMST, EMST or VFE
for groups I+VFE, E+VFE and VFE, respectively; then 20 minutes of voice exercises for all three
groups and; lastly 15 minutes of patient education and post-session measures. Participants were
asked to practice their respective exercises for 10 minutes, twice daily, seven days a week during
the duration of the study. A final assessment session, after the 4th therapy session, mirrored the
baseline measures. Outcomes that rely on subjective judgment (visual ratings of
videostroboscopy and auditory-perceptual judgments of voice quality) were rated by trained
judges (SLPs) blinded to the group assignment. [Note: Long-term follow-up was not conducted.
This study’s focus is on the mechanistic effects of the intervention; future studies, given positive
outcomes from this study, will explore the effectiveness and long-term effects.]
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Study Design
Aims 1 and 2
This is a prospective cross-sectional study (Aim 2), with a repeated measures baseline assessment
(Aim 1). Participants were assessed on various voice and respiratory measures, with the objective
of assessing potential relationships between respiratory function and voice. Patients with various
levels of respiratory function were included in the study. A subset of participants underwent two
baseline assessment sessions within two months of the first session, in order to assess intrasubject reliability of the measures. Specific details regarding eligibility criteria, assessment tasks
and outcomes measures are provided in subsequent sections.
Aim 3
This is a prospective stratified randomized 3-arm parallel pilot study. Participants were divided
into four strata based on baseline respiratory muscle strength measures: 1) within normal limits
MIP and MEP; 2) preserved MIP and decreased MEP; 3) preserved MEP and decreased MIP;
4) decreased MIP and MEP. Participants were block-randomized into three groups (allocation
ratio of 1:1:1): IMST and VFE (I+VFE); EMST and VFE (E+VFE); voice therapy only (VFE).
Stratification was used to ensure a balanced representation of different respiratory profiles
between intervention groups.

Participants
The study was approved by the Institutional Review Board of the Medical University of South
Carolina. Participants were recruited from the treatment-seeking population at the Evelyn
Trammell Institute for Voice and Swallowing (division of the Department of Otolaryngology-Head
& Neck Surgery) - Medical University of South Carolina (MUSC). As part of usual care, patients
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underwent a videostroboscopic assessment conducted by the laryngologist. During the 10-month
recruitment period, all consecutive patients who were diagnosed with presbyphonia underwent
a brief screening interview by the laryngologist, after which qualifying patients were offered
participation in the study. A member of the study team met with interested participants and
obtained formal written consent. Table 3 presents the inclusion and exclusion criteria for Aims 1
and 2 of the study. Table 4 presents additional exclusion criteria that were applied for Aim 3.

Table 3. Inclusion and Exclusion Criteria for Aims 1 and 2

Inclusion Criteria
Is 50 years or older
Has a diagnosis of presbyphonia given by the
laryngologist and consistent with the
hallmarks of the disorder (vocal fold bowing,
glottal gap during phonation, and/or
prominence of the vocal processes indicative
of vocal fold atrophy)

Exclusion Criteria
Presents with a vocal fold pathology other
than presbyphonia
Has a known neurologic or progressive
neuromuscular disease

Has dysarthria
Has any other condition judged by the
physician as being unsuitable for spirometry
or muscle pressure testing
Is unable to give informed consent
Table 4. Additional Exclusion Criteria for Aim 3

Exclusion Criteria
Has received voice therapy in the past year
Has a medical condition that could be aggravated by the experimental intervention, or any
condition judged by the physician as being unsuitable for RMST.
Has a language disorder
Has a hearing loss that is not adequately mathat naged
Has a cognitive disorder that might affect treatment compliance
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Respiratory Assessments and Outcome Measures
Pulmonary Function
A computer-based spirometer was used (KokoÒSx 1000, NSPIRE HEALTH), and pulmonary
function testing was conducted following the American Thoracic Society and European
Respiratory Society recommendations (Miller et al., 2005). Prior to the task, participants were
instructed to put on a nose clip and to made sure that their lips were sealed around the
mouthpiece connected to the pneumotach. They were then asked to breathe normally in the
spirometer for about four breaths before taking a full inspiration, blowing out with force during
at least 6 seconds, and taking another full inspiration. Those maneuvers were repeated at least
three times, until the two best measurements of FVC and FEV1 differed by no less than 0.15L, to
ensure acceptable repeatability (Miller et al., 2005). The study team member responsible for
conducting spirometry testing received training in the MUSC pulmonary department.
In addition to FVC and FEV1, the FEV1/FVC ratio was also collected from spirometry testing. Both
raw and predicted normal values were reported. Predicted normal values were generated by the
spirometer software based on the participants’ age, sex, and height.
Maximum Respiratory Strength
1) Maximum Inspiratory Pressure (MIP): participants were instructed to exhale slowly and
completely, seal lips firmly around the mouthpiece, and then breathe in forcefully in the
respiratory pressure meter (MicroRPM, MD Spiro/Micro Direct). The maneuver was repeated
approximately four times, with the goal of matching the two highest trials within 10
cmH2O)(Sachs, Enright, Hinckley Stukovsky, Jiang, & Barr, 2009).
2) Maximum Expiratory Pressure (MEP): participants were instructed to take a maximal
inspiration, seal lips firmly around the mouthpiece, and then breathe out forcefully in the
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respiratory pressure meter (MicroRPM, MD Spiro/Micro Direct). The maneuver was repeated
approximately four times, with the goal of matching the two highest trials within 10 cmH2O)(Sachs
et al., 2009).
The lower limit of normal for MIP and MEP were calculated using reference equations (Enright,
Kronmal, Manolio, et al., 1994).

Voice Assessments and Outcome Measures
Laryngeal Features
Videostroboscopy was used to visualize the vocal folds, using either a transnasal flexible
endoscope or a rigid endoscope via the mouth, depending on the tolerability of the subject
(KayPENTAX, model 9400; Olympus, VISERA Elite). Transnasal endoscopy: prior to the
examination, topical lidocaine (numbing medication) and neosynepherine (vasoconstrictive
medication) in a spray were administered if needed in the nasal cavities. Rigid endoscopy: prior
to the examination, topical lidocaine was administered in the back of the mouth if needed to
inhibit gagging. Participants were asked to sustain phonation on the vowel /i/ at a comfortable
pitch and loudness.

Images obtained from videostroboscopy were rated through consensus by two SLPs specialized
in voice disorders, using the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating
form (Poburka et al., 2016). This standardized assessment form was developed with the objective
of improving the validity and reliability of visual examinations from videostroboscopy and highspeed videoendoscopy (HSV). The form contains definitions, graphics, rating instructions for each
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of the 10 laryngeal parameter: 1) amplitude (magnitude of lateral excursion of the vocal folds), 2)
mucosal wave (magnitude of movement of the mucosa), 3) nonvibratory portion, 4) supraglottal
activity (antero-posterior and medio-lateral), 5) phase symmetry, 6) regularity (periodicity of
vibration), 7) vertical level of approximation, 8) free-edge contour (smoothness and straightness),
9) glottal closure (type), and 10) phase closure. Prior to rating the images, the judges underwent
the VALI video training suggested by the authors of the form (Poburka et al., 2016). The video
training presents each of the laryngeal parameters and how to assess them with the form.
Training has been shown to improve the reliability of ratings, especially for temporally dependent
ones such as phase closure and regularity of vibration (Poburka et al., 2016)

Videostroboscopy images were also used to measure bowing index (BI), using the Fiji Is Just
ImageJ software for biological image analysis (Schindelin et al., 2012) developed by Wayne
Rasband (U.S. National Institutes of Health, Bethesda, Maryland, USA 1997-2008). A still image of
the open glottis was captured from the videostroboscopy assessment and entered into the
software. The image was taken immediately prior to or following a sustained /i/ at comfortable
pitch and loudness, during quiet breathing, with the vocal folds remaining in a resting position for
at least 166.66 milliseconds (5 frames at a rate of 30 frames per second).
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BI was calculated following the methodology suggested
by Omori et al. (1997), which was replicated by Kaneko
et al. (2015). The length of the membranous vocal fold
(L) was measured from the anterior commissure to vocal
process by using the straight-line tool in the software
(see Figure 1). Using the same straight-line tool, the Figure 1. Measurement of Bowing Index
maximum distance (d) between the edge of the vocal fold and the line linking the anterior
commissure to the tip of the vocal process was measured. BI was computed with the following
formula: BI = d/L x 100, and the sum of the BI for both vocal folds was used for analyses (Kaneko
et al., 2015; Omori et al., 1997). The BI measurements were performed by two SLPs specialized in
voice disorders, and the measures were averaged.

Acoustic Assessments and Maximum Phonation Time
Acoustic data was recorded using a hand-held microphone held at a distance of 5.5 inches from
the patient’s mouth and at a 45˚ angle. Recordings were made using the Multi-Dimensional Voice
Program Advanced and the Real-Time Pitch program from the Computerized Speech Laboratory
(CSL) (KayPENTAX, Montvale, NJ). Specific tasks and measurements recorded for each task are
described in Table 5.
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Table 5. Tasks and Outcome Measures for Acoustic Analysis and MPT

Tasks
Outcome Measures
Sustained /a/ and /i/ at comfortable pitch and Jitter percent, shimmer percent, noise-toloudness for approximately 5 seconds
harmonic ratio (NHR), soft phonation index
(SPI), voice turbulence index (VTI), amplitude
perturbation quotient (APQ), pitch
perturbation quotient (PPQ), and standard
deviation of F0 (STD), smoothed cepstral
peak prominence measure (CPPS)
Sustain /a/ at comfortable pitch and loudness Maximum phonation time (MPT)
for as long as possible
Glide from the lowest pitch to the highest Minimum fundamental frequency (F0)
pitch on /a/
Maximum F0
Glide from the softest voice to the loudest Maximum sound pressure level (SPL)
voice on /a/
Read the 6 sentences from the CAPE-V
Mean F0 during reading
Mean SPL during reading
CPPS during reading
Natural speech for approximately one minute Mean F0 during conversation
Mean SPL during conversation
In order to obtain smoothed cepstral peak prominence (CPPS), recordings of sustained /a/ at
comfortable pitch and loudness and the three middle sentences from the CAPE-V (21 syllables)
were imported into the software Pratt (version 6.0.46) and were analyzed using the methodology
recommended by Maryn and Weenink (Maryn & Weenink, 2015) and reported in Phadke et al.
(Phadke et al., 2018).

Auditory-Perceptual Judgments of Voice Quality
Voice recordings were also used to obtain perceptual ratings of voice quality, using the CAPE-V.
Voice samples from the following tasks were submitted to raters: /a/ and /i/ sustained at
comfortable pitch and loudness, readings from the six CAPE-V sentences, and sample of
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spontaneous speech. The following parameters were assessed using a visual analog scale of 100
mm: overall severity, roughness, breathiness, strain, pitch, and loudness.

Aerodynamic Assessments
The Phonatory Aerodynamic System (KayPENTAX, model 6600) was used to collect measures of
airflow and pressure. The participants wore a face mask over their nose and mouth. A small tube
connected to a pressure transducer was passed through a hole in the mask and inserted between
the lips. Subjects were asked to produce short utterances each comprised of five /pi/ syllables at
a rate approximating 1.5 - 2 syllables per second (/pi-pi-pi-pi-pi/). Each string of five syllables was
produced on one breath/exhalation. The task was repeated three times at comfortable pitch and
loudness. The following measures were recorded: 1) mean airflow during voicing; 2) mean peak
air pressure (Ps); and 3) aerodynamic resistance.

Self-Assessments
Four questionnaires were filled out by the subjects to assess the impact of their voice disorder on
their daily activities: 1) The Voice Handicap Index 10 (VHI-10), which contains 10 clinically relevant
questions chosen through expert consensus to capture the degree of perceived handicap related
to voice (Rosen et al., 2004). Each item is rated on a 5-point scale, from 0 (no problem) to 4 (always
a problem)(Jacobson et al., 1997). A score above 11 is indicative of a voice-related handicap (Arffa
et al., 2012). 2) The GFI (Bach et al., 2005), a disease-specific impairment instrument meant to
assess symptoms related to glottal insufficiency. The questionnaire contains four items rated on
an ordinal scale from 0 (no problem) to 5 (severe problem), with a maximal score of 20 indicative
of the highest severity. A GFI score higher than 4 is considered the cut-off value differentiating
normal and abnormal voices (Bach et al., 2005). 3) The RSI (Belafsky et al., 2002), a validated self-
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administered questionnaire to assess symptoms related to LPR. It contains nine items scored on
an ordinal scale with values from 0 (no problem) to 5 (severe problem), for a total of 45 points.
The cut-off value to differentiate a LPR related problematic is a RSI score higher than 13. 4) The
Communicative Participation Item Bank (CPIB) (Baylor et al., 2013), a 10-item instrument designed
to assess the construct of communicative participation across various communication disorders
and situations. The items are score from 0 (the condition interferes very much with the situation)
to 3 (the condition does not interfere at all). The total score ranges from 0 to 30, with a higher
score being more favorable.
Lastly, subjects were asked to rate their perceived phonatory effort (PPE) on a direct magnitude
estimation scale (Stevens, 1975) following the speaking and voicing tasks recorded with the CSL.
They were instructed that 100 represents the most comfortable effort, comparable to before they
experienced any difficulty with their voice. If their current effort was twice as much, they would
say 200. If it was three times as much, they would say 300, and so on.

Assessment Timepoints
Participants included exclusively in aim 2 underwent only one assessment session (baseline),
and did not receive any intervention. A subset of participants underwent two baseline sessions
to assess intra-subject reliability (Aim 1).
Participants included in aim 3 underwent two main assessment sessions: at pre-treatment
(baseline) and post-treatment (after the fourth treatment session). In addition, interim
assessments were conducted before and after each session.
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Main assessment sessions included all measures listed above: pulmonary function tests,
respiratory muscle strength tests, laryngeal imaging, acoustic assessments, auditory-perceptual
judgments of voice quality, aerodynamic assessments, and patient self-assessments (Appendix I).
Interim assessment sessions included: acoustic assessments and respiratory muscle strength
tests.
**The two following sections apply only to aim 3**

Randomization
Following baseline assessments, participants were divided into four strata based on baseline
respiratory muscle strength measures: 1) within normal limits MIP and MEP; 2) preserved MIP
and decreased MEP; 3) preserved MEP and decreased MIP; 4) decreased MIP and MEP. The lower
limit of normal (LLN) for MIP and MEP were determined using Enright et al.’s reference equations
(Enright, Kronmal, Manolio, et al., 1994). Table 6 provides the reference equations predicting MIP
and MEP based on gender, weight, and age, as well as the number to be subtracted from the
result to determine LLN. Using a random number algorithm, participants were block-randomized
into three groups (allocation ratio of 1:1:1): IMST and VFE (I+VFE); EMST and VFE (E+VFE); voice
therapy only (VFE). The goal of the stratification was to ensure a balanced representation of
different respiratory profiles between intervention groups.
The interventions are described in the following sections.

Table 6. Reference Equations for Respiratory Muscle Strength(Enright, Kronmal, Manolio, et al., 1994)

Women
Men

Linear Regression Equations
MIP = (0.133*Weight) - (0.805*Age) + 96
MEP = (0.344*Weight) – (2.12*Age) + 219
MIP = (0.131*Weight) – (1.27*Age) + 153
MEP = (0.250*Weight) – (2.95*Age) + 347

LLN
-32
-52
-41
-71

Abbreviations: LLN: lower limit of normal; MIP: maximum inspiratory pressure; MEP: maximum expiratory pressure
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Interventions
Participants attended four 1-hour therapy sessions with a SLP and a research team member. Each
session consisted of 15 minutes of pre-session measures; followed by 10 minutes of IMST, EMST
or VFE for groups I+VFE, E+VFE and VFE, respectively; then 20 minutes of voice exercises for all
three groups and; lastly 15 minutes of patient education and post-session measures. Participants
were asked to practice their respective exercises for 10 minutes, twice daily, seven days a week
during the duration of the study.

Inspiratory Muscle Strength Training (IMST)
IMST was conducted using an inspiratory pressure threshold trainer (Philips Respironics®
Threshold IMT or POWERbreathe® Medic Plus, for patients with a MIP of 55 cmH20 and over),
which consists of a mouthpiece with a spring-loaded valve (C. M. Sapienza, 2008; C. M. Sapienza
et al., 1999). The valve blocks the airflow until the threshold pressure is achieved and allows
airflow as long as the sufficient pressure is maintained. The threshold was set at 75% of the
participant’s initial MIP, as reported in the literature with elderly participants (C. H. Huang, Yang,
Wu, & Lee, 2011). However, the load was lowered if the participant was unable to perform the
exercise regimen. The load was adjusted weekly by the SLP based on the participant’s MIP. Daily
practices consisted of 5 sets of 5 breaths with the device with a 1-minute break between sets,
repeated twice daily (Kim et al., 2009; Mills et al., 2015; Souza et al., 2014).
Expiratory Muscle Strength Training (EMST)
EMST was conducted using an expiratory pressure threshold trainer (EMST150TM) which consists
of a mouthpiece with a spring-loaded valve. The valve blocks the airflow until the threshold
pressure is produced (set at 75% of the participant’s initial MEP, per literature with similar age
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groups (Pitts et al., 2009; C. Sapienza, Troche, Pitts, & Davenport, 2011; Troche et al., 2010)), and
allows the airflow as long as the sufficient pressure is maintained. The load was lowered if the
participant was not able to perform the exercise regimen. Participants were instructed to exhale
forcefully into the mouthpiece after a full inspiration. The load was adjusted weekly by the SLP to
maintain a threshold at 75% of the participant’s MEP. Daily practices consisted of 5 sets of 5
breaths with the device with a 1-minute break between sets, repeated twice daily (Pitts et al.,
2009; C. Sapienza et al., 2011; Troche et al., 2010).
Voice therapy
Participants were instructed to follow the four steps of the VFE protocol, developed by Stemple
(Stemple, 2005) and commonly used by SLPs with patients with presbyphonia. The protocol was
slightly adapted and the following exercises were used: (a) sustain “mi” on the musical note F
(above middle C for women; below middle C for men) for as long as possible. (b) Glide from the
lowest note to the highest note on the word "whoop". (c) Glide from the highest note to the
lowest note of the word "boom". (d) Sustain the notes C-D-E-F-G (starting from middle C for
women and an octave below middle C for men) on the word "moo", for as long as possible. Each
note was repeated until the participants found the right placement (forward-focused voice), as
judged by the SLP. Daily practices, 2x/day, consisted of two repetitions of the VFE protocol for the
I+VFE and E+VFE groups and four repetitions of the VFE protocol for the VFE group. Recordings of
the voice exercises or a link to an online keyboard were provided to facilitate home practice,
depending on the preference of the participant.
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Home Practice
Participants were instructed to practice their respective exercises twice daily, and to log their
practice in a compliance journal (days of training, perceived effects of treatment or other
comments). In addition to in-person therapy sessions, weekly phone calls to the participants were
given to clarify aspects of the training and encourage treatment adherence.

Statistical Approaches and Data Analysis
All statistical analyses were conducted using SAS statistical software (version 9.4, released 2016,
SAS Institute Inc., Cary, N.C., USA) or IBM SPSS Statistics for Windows (version 24, released 2016,
IBM Corp., Armonk, N.Y., USA).

Measures of Reliability
Intraclass Correlation Coefficients (ICCs)
ICCs are indexes of reliability that provide information on the ratio of true variance to total
variance (true variance plus error)(Shrout & Fleiss, 1979; Weir, 2005). More specifically, the
Shrout and Fleiss ICC3,1 was computed to assess intra-subject reliability of each outcome (Shrout
& Fleiss, 1979). This model is based on a two-way mixed model ANOVA, in which the effect of the
trial is fixed and therefore is considered to be the same for all participants (same therapists
administering the task, and same equipment). The true score variance, since it is unknown, is
estimated from the between-subjects variance resulting from the ANOVA’s mean square values
(Weir, 2005). A disadvantage from this model is that it only accounts for random error, and not
for systematic error. Therefore, if all subjects vary consistently across trials, the resulting ICC may
be strong despite a significant trial effect (Weir, 2005). This may cause an issue when using the
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outcome measures to assess pre- to post-treatment effect, and therefore it is recommended that
an ANOVA be conducted in addition to the ICC, to assess potential systematic trial effect (Weir,
2005).

ICCs can have a value between 0 (or lower) and 1, for which 0 indicates a concordance that could
have occurred by chance, whereas 1 indicates perfect reliability (100% of the variance is explained
by the true variance)(Chinn, 1991; Weir, 2005). The ICC values can be interpreted following
guidelines established in the literature and applied in various studies: values of less than 0.40 are
considered indicative of poor reliability; values equal or greater than 0.40 and equal or smaller
than 0.75 indicate fair to good reliability, and values greater than 0.75 indicate excellent reliability
(Awan et al., 2013; Rosner, 2005). Importantly, outcome measures presenting with an ICC of less
than 0.60 were excluded from further analyses, as they were deemed not reliable enough to
accurately inform on pre- to post-therapy changes (Awan et al., 2013; Chinn, 1991).

Standard Error of Measurement (SEM)
SEM represents the random error, or “noise”, that is expected when one subject is tested more
than once for the same outcome measure (Hopkins, 2000). Contrarily to ICC, SEM is not affected
by the between-subject variability and represents an absolute measure of reliability (Weir, 2005).
SEM theoretically corresponds to the within-subject standard deviation (Hopkins, 2000);
however, since this exact value cannot be computed because there is usually a small number of
trials for each participant, it is estimated by using the ICC value in the following formula:
SEM=SDÖ1-ICC, where SD corresponds to the between-subject standard deviation across all trials
(Hopkins, 2000; Weir, 2005). SEM can also be determined by computing the square root of the
mean square error term in the ANOVA output (ÖMse)(Hopkins, 2000; Weir, 2005). In fact, SEM is
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equivalent to the SD of the residuals (random error) for each subjects (Hopkins, 2000). The former
calculation method was used in the present study.

Coefficient of variation (CV)
CV is the ratio of the SEM to the mean multiplied by 100 (Awan et al., 2013; Higgins et al., 1994;
Hopkins, 2000; Weir, 2005). Therefore, it relates the estimated within-subjects spread of
measurements to the mean and provides a relative magnitude of the SEM (Awan et al., 2013).
This measure facilitates comparisons across outcome measures and across samples, because it is
unit-less and independent of the size of the value. In fact, for most measurements, SEM increases
as the value of the outcome increases, which makes comparisons of reliability difficult across
different population samples (Hopkins, 2000; Nevill & Atkinson, 1997).

Minimum difference (MD) or Minimum Detectable Change (MDC)
MD provides an indication of how much difference is needed for two measurements to be
considered different, and not only due to random error in measurement (Weir, 2005). In other
words, it is the least amount of change that needs to occur between two trials in order to be
ensured that there was an intervention effect. This measure is therefore very relevant in
interpreting the results of an intervention study. It is calculated with the following formula:
MD= SEM x 1.96 x Ö2 (Weir, 2005).

Data analysis: Aim 1
For Aim 1, a previously described methodology was followed (Awan, 2006). Firstly, the
distribution of the data was verified for each outcome with the Shapiro-Wilk test, using the SAS
statistical software. For each outcome presenting with a non-normal distribution, a linear
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regression analysis was conducted between the two trials. Residuals that were more than three
SD from the mean were identified, and the corresponding outliers were removed. The ShapiroWilk test was then conducted again on the data to test for normality. Distributions that remained
non-normal even after the removal of outliers were log10 transformed. A two-way ANOVA was
then conducted with one between-subject factor (gender) and one within-subject factor (time).
Time effect was assessed to identify any systematic variability between the two asessements,
which is not taken into account in the ICC3,1 calculation (Shrout & Fleiss, 1979). If a gender effect
was found, further analyses were conducted separately for males and females to avoid bias from
heteroscedasticity.
Data was then imported in IBM SPSS Statistics for Windows for computation of ICCs. To be
consistent with the ICC3,1 as described by Shrout and Fleiss (1979), two-way mixed model and
consistency were chosen from the scroll-down menus. The single measures values were reported.
Outcome measures presenting with an ICC of 0.60 or more were deemed to present with
sufficient intra-subject reliability (Awan et al., 2013; Chinn, 1991).
SEM was calculated with the formula: SEM=SDÖ1-ICC, in which SD represents the pooled standard
deviation for both trials. CV was calculated by dividing SEM by the grand mean of all trials, and by
multiplying the result by 100. MD was computed with the formula MD= SEM x 1.96 x Ö2. SEM and
MD were not reported for outcomes with non-normal distributions, because log transformations
of these values are not valid measures (Awan et al., 2013; Bland & Altman, 1996). However, it was
shown that the SEM of the log transformed value was approximately equal to the CV of the
original outcome, so this association was used to provide CV of log transformed variables
(CV=(ln(10)SEM)x100) (Euser, Dekker, & le Cessie, 2008). CV can only be computed for variables
with an absolute 0 and therefore was not provided for PPE, which was rated on a magnitude scale
with no absolute 0 (Euser et al., 2008).
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Data Analysis: Aim 2
Descriptive statistics including mean, standard deviation, median, and interquartile range, were
computed on each respiratory and voice outcome, for the total sample and for males and females
separately. Normality of the distributions was assessed with the Shapiro-Wilk test (alpha level set
at 0.05). A Mann-Whitney U test was conducted to assess any significant difference between
genders (alpha level set at 0.05). Even when the data was normal, the non-parametric test was
chosen considering the small sample size. Missing data from the self-assessment questionnaires
were imputed using linear regression on the other questions from the same questionnaire.

In SAS, voice and respiratory outcomes were standardized (mean=0, SD=1) and then added +5 to
eliminate negative values. An exploratory factor analysis was conducted on the standardized
respiratory and voice measures to extract the latent constructs of the sets of outcome measures.
The cut-off value of the loading score for inclusion in the factor was set at 0.71 because of the
small sample size (Comrey & Lee, 2013). A weighted variable was then created for each factor, by
multiplying the standardized values of its variables by their associated loading score. In total, two
respiratory factors and eight voice factors were created. A cluster analysis was then conducted
and included all the respiratory and voice factors, as well as age and gender.

Spearman correlations were conducted between all respiratory and voice factors and between
age and all factors. Linear regressions were then computed between respiratory variables and the
voice factors that were found to have a significant (p£0.05) or marginally significant (p£0.1)
correlation with one of the respiratory factors (we considered statistically significant and
marginally significant values to be relevant because this is a pilot study. We erred on the side of
smaller type II versus type I error). Model fit was verified by visual examination of the residual
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plots, and all assumptions for linear regression were met. We examined if adding age/gender
increased the model’s explanatory ability by looking at their respective p-values as well as the
adjusted R-squared for the overall model. Age and gender were kept in the model only if they
improved its explanatory ability.

Data Analysis: Aim 3a
Comparisons of the three intervention groups at baseline were conducted using a one-way
ANOVA for continuous data in SPSS. The assumption of homogeneity of variances was verified for
each variable using Levene’s test. If the assumption was not met, result from the Welch test was
reported. For ordinal data, groups were compared using the Kruskal-Wallis analysis of variance by
ranks.

For single-subject analyses, standard mean difference (SMD) were computed for each variable.
To compute SMD, the numerator is usually calculated by averaging the baseline data and the
intervention data (or 3 baseline points and the last 3 intervention points, to obtain SMD3). The
former is then subtracted from the latter to obtain the numerator. The denominator is the pooled
standard deviation from the population sample, at baseline (Gierut, Morrisette, & Dickinson,
2015). Since only two baseline data points (or one for some participants) were obtained in this
study, the two baseline data points were averaged, as well as the two last intervention points, to
obtain SMD2. Magnitude of the effect sizes were based on Cohen’s (1988) and Sawilowsky’s (2009)
interpretation guidelines: small (0.20), medium (0.50), large (0.80), very large (1.20), and huge
(2.0).
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For group analyses, a two-way mixed ANOVA was computed in SPSS for each continuous variable
with time as a within-subject factor and intervention group as a between-subject factor. Tukey
test was used for post-hoc group comparisons. Once again we considered statistically significant
(0.05) and marginally significant (0.1) values to be relevant because this is a pilot study. We erred
on the side of smaller type II versus type I error.
Pre-post effect sizes within and between the intervention groups were computed using Cohen’s
d. The standard deviation used in the calculation of the effect sizes was that of the dependent
variable at pre-treatment for the total sample (N=10). Because of the very small sample size of
each of the intervention group, the standard deviation of the total sample was more likely to
approach the real standard deviation of that measure for this particular population, thus reducing
the risk of over or underestimating the true effect size (Carlson & Schmidt, 1999). Effect sizes
between groups were adjusted considering the baseline means for each group (Carlson &
Schmidt, 1999; Durlak, 2009). The formula used was the following: db=(E2-E1)-(C2-C1)/SE1C1 where
E is the mean of the experimental group (IMST or EMST) and C is the mean of the control group
(VFE); 2 represents post-treatment and 1 pre-treatment; and S represents the standard deviation
of the population sample at pre-treatment (experimental and control groups pooled)(Carlson &
Schmidt, 1999). Effect sizes within each group were calculated using the following formula: dw=G2G1/ SE1C1, where G1 is the mean for the dependent variable at pre-treatment for this group, G2 is
the mean at post-treatment, and SE1C1 is the pooled standard deviation of all the groups
(experimental and control groups) at pre-treatment.

Lastly, Spearman correlations were computed in SAS, between the pre-post difference in
respiratory measures and voice measures.
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Data Analysis: Aim 3b
Multiple linear regressions were conducted in SAS to assess the relationships between the
difference in VHI-10 score and potential predictors and covariates. The standardized estimate
parameter (b) was computed to facilitate comparison across predictors, which have different
units. The b represents the change in the outcome, in terms of number of SDs, that occurs for a
change of one SD in the independent variable (Nathans, Oswald, & Nimon, 2012).

A univariate ANCOVA was then conducted in SPSS with the change in VHI-10 as the dependent
variable, the intervention group as the independent variables, and baseline respiratory function
(using the strongest predictor) as the covariate. The results were compared to those of a
univariate ANOVA (without controlling for baseline respiratory function). For both the ANOVA and
the ANCOVA, pairwise comparisons between intervention groups were computed, with
Bonferroni adjustment for multiple comparisons.

Chapter 4: Results
Results Aim 1
To determine the measurements that were most appropriate for investigating the relationship
between respiration and voice, we assessed the stability of common measurements using intrasubject reliability in participants that had two baseline assessments.

Participant Characteristics
Twelve participants (7 females, 5 males) underwent two baseline assessments for analysis of
intra-subject reliability. Table 7 presents the characteristics of these participants.
Table 7. Participant characteristics for test-retest reliability assessment

SUBJECT

AGE

GENDER

SMOKING
STATUS

1
2
3
4
5
6
7
9
12
13
16
17
MEAN (SD)
OR
FREQUENCY

75
79
66
59
56
67
75
58
65
79
68
74
68.42
(8.05)

Female
Female
Female
Male
Male
Female
Male
Male
Female
Female
Female
Male
Female: 7
Male: 5

Quit
Quit
Never
Never
Never
Quit
Quit
Never
Quit
Never
Quit
Quit
Quit: 7
Never: 5

PROFESSIONAL REFLUX
VOICE USE
SYMPTOM
INDEX
Yes
13
No
19
No
36
No
18
No
31
No
20
Yes
15
Yes
17
Yes
25
No
21
Yes
18
Yes
6
Yes: 6
19.92
No: 6
(7.93)

DAYS
BETWEEN
TRIALS
16
15
14
8
28
23
15
5
62
49
15
5
21.25 (17.53)
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Rater Reliability
Intra-rater reliability was calculated for the CAPE-V, as well as for each of its individual
parameters. Reliability for the CAPE-V was excellent, with an overall ICC of 0.938. Intra-rater
reliability for each of the parameters were: 0.958 for overall severity; 0.895 for roughness; 0.976
for breathiness; 0.544 for strain; 0.719 for pitch; and 0.873 for loudness. All parameters presented
with an excellent intra-rater reliability except for the parameters of strain and pitch.

Time and Gender Effects
Table 8 shows the results of the mixed ANOVAs for effects of time and gender. Four variables
showed a significant time effect, indicating a potential systematic error: SPL reading (F1,10=6.735;
p=0.027); F0 reading (F1,10=6.546; p=0.028); F0 speech (F1,10=7.461; p=0.021); and SPI /i/
(F1,10=13.274; p=0.007). For the four variables, the mean values decreased significantly from the
first to the second trial.
Seventeen variables demonstrated a significant gender effect and/or a significant time by gender
interaction effect (see Table 8). Gender effects were found as expected for all measures involving
F0 (F0 reading F0 speech, minimum F0, and maximum F0), and for measures of respiratory muscle
strength (MIP and MEP). In addition, significant gender effects were found for jitter /a/, shimmer
/a/, PPQ /a/, STD /a/, jitter /i/, PPQ /i/, and for the overall and breathiness parameters of the
CAPE-V. Significant time by gender interactions were found for STD /a/, PPE, and for the
roughness and loudness parameters of the CAPE-V.
For all variables with significant gender or interaction effects, separate reliability analyses were
conducted for males and females in order to avoid bias caused by the gender differences.
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Table 8. Two-Way Mixed ANOVA Results for within-subject effects (time) and between-subject effects (gender)

Variable
SPL reading
SPL speech
Max SPL
F0 reading
F0 speech
Max F0
Min F0
CPPS sustained /a/
CPPS reading
Jitter % /a/
Shimmer % /a/
(log10)
NHR /a/ (log10)
SPI /a/
VTI /a/
APQ /a/ (log10)
PPQ /a/
STD /a/ (log10)
Jitter % /i/
Shimmer % /i/
(log10)
NHR /i/ (log10)
SPI /i/
VTI /i/
APQ /i/ (log10)
PPQ /i/
STD /i/
PPE (log10)
MPT
MIP
MEP
Overall
Roughness
Breathiness
Strain (log10)
Pitcha
Loudnessa

Time
F (p-value)
6.735 (0.027)*
3.396 (0.095)
0.610 (0.453)
6.546 (0.028)*
7.461 (0.021)*
0.360 (0.562)
0.126 (0.730)
0.002 (0.966)
0.181 (0.680)
0.012 (0.916)
0.082 (0.781)

Time*gender
F (p-value)
0.648 (0.440)
0.385 (0.549)
0.187 (0.675)
2.465 (0.147)
2.217 (0.167)
0.183 (0.678)
0.034 (0.857)
0.545 (0.477)
0.007 (0.937)
0.845 (0.382)
1.321 (0.280)

Gender
F(p-value)
2.02 (0.186)
0.500 (0.496)
0.752 (0.406)
30.817 (0.000)*
34.013 (0.000)*
8.547 (0.015)*
22.271 (0.001)*
0.776 (0.399)
0.981 (0.345)
20.534 (0.001)*
7.780 (0.021)*

0.188 (0.675)
2.10 (0.168)
0.038 (0.851)
0.702 (0.424)
0.073 (0.793)
0.203 (0.663)
0.002 (0.970)
0.044 (0.839)

0.11 (0.919)
2.782 (0.126)
0.182 (0.680)
0.497 (0.499)
0.995 (0.345)
5.773 (0.040)*
0.268 (0.618)
1.202 (0.301)

2.137 (0.178)
1.347 (0.273)
0.045 (0.836)
3.921 (0.079)
18.745 (0.002)*
18.199 (0.002)*
7.904 (0.023)*
0.846 (0.382)

0.133 (0.724)
13.274 (0.007)*
0.405 (0.540)
0.244 (0.633)
0.001 (0.972)
1.439 (0.265)
0.201 (0.663)
0.580 (0.464)
0.388 (0.547)
0.506 (0.493)
2.699 (0.131)
4.270 (0.066)
0.227 (0.644)
1.095 (0.320)
1.255 (0.289)
3.216 (0.103)

0.491 (0.501)
2.543 (0.149)
1.582 (0.240)
0.596 (0.460)
0.154 (0.705)
2.033 (0.192)
8.802 (0.014)*
3.478 (0.092)
2.222 (0.167)
0.549 (0.476)
0.450 (0.518)
5.846 (0.036)*
0.227 (0.644)
1.039 (0.332)
1.255 (0.289)
5.247 (0.045)*

0.364 (0.561)
0.058 (0.816)
3.514 (0.094)
0.011 (0.918)
8.346 (0.020)*
4.627 (0.064)
0.198 (0.666)
0.278 (0.610)
6.945 (0.025)*
17.242 (0.002)*
7.876 (0.019)*
4.178 (.068)
12.835 (0.005)*
1.420 (0.261)
3.775 (0.081)
2.262 (0.164)

*Indicates significance at a 0.05 alpha level.
aLevene’s test of equality of variances was significant
SPL=sound pressure level; F0=fundamental frequency; CPPS=smoothed cepstral peak prominence; NHR= noise-toharmonic ratio; SPI=soft phonation index; VTI=voice turbulence index; APQ=amplitude perturbation quotient;
PPQ=pitch perturbation quotient; STD=standard deviation of F0; PPE=perceived phonatory effort; MPT=maximum
phonation time; MIP=maximum inspiratory pressure; MEP=maximum expiratory pressure
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Intraclass Correlation Coefficients
Table 9 displays the two trials’ means and SDs (or medians and interquartile ranges for logtransformed or non-normal outcomes), as well as the ICCs for each variable. ICCs varied between
-0.866 and 0.970. The following variables were found to have a poor reliability (ICC<0.40):
minimum and maximum F0 (in females), jitter /a/, jitter /i/ (in females), shimmer /a/ (in males),
shimmer /i/, SPI /a/, VTI /a/, VTI /i/, PPQ /a/, PPQ /i/ (in females), STD /a/ (in males), STD /i/,
NHR /i/, APQ /i/, PPE, MPT, and roughness (in females). The following variables showed a fair to
good reliability (0.40£ICC£0.75): maximum SPL, minimum F0 (males), CPPS /a/, CPPS reading,
shimmer /a/ (females), APQ /a/, STD /a/ (females), SPI /i/, MEP (males). The following variables
demonstrated an excellent reliability (ICC>0.75): SPL reading, SPL speech, F0 reading, F0 speech,
maximum F0 (males), NHR /a/, jitter /i/ (males), PPQ /i/ (males), MIP, MEP (females), breathiness
(in females), strain, pitch (in females), and loudness (in males).
Variables with an ICC of 0.60 or greater were considered to present with sufficient intra-subject
reliability to inform on pre- to post-treatment changes. Variables with an ICC greater or equal to
0.60 (for both females and males when analyses were conducted separately), were: SPL reading
(ICC=0.807), SPL speech (ICC=0.850), F0 reading (ICC=0.806 for females and ICC=0.853 for males),
F0 speech (ICC=0.881 for females and ICC=0.957 for males), CPPS /a/ (ICC=0.666), CPPS reading
(ICC=0.715), NHR /a/ (ICC=0.782), APQ /a/ (ICC=0.642), SPI /i/ (ICC=0.643), MIP (ICC=0.804 for
females and ICC=0.941 for males), MEP (ICC=0.853 for females and ICC=0.746 for males), overall
perceptual judgment of voice quality (ICC=0.805 for females and ICC=0.858 for males).
Table 10 displays the ICCs and other measures of reliability (SEMs, MDs, and CVs) for these
variables. However, SPL reading, F0 reading, F0 speech, and SPI /i/ were removed because they
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presented with a significant time effect indicative of systematic error. The pitch parameter from
the CAPE-V was also removed because it presented with zero variance for males.
Table 9. Intraclass Correlation Coefficients

Variable
SPL reading
SPL speech
Max SPL
F0 reading
Females
Males
F0 speech
Females
Males
Max F0
Females
Males
Min F0
Females
Males
CPPS /a/
CPPS reading
Jitter % /a/
Females
Males
Shimmer/a/
Females
Males
NHR /a/
SPI /a/
VTI /a/
APQ /a/
PPQ /a/
Females
Males
STD /a/
Females
Males
Jitter % /i/
Females
Males

Test
Mean (SD)
76.24 (5.80)
70.75 (5.40)
96.89 (7.18)

Re-test
Mean (SD)
73.71 (5.32)
72.53 (5.69)
98.52 (6.92)

194.92 (23.35)
137.82 (12.62)

191.32 (25.85)
122.75 (9.14)

209.67 (30.14)
121.74 (17.01)

195.56 (28.01)
117.59 (16.88)

745.92 (139.37)
454.01 (181.77)

755.26 (195.39)
509.94 (216.33)

148.55 (40.76)
102.17 (26.28)
22.13 (3.02)

145.96 (33.02)
93.95 (11.96)
22.03 (2.08)

16.02 (1.36)

16.13 (0.81)

2.63 (0.83)
1.06 (0.38)

2.93 (1.06)
0.82 (0.23)

6.14 (3.05)
3.99 (0.85)
Median: 0.15
IQ range: 0.06
22.46 (12.46)
0.04 (0.02)
Median: 3.75
IQ range: 1.74

6.95 (2.20)
3.59 (0.74)
Median: 0.16
IQ range: 0.39
16.67 (7.16)
0.04 (0.01)
Median: 3.97
IQ range: 2.16

1.56 (0.47)
0.62 (0.22)

1.79 (0.72)
0.48 (0.12)

Median: 6.93
IQ range: 3.60
Median: 2.60
IQ range: 1.43

Median: 19.14
IQ range: 20.57
Median: 1.97
IQ range: 0.21

1.78 (0.29)
0.95 (0.61)

1.98 (1.23)
0.74 (0.31)

ICC3,1
0.807
0.850
0.429
0.938
0.806
0.853
0.970
0.881
0.957
0.677
0.116
0.876
0.203
-0.553
0.589
0.666
0.715
0.707
0.362
-0.449
0.579
0.738
-0.866
0.782
0.293
0.169
0.642
0.693
0.363
-0.467
0.549
0.469
0.066
0.213
-0.216
0.885
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Shimmer % /i/
NHR /i/
SPI /i/
VTI /i/
APQ /i/
PPQ /i/
Females
Males
STD /i/
PPE
MPT
MIP
Females
Males
MEP
Females
Males
Overall
Females
Males
Roughness
females
Males
Breathiness
females
males
Strain
Pitch
Females
Males
Loudness
females
males

Median: 2.71
IQ range: 2.51
Median: 0.13
IQ range: 0.04
15.53 (6.4)

Median: 2.74
IQ range: 1.79
Median: 0.13
IQ range: 0.02
10.01 (3.73)

0.018

0.04 (0.02)
Median: 2.36
IQ range: 1.18

0.05 (0.01)
Median: 2.41
IQ range: 1.54

-0.045
0.033

1.04 (0.17)
0.52 (0.29)
4.29 (1.83)
Median: 135
IQ range: 100
17.48 (5.76)

1.15 (0.73)
0.44 (0.19)
10.18 (14.10)
Median: 150
IQ range: 160
18.60 (8.45)

75.57 (26.30)
117.80 (24.35)

83.86 (25.02)
114.40 (20.86)

96.14 (18.05)
149.60 (24.28)

96.00 (18.56)
156.60 (38.67)

56.00 (18.15)
27.60 (16.59)

58.86 (17.45)
34.40 (13.90)

42.71 (15.55)
32.40 (24.07)

60.57 (13.08)
31 (20.52)

51.00 (25.99)
9.20 (13.03)
Median: 0.90
IQ range: 0.84

45.29 (24.05)
9.20 (13. 99)
Median: 0.93
IQ range: 0.59

Median: 4.00
IQ range: 11
Median: 0
IQ: 0

Median: 4.00
IQ range: 6.00
Median: 0
IQ: 0

Median: 11
IQ range: 38
Median: 0
IQ range: 0

Median: 0
IQ range: 11
Median: 0
IQ range: 0

-0.475
0.643

0.196
-0.240
0.970
0.040
0.162
0.165
0.890
0.804
0.941
0.909
0.853
0.746
0.892
0.805
0.858
0.686
0.355
0.937
0.760
0.454
0.945
0.493
0.784
0.741
No
variance
0.764
0.811
0.471

Abbrevations: SD: standard devation; ICC: intraclass correlation coefficient; SPL: sound pressure level; F0: fundamental frequency;
CPPS: smoothed cepstral peak prominence; NHR: noise-to-harmonic ratio; SPI: soft phonation index; VTI: voice turbulence index;
APQ: amplitude perturbation quotient; PPQ: pitch perturbation quotient; STD: standard deviation of F0; PPE: perceived phonatory
effort; MPT: maximum phonation time; MIP: maximum inspiratory pressure; MEP: maximum expiratory pressure
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Table 10. Measures of Reliability

Variable
SPL speech
CPPS /a/
CPPS
reading
NHR /a/
APQ /a/
MIP
Females
Males
MEP
Females
Males
Overall
severity
Females
Males

Test
Mean (SD)
70.75 (5.40)
22.13 (3.02)
16.02 (1.36)

Re-test
Mean (SD)
72.53 (5.69)
22.03 (2.08)
16.13 (0.81)

ICC3,1

SEM

CV (%)

MD

0.850
0.666
0.715

SD
(pooled)
5.54
2.55
1.08

2.15
1.47
0.58

3.00
6.67
3.60

5.95
4.08
1.60

Median: 0.15
IQ range:
0.06
Median: 3.75
IQ range:
1.74

Median: 0.16
IQ range:
0.39
Median: 3.97
IQ range:
2.16

0.782

N/A

N/A

7.00

N/A

0.642

N/A

N/A

9.70

N/A

75.57 (26.30)
117.80
(24.35)

83.86 (25.02)
114.40
(20.86)

0.890
0.804
0.941

25.66
22.60

11.36 14.25
5.49 4.73

31.49
15.22

0.909
0.853
0.746

96.14 (18.05)
149.60
(24.28)

96.00 (18.56)
156.60
(38.67)

18.30
31.47

7.02 7.30
15.86 10.36

19.45
43.97

56.00 (18.15)
27.60 (16.59)

58.86 (17.45)
34.40 (13.90)

0.892
0.805
0.858

17.80
15.25

7.86
5.74

21.79
15.92

13.69
18.53

SD=standard deviation; ICC=intraclass correlation coefficient; SEM=standard error of measurement; CV=coefficient of
variation; MD=minimum difference; SPL=sound pressure level; CPPS=smoothed cepstral peak prominence;
NHR=noise-to-harmonic ratio; APQ=amplitude perturbation quotient; MIP=maximum inspiratory pressure;
MEP=maximum expiratory pressure

Other Measures of Reliability (SEMs, MDs, and CVs)
Among the variables presenting with an ICC greater or equal to 0.60, SPL speech had the smallest
CV (CV=3.00%), and overall severity in males had the largest CV (CV=18.53%). The CV for MIP was
much smaller in males (CV=4.73%) than in females (CV=14.25%). This also translated into a greater
MD needed in females in order to be confident that a true difference occurred (MD= 31.49 cmH20
in females; MD=15.22 cmH20 in males). The opposite was found regarding MEP, for which higher
CVs and MDs were found in males (CV=10.36%; MD=43.97 cmH20) than in females (CV=7.30%;
MD=19.45 cmH20). CPPS /a/, CPPS reading, NHR /a/, and APQ /a/ were the only voice quality
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measures that presented with adequate reliability based on the 0.60 cut-off for ICC. CPPS /a/
showed a CV of 6.67 and a MD of 4.08dB. CPPS during reading showed a higher reliability than
CPPS /a/, as well as a smaller CV (CV=3.60%) and MD (MD=1.60 dB). NHR /a/ and APQ /a/
presented with CVs of 7% and 9.7%, respectively. SEMs and MDs were not computed for these
variables because they were log transformed. Auditory-perceptual judgment of overall severity
was the only parameter of the CAPE-V to present with an adequate ICC for both females and
males. Overall severity as well as standard deviations were greater in females than in males. The
SEM, CV, and MD were also greater in females when compared to males (Table 10).
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Results: Aim 2
To address Aim 2, we first assessed the descriptive statistics for the various measurements. We
then used exploratory factor analysis to extract the main constructs measured by the respiratory
and voice outcomes, and cluster analysis to identify groups of participants with similar profiles
based on these constructs. Lastly, we used correlations and linear regression models to specify
the relationships between respiratory and voice constructs. All measurements were taken from
the participants’ baseline assessements.
Participant Characteristics
Twenty-one participants met inclusion criteria for this aim. Age was normally distributed among
the participants, and the mean age was 72 years old (range: 56 to 91). Ten participants were
females and eleven participants were males. The median age for both females and males were 74
years old. Twelve participants had never smoked and nine participants were former smokers. Nine
participants were active or retired professional voice users. Table 11 displays the characteristics
of the participants. The majority of participants were Caucasian, one was Asian.
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Table 11. Participant Characteristics

CHARA

AGE

GENDER

SMOKING
STATUS

1
2
3
4
5
6
7
8
9
10
11
12
13
14
16
17
18
19
20
21
22
MEAN (SD)
OR
FREQUENCY

75
79
66
59
56
67
75
91
58
74
80
65
79
73
68
74
82
75
64
65
81
71.71
(8.94)

Female
Female
Female
Male
Male
Female
Male
Female
Male
Male
Female
Female
Female
Female
Female
Male
Male
Male
Male
Male
Male
Male:11
Female:10

Quit
Quit
Never
Never
Never
Quit
Quit
Never
Never
Quit
Never
Quit
Never
Never
Quit
Quit
Never
Quit
Never
Never
Never
Never:12
Quit: 9

PROFESSIONAL RACE
VOICE USE
Yes
No
No
No
No
No
Yes
No
Yes
No
No
Yes
No
No
Yes
Yes
Yes
No
No
Yes
Yes
Yes:9
No: 12

REFLUX
SYMPTOM
INDEX
Caucasian
13
Caucasian
19
Caucasian
36
Asian
18
Caucasian
31
Caucasian
20
Caucasian
15
Caucasian
5
Caucasian
17
Caucasian
16
Caucasian
8
Caucasian
25
Caucasian
21
Caucasian
25
Caucasian
18
Caucasian
6
Caucasian
9
Caucasian
22
Caucasian
7
Caucasian
14
Caucasian
17
Caucasian:20
17.24
Asian:1
(8.00)
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Respiratory Measures
Table 12 presents the group results for pulmonary function and respiratory muscle strength.
Appendix II presents individual results for these respiratory outcomes.

All respiratory measures presented with a normal distribution across the sample, with the
exception of the FEV1/FVC ratio (raw and predicted percent values). As expected, the raw values
of FVC, FEV1, and MEP were significantly different between males and females (p=0.013, p=0.020,
and p=0.003, respectively). Although it did not reach significance, a considerable difference in
means and medians for MIP was also found between genders, with males having a larger MIP
than females.

Males presented with a mean FVC of 3.80 liters (L) (SD=1.15), and females with a mean FVC of
2.56 L (SD=0.43). The mean FEV1 was 2.77 L (SD=0.94) in males and 1.87 L (SD=0.32) in females.
The FEV1/FVC ratio had a median of 0.73 (IQ range=0.06) across the total sample, and a median
percent predicted value of 98% (IQ range=9). The mean percent predicted value of FVC was
89.81% (SD=23.81) and the mean percent predicted value of FEV1 was 88.43% (SD=26.38), for the
total sample. One third of the participants (seven participants) presented with FVC% and FEV1%
values below 80%. One participant presented with a percent predicted FEV1/FVC below 80%.

Males had a mean MEP of 141.18 cmH20 (SD=34.89), while females had a mean MEP of 92.90
cmH20 (SD=15.78). As expected, MIP was lower than MEP in both genders, with a mean of 93.73
cmH20 (SD=36.95) in males and 70.50 cmH20 (SD=23.58) in females. Nine percent of the males
(one participant) and 0% of the females had a MIP below the lower limit of normal (LLN) expected
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for their age, gender, and weight. Eighteen percent of the males (two participants) and 20% of
the females (two participants) fell below the LLN for MEP.

Table 12. Descriptive Statistics for Pulmonary Function and Respiratory Muscle Strength Measures

Respiratory
Parameter

FVC (L)
FVC %
FEV1 (L)
FEV1 %
FEV1/FVC
FEV1/FVC %
MIP (cmH20)
MEP (cmH20)

ALL
Mean
(SD)
3.21
(1.07)
89.81
(23.81)
2.34
(0.84)
88.43
(26.38)
0.73
(0.06)
97.38
(8.15)
82.67
(32.77)
118.19
(36.48)

Males
Median
(IQ)
2.97
(1.55)
85.00
(32.00)
2.06
(1.17)
88.00
(31.00)
0.73
(0.06)
98.00
(9.00)
80.00
(54.00)
114.00
(58.00)

Mean
(SD)
3.80
(1.15)
87.73
(24.08)
2.77
(0.94)
87.00
(27.46)
0.72
(0.08)
97.55
(9.77)
93.73
(36.95)
141.18
(34.89)

Median
(IQ)
3.83
(1.49)
85.00
(23.00)
2.84
(1.06)
88.00
(30.00)
0.73
(0.06)
100.00
(6.00)
107.00
(59.00)
147.00
(57.00)

Females
Mean
(SD)
2.56
(0.43)
92.10
(24.56)
1.87
(0.32)
90.00
(26.52)
0.73
(0.05)
97.20
(6.43)
70.50
(23.58)
92.90
(15.78)

Median
(IQ)
2.45
(0.69)
89.50
(45.00)
1.85
(0.39)
85.00
(38.00)
0.73
(0.06)
95.50
(8.00)
64.00
(25.00)
89.50
(15.00)

p-value

0.013*
1.000
0.020*
1.000
0.756
0.426
0.085
0.003*

*Mann-Whitney U test significant at an alpha level of 0.05
SD=standard deviation; IQ=interquartile range; FVC=forced vital capacity; FEV1=forced expiratory volume in one
second; MIP=maximal inspiratory pressure; MEP=maximal expiratory pressure

Laryngeal Features
Laryngeal features were rated using the VALI form. Three participants (males) had a complete
glottal closure, three (males) had an anterior gap, three (2 females, 1 male) had a posterior gap,
one (female) had an hourglass gap, and eight (5 females, 3 males) had a spindle gap. Regarding
vertical level of approximation, nine participants (3 females, 6 males) had vocal folds on-plane
and nine (5 females, 4 males) had vocal folds off-plane. Twenty participants (10 females, 10 males)
had a concave free edge contour of the right vocal fold, while one (male) had a convex free edge.
Sixteen participants (8 females, 8 males) had a concave free edge of the left vocal fold, while three
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(1 female, 2 males) had a convex edge and one (male) had a normal edge. Only one participant
(male) had non-vibrating segments of tissue on their vocal folds; however, the small size of the
area was not deforming the vocal fold and was not clinically significant, which is why the
participant could still be included in the study. Lastly, all participants had a predominantly open
phase.
Amplitude of vibration, mucosal wave, supraglottic activity (anteroposterior and mediolateral),
phase symmetry, and regularity were not normally distributed across the sample. Means and
medians and measures of variability are presented in Table 13. Results were not different across
males and females, as indicated by the results from the Mann-Whitney U test.
Table 13 also displays the results for bowing index, which were not significantly different between
males and females. Bowing index was normally distributed across the sample and the mean was
8.80, with a standard deviation of 4.19.
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Table 13. Descriptive Statistics for Laryngeal Features

Laryngeal Feature

Amplitude of
vibration (right)
Amplitude of
vibration (left)
Amplitude of
mucosal wave
(right)
Amplitude of
mucosal wave (left)
Supraglottic
activity
(anteroposterior)
Supraglottic
activity
(mediolateral)
Phase symmetry
Regularity of
vibration
Bowing Index

All

Males

Females

pvalue

Mean
(SD)
57.50
(12.38)
56.67
(17.15)
57.50
(20.49)

Median
(IQ)
60.00
(10.00)
60.00
(40.00)
60.00
(40.00)

Mean
(SD)
62.00
(11.35)
58.00
(14.76)
64.00
(15.78)

Median
(IQ)
60.00
(0)
60.00
(20.00)
60.00
(20.00)

Mean
(SD)
50.00
(10.95)
55.00
(20.70)
46.67
(24.22)

Median
(IQ)
50.00
(20.00)
40.00
(40.00)
50.00
(40.00)

54.71
(26.01)
1.52
(0.98)

60.00
(40.00)
2.00
(1.00)

62.00
(22.01)
1.64
(0.92)

70.00
(40.00)
2.00
(1.00)

44.29
(29.36)
1.40
(1.07)

40.00
(60.00)
2.00
(2.00)

0.230

2.67
(1.24)

3.00
(3.00)

2.55
(1.13)

3.00
(2.00)

2.80
(1.40)

3.5
(3.00)

0.512

66.11
(27.47)
69.47
(30.64)
8.80
(4.19)

75.00
(40.00)
90.00
(40.00)
8.28
(3.99)

70.00
(28.28)
74.55
(28.41)
10.07
(5.10)

85.00
(40.00)
90.00
(30.00)
8.71
(6.02)

61.25
(27.48)
62.50
(34.12)
7.52
(2.74)

70.00
(35.00)
80.00
(60.00)
7.87
(2.94)

0.360

0.118
0.633
0.181

0.705

0.545
0.393

SD=standard deviation; IQ=interquartile range.

Acoustic Measures and Auditory-Perceptual Judgments of Voice Quality
Voice quality measures, including acoustic measures and CAPE-V overall severity rating, are
reported in Table 14.

Results from the Shapiro-Wilk test revealed a normal distribution for three of the five acoustic
measures: SPL during running speech, CPPS during /a/, and CPPS during reading. Mean SPL for the
total sample was 71.7 dB (SD=4.5); mean CPPS during /a/ was 21.28 dB (SD=3.32); and mean CPPS
during reading was 16.29 dB (SD=1.46). NHR and APQ during /a/ were not normally distributed
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across the sample. The median for NHR /a/ was 0.16, and the interquartile range was 0.05. The
median for APQ /a/ was 4.06%, and the interquartile range was 2.53%.

Results from the Shapiro-Wilk test revealed a normal distribution for the CAPE-V parameter of
overall severity. The mean for the total sample was 45.57 (SD=23.80) on a visual analog scale (VAS)
of 100 mm.

Results from the Mann-Whitney U test indicated that the values of the acoustic measures were
similar in males and females, since no significant differences were found. However, the parameter
of overall severity almost reached significance (p=0.051), with the females having a higher mean
than the males. Table 14 reports the acoustic values for the total sample as well as for males and
females separately, and the p-values from the Mann-Whitney U test.

Table 14. Descriptive Statistics for Voice Quality Measures

Acoustic
Parameter

SPL speech
(dB)
CPPS /a/ (dB)
CPPS reading
(dB)
NHR /a/
APQ /a/ (%)
Overall
Severity (100
mm VAS)

ALL
Mean
(SD)
71.7
(4.5)
21.28
(3.32)
16.29
(1.46)
0.19
(0.11)
5.39
(4.47)
45.57
(23.80)

Males
Median
(IQ)
71.20
(6.0)
21.78
(3.73)
16.15
(2.25)
0.16
(0.05)
4.06
(2.53)
43.00
(42.00)

Mean
(SD)
72.13
(2.70)
21.30
(4.23)
16.04
(1.14)
0.20
(0.15)
6.20
(5.99)
36.36
(26.15)

Median
(IQ)
71.2
(3.9)
21.78
(6.78)
16.15
(1.0)
0.14
(0.06)
3.53
(3.48)
33.00
(39.00)

Females
Mean
(SD)
71.23
(6.03)
21.27
(2.14)
16.56
(1.78)
0.19
(0.05)
4.51
(1.69)
55.70
(16.77)

Median
(IQ)
71.3
(8.7)
21.81
(2.56)
16.46
(3.09)
0.18
(0.05)
4.08
(1.77)
59.00
(25.00)

pvalue

0.605
0.756
0.705
0.152
0.809
0.051

SD=standard deviation; IQ=interquartile range; SPL=sound pressure level; CPPS=smoothed cepstral peak prominence;
NHR=noise-to-harmonic ratio; APQ=amplitude perturbation quotient; VAS=visual analog scale.
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Aerodynamic Measures
Results for aerodynamic measures are presented in Table 15.
Aerodynamic measures were not normally distributed across the sample. The median for airflow
during voicing was 0.17 L (IQ range=0.16). The median for subglottal pressure (mean peak air
pressure) was 6.47 cmH20 (IQ range=2.46). The median for aerodynamic resistance was 35.36
cmH20/(l/s) (IQ range=27.02). No significant difference between males and females were found
for the aerodynamic parameters.
Table 15. Descriptive Statistics for Aerodynamic Measures

Aerodynamic
Parameter

Mean airflow
during voicinG (L/s)
Subglottal pressure
(cmH20)
Aerodynamic
resistance
(cmH20/(l/s)

All
Mean
(SD)
0.21
(0.15)
7.15
(3.57)
43.93
(30.98)

Median
(IQ)
0.17
(0.16)
6.47
(2.46)
35.36
(27.02)

Males
Mean
(SD)
0.25
(0.18)
7.20
(4.21)
36.67
(21.83)

Median
(IQ)
0.23
(0.23)
5.87
(2.71)
30.17
(25.96)

Females
Mean
(SD)
0.15
(0.08)
7.07
(2.56)
55.34
(40.96)

Median
(IQ)
0.14
(0.05)
7.00
(2.06)
47.04
(52.47)

p-value

0.201
0.791
0.246

*Mann-Whitney U test significant at an alpha level of 0.05
SD=standard deviation; IQ=interquartile range.

Self-Assessments Measures
Table 16 displays the results for the three self-assessment questionnaires administered. Total
scores for Voice Handicap Index-10 (VHI-10), Glottal Function Index (GFI), and Communicative
Participation Item Bank (CPIB) were not different across males and females, as indicated by the
results of the Mann-Whitney U test. The scores of the three questionnaires were normally
distributed across the total sample of participants. The mean score for VHI-10 was 19 (SD=8.14).
The mean score for GFI was 10.90 (SD=3.71). The mean score for CPIB was 17.65 (SD=7.88).
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Table 16. Descriptive Statistics for Self-Assessment Measures

Self-assessment
questionnaire

All
Mean
(SD)
19
(8.14)
10.90
(3.71)
17.65
(7.66)

VHI-10
GFI
CPIB

Males
Median
(IQ)
20.00
(10.00)
12.00
(6.00)
17.50
(9.00)

Mean
(SD)
17.27
(7.30)
10.91
(3.56)
16.45
(8.15)

Median
(IQ)
17.00
(9.00)
13.00
(7.00)
15.00
(10.00)

Females
Mean
(SD)
20.90
(8.96)
10.90
(4.07)
19.11
(7.20)

Median
(IQ)
25.00
(9.00)
11.5
(5.00)
19.00
(9.00)

p-value

0.173
0.809
0.331

SD=standard deviation; IQ=interquartile range; VHI-10=Voice Handicap Index-10; GFI=Glottal Function Index;
CPIB=Communicative Participation Item Bank.

Respiratory Factors
Two distinct factors emerged from the factor analysis conducted on all eight respiratory variables.
Factor 1 included: MIP, MEP, FVC, and FEV1. Factor 2 included FEV1%, FEV1/FVC, and FEV1/FVC%.
FVC% was the only respiratory parameter to not make it into one of the factors. Factor 1 was
named “raw respiratory” because it included the raw measures for respiratory muscle strength,
FVC, and FEV1. Factor 2 was named “standard respiratory” because it included percent predicted
values, as well as the FEV1/FVC ratio. The factor loading scores for each respiratory variable are
displayed in Table 17 (only variables with a loading score above the 0.71 cut-off value were
included).
Table 17. Respiratory Factors

Respiratory
Parameter
MIP
MEP
FVC
FVC%
FEV1
FEV1%
FEV1/FVC
FEV1/FVC%

Factor 1
(Raw respiratory)
0.89
0.88
0.93
0.87

Factor 2
(Standard respiratory)

0.80
0.88
0.93
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Voice Factors
Firstly, a factor analysis was conducted on all voice measures (except for the laryngeal
parameters) (Table 18). Factor 1, representing the construct of perceived handicap, included
scores from the three self-assessment questionnaires: VHI-10, GFI, and CPIB. Factor 2 included
NHR and APQ during a sustained /a/ and was therefore named the “perturbation” factor. Overall
severity and CPPS for sustained /a/ were not included in this factor (or any factor), because the
loading scores were below the cut-off value of 0.71. Factor 3 included mean airflow during voicing
and mean peak air pressure (subglottal pressure) and was named the “aerodynamic” factor.
Factor 4 included SPL during running speech and CPPS during reading and was named “speech”.
Lastly, factor 5 included only the variable of aerodynamic resistance and was therefore named
“resistance”. The factor loading values for each variable are presented in Table 18.

A second factor analyses was conducted on the laryngeal parameters from the VALI form and the
bowing index measure. Three factors emerged from this analysis. The factor “pliability” included
measures of amplitude of vibration, mucosal wave amplitude, and regularity of vibration. The
factor “integrity” included phase symmetry and bowing index (multiplied by -1 to obtain a
negative value, because a lower bowing index is indicative of a greater vocal fold integrity).
Therefore, a higher score on the integrity factor would be indicative of a greater phase symmetry
and less bowing of the vocal folds. Lastly, the factor “hyperfunction” included both types of
supraglottic activity: anteroposterior and mediolateral. Factor loading scores are presented in
Table 19.
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Table 18. Voice Factors

Voice
Parameter
VHI-10
GFI
CPIB
CPPS /a/
NHR /a/
APQ /a/
Airflow
Subglottal
pressure
SPL speech
CPPS reading
Resistance
Overall
severity

Factor 1
(handicap)
0.82
0.73
-0.89
-

Factor 2
(perturbation)

Factor 3
(aerodynamics)

Factor 4
(speech)

Factor 5
(resistance)

0.97
0.98

-

-

-

0.80
0.93
0.91
0.85
-

-

-

-

Table 19. Voice Factors (Laryngeal Parameters)

Laryngeal Parameter
Amplitude right
Amplitude left
Mucosal wave right
Mucosal wave left
Supraglottic activity
(anteroposterior)
Supraglottic activity
(mediolateral)
Phase symmetry
Regularity
Bowing Index

Factor 1
(pliability)
0.88
0.80
0.86
0.83

Factor 2
(integrity)

Factor 3
(hyperfunction)

0.91
0.80
0.88
0.82
-0.83

0.86
-
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Cluster Analysis
Three distinct clusters emerged from the cluster analysis including the two respiratory factors,
the eight voice factors, as well as age and gender. The overall R-squared value for the cluster
analysis was 0.63 (F=13.34; cubic clustering criterion=-0.69). Table 20 presents mean values on
each factor for the three clusters. Since the factors were weighted measures of standardized
values, these means do not have any specific units (with the exception of age, which remained on
the original scale).

Mean age was the highest in cluster 1 (78.9 years old, SD=5.28) and the lowest in cluster 3 (60.40
years old, SD=3.91). Cluster 2 had a mean age of 69.17 years old (SD=4.26). Cluster 1 was
comprised of five males and five females, cluster 2 was comprised of one male and five females,
and cluster 3 was constituted of males exclusively (five males). In total, cluster 1 had 10
participants, cluster 2 had six, and cluster 3 had five. Table 21 presents the age and gender
repartition in each cluster.

Cluster 1 and 3 (the oldest and youngest clusters) had a similar mean for the standard respiratory
factor, while the raw respiratory value of cluster 1 was the highest of all three clusters. Cluster 2
had the lowest means for both respiratory factors. Cluster 2 also had the highest mean value for
handicap, resistance, and hyperfunction, and a considerably lower value for the pliability factor.
As for the aerodynamic factor, it was the highest in cluster 3. Cluster 3 also had the highest value
for integrity of the vocal folds, and the lowest value for hyperfunction. Cluster 1 had the lowest
value for integrity, and a slightly higher value for perturbation.
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Table 20. Factor Means by Cluster

Cluster

Raw
respiratory

Standard
respiratory

handicap

Perturbation

Aero

Speech

Resistance

Hyperfunction

Integrity

Pliability

Age

1

3.98

5.42

4.47

5.45

4.44

5.24

4.88

4.69

4.20

6.07

78.9

2

2.89

3.55

6.14

4.42

4.80

4.99

5.63

6.02

5.30

0.84

69.17

3

9.57

5.90

4.40

4.80

6.31

4.54

4.57

4.38

6.26

6.64

60.4

Table 21. Age and Gender Repartition in Clusters

Males
5
1
5
11

Cluster 1
Cluster 2
Cluster 3
Total

Females
5
5
0
10

Total
10
6
5
21

Age (SD)
78.9 (5.28)
69.17 (4.26)
60.4 (3.91)
71.71 (8.94)

Table 22. Correlations Between Age and Respiratory and Voice Factors

age (r)
p-value
N

Standard
Hyper
Raw
function Respiratory Respiratory

Perturbation

Aero

Speech

Resistance

Handicap

Integrity

Pliability

0.24
0.304
21

-0.49
0.039**

0.08
0.730

0.15
0.544

-0.09
0.700

-0.56
0.020**

-0.10
0.710

-0.03
0.898

-0.43
0.050**

0.02
0.918

18

21

18

20

17

16

21

21

21

**Significant at an alpha level of 0.05
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Table 23. Correlations Between Factors

Factor
Perturbation (r)
p-value
N
Aero

Speech

Resistance

Handicap

Integrity

Pliability

Hyperfunction

Raw respiratory

Standard
respiratory

Perturbation

Aero

Speech

Resistance

Handicap

Integrity

Pliability

Raw
Hyper
function Respiratory

Standard
Respiratory

1.00000
21
-0.18885
0.4529
18

1.00000

-0.44675
0.0423**
21

0.08153
0.7478
18

1.00000

-0.02993
0.9062
18

-0.44066
0.0672*
018

0.00722
0.9773
18

1.00000

-0.09624
0.6865
20

-0.01225
0.9628
17

0.05714
0.8109
20

0.70098
0.0017**
17

1.00000

-0.43873 0.66071
0.0781* 0.0073**
17
15

0.12990
0.6192
17

-0.12143
0.6664
15

-0.20000
0.4577
16

1.00000

18

21

18

20

17

0.09131
0.7366
16

0.06381
0.8284
14

0.23122
0.3889
16

-0.62266
0.0174**
14

-0.28086
0.3106
15

-0.03038
0.9144
15

1.00000

-0.01373
0.9529
21

-0.13736
0.5868
18

0.22092
0.3359
21

0.26120
0.2951
18

0.40365
0.0776*
20

-0.14207
0.5865
17

0.25836
0.3340
16

1.00000

-0.16234
0.4820
21

0.12693
0.6157
18

-0.29351
0.1966
21

-0.40970
0.0913*
18

-0.27970
0.2323
20

0.25000
0.3332
17

0.19293
0.4741
16

-0.15294
0.5081
21

1.00000

0.13766
0.5518
21

-0.14345
0.5701
18

0.28312
0.2136
21

-0.36636
0.1348
18

-0.53985
0.0140**
20

-0.07843 0.66274
0.7648 0.0051**
17
16

0.24772
0.2790
21

0.24805
0.2783
21

16

21

21
1.00000
21

144

Correlations Between Respiratory Factors, Voice Factors, and Age
Spearman correlations were computed to better understand the relationships between the
respiratory and voice factors, as well as between age and all the factors. Correlation coefficients
and corresponding p-values are presented in Tables 22 and 23.

Significant correlations were found between the standard respiratory factor and two voice
factors: handicap (r=-0.54, p=0.014) and pliability (r=0.66 p=0.005). The raw respiratory factor was
negatively correlated with the resistance factor and the relationship was marginally significant
(r=-0.41, p=0.091). Significant or marginally significant correlations were also found between the
voice factors: perturbation and speech (r=-0.45, p=0.042); perturbation and integrity (r=-0.44,
p=0.078); aerodynamic and resistance (r=-0.44, p=0.067); aerodynamic and integrity (r=0.66,
p=0.007); resistance and handicap (r=0.70, p=0.002); resistance and pliability (r=-0.62, p=0.017);
and handicap and hyperfunction (r=0.40, p=0.078).

Moreover, age was found to be significantly correlated with three factors: aerodynamic (r=-0.49,
p=0.039), integrity (r=-0.56, p=0.020), and raw respiratory (r=-0.43, p=0.050). The direction of the
correlations showed that a younger age was correlated with a higher aerodynamic factor (airflow
and subglottal pressure), a higher integrity factor (greater phase symmetry and less bowing of the
vocal folds), and a higher raw respiratory factor (higher MIP, MEP, FVC, and FEV1). These
correlations were expected.
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Linear Regressions Models
Linear regressions were computed based on the results from the correlations, between the
respiratory variables and the voice factors that showed a moderate to strong correlation and a
significant or marginally significant relationship (p£0.1) with the respiratory factors.

Handicap Factor
Among all the respiratory variables, FVC% and FEV1% were the strongest predictors for the
handicap factor (p=0.006 and p=0.007, respectively). For an increase of one standard deviation in
FVC% or FEV1%, an associated decrease of 0.60 and 0.58 standard deviations in handicap factor
score was observed, respectively. Age, sex, and height were tested in the model and were not
found to be significant confounders (Figure 2, table 24).

Resistance Factor
The strongest respiratory predictor for the resistance factor were FEV1 and FVC (Figure
3, Table 25). Although they did not quite reach significance (p=0.106 and p=0.109, respectively),
scatter plots show an inverse relationship with resistance for both FEV1 and FVC. Because the
resistance factor was comprised of only one variable, aerodynamic resistance, scatter plots were
drawn using the raw values for this variable instead of the standardized values from the factor.
This allowed for easier interpretation of the results. An increase of one standard deviation in FEV1
(0.84 L) or in FVC (1.07 L) was associated with a decrease in aerodynamic resistance of 0.39
standard deviation, which corresponds to approximately 12 cmH20/l/s, in this sample. Age, sex,
and height were tested in the model and were not found to be significant confounders. The
direction of the relationship was the same for percent predicted values, but with smaller betaweight values and higher p-values.
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Figure 2. Scatter plots and linear regression fitted-lines for handicap factor (y-axis) and FVC% (x-axis) (left) and FEV1%
(x-axis) (right).

Table 24. Linear Regression Outcomes for the Handicap Factor. (Above: results for FVC% as the respiratory predictor;
below: results for FEV1% as the respiratory predictor).

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

9.80

1.59

0

6.17

<0.001

9.96
(0.006)

0.36

FVC%

-0.05

0.02

-0.60

-3.16

0.006**

0.32

**Significant at an alpha level of 0.05

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

9.16

1.44

0

6.37

<0.001

9.34
(0.007)

0.34

FEV1%

-0.05

0.02

-0.58

-3.06

0.007**

**Significant at an alpha level of 0.05

0.31
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Figure 3. Scatter plots and linear regression fitted-lines for aerodynamic resistance (y-axis) and FEV1 (x-axis) (left)
and FVC (x-axis) (right).

Table 25. Linear Regression Outcomes for Aerodynamic Resistance. (Above: results for FEV1 as the respiratory
predictor; below: results for FVC as the respiratory predictor).

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

6.07

0.66

0

9.24

<0.001

2.94
(0.106)

0.16

FEV1

-0.43

0.25

-0.39

-1.71

0.106

0.10

**Significant at an alpha level of 0.05

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

6.14

0.70

0

8.71

<0.001

2.88
(0.109)

0.15

FVC

-0.34

0.20

-0.39

-1.70

0.109

**Significant at an alpha level of 0.05

0.10
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A regression model was built with other voice factors as predictors to better understand what
voice parameters impact resistance. The best explanatory model included the pliability factor
(encompassing amplitude of vibration and of mucosal wave, as well as regularity of vibration) and
the hyperfunction factor (encompassing anteroposterior and mediolateral supraglottic activity).
The pliability factor had a beta-weight b of -0.65 (p=0.012), indicating that an increase in one
standard deviation on this factor was associated with a decrease in 0.65 standard deviation in
resistance. The hyperfunction factor had a beta-weight of 0.38 (p=0.102), indicating that an
increase of one standard deviation on this factor was associated with an increase of 0.38 standard
deviation in resistance (Table 26).

Figure 4 shows a scatter plot of the relationship between raw values of aerodynamic resistance
and the hyperfunction factor. The plot shows that the four data points corresponding to the
highest aerodynamic resistance values were all associated with an elevated degree of
hyperfunction. These four points also seemed to play an important role in driving the relationship
between resistance and handicap (Figure 5, Table 27). On the other hand, the presence of
hyperfunction was not necessarily associated with an elevated aerodynamic resistance.
Table 26. Linear Regression Outcomes for Aerodynamic Resistance with Hyperfunction and Pliability Factors as
Predictors

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

4.59

0.50

0

9.13

<0.001

5.52
(0.022)

0.50

Hyperfunction
Pliability

0.18
-0.11

0.10
0.03

0.38
-0.65

1.78
-3.01

0.102
0.012**

**Significant at an alpha level of 0.05

0.41
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Figure 4. Scatter plot of aerodynamic resistance (y-axis) by handicap (xaxis)

Figure 5. Scatter plot and linear regression fitted-line for handicap
factor (y-axis) and aerodynamic resistance (x-axis)

Table 27. Linear Regression Outcomes for Handicap Factor with Aerodynamic Resistance as a Predictor

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

3.43

0.71

0

4.83

<0.001

8.06
(0.012)

0.35

Aerodynamic 0.04
resistance

0.01

0.59

2.84

0.012**

**Significant at an alpha level of 0.05

0.31
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Pliability Factor
Although the pliability factor was strongly correlated with the standard respiratory factor, the
strongest individual predictor was the raw respiratory parameter MEP (p=0.092) (Figure 6, Table
28). An increase of one standard deviation in MEP (36.48 cmH20) was associated with an increase
of 0.44 standard deviations in the pliability factor. Age, sex, and height were not found to be
significant confounders and were therefore not included in the model because they did not
improve its explanatory ability.
Fit Plot for Pliability

Figure 6. Scatter plot and linear regression fitted-line for pliability factor (y-axis) and MEP (x-axis)

Table 28. Linear Regression Outcomes for Pliability Factor with MEP as a Respiratory Predictor

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

0.27

2.89

0

0.09

0.93

3.28
(0.092)

0.19

MEP

0.04

0.02

0.44

1.81

0.092*

**Significant at an alpha level of 0.05

0.13
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Results: Aim 3a
Results from Aim 2 revealed that respiratory function has an impact on various aspects of
phonation and on voice-related handicap. The objective of aim 3a was to assess whether adding
respiratory exercises to improve respiratory function would lead to improved voice outcomes.
Results are presented below.

Participant Characteristics and Baseline Measures
Ten participants completed the intervention (five females, five males), aged 58 to 82 years old
(mean=71.6, SD=7.68). Table 29 displays the characteristics of the participants (age, reflux
symptom index scores, gender, smoking status, and professional voice use) for the total sample,
as well as for each of the three intervention groups (IMST, EMST, and VFE). No significant
difference between the groups were found for mean age and RSI scores. Chi-square values could
not be computed for categorical variables because of the small sample size.
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Table 29. Comparison of Groups Demographics at Baseline

Age
Mean (SD)
RSI
Mean (SD)
Gender
Females
Males
Smoking
status
Never
Quit
Professional
voice use
Yes
No

Total
sample
(N=10)

IMST (N=4)

EMST (n=3)

VFE (n=3)

p-value

72.33 (7.64)

67.50 (8.74)

72.33 (7.64)

76.33 (4.93)

0.354

16.3 (6.91)

19.75 (3.59)

14.67 (7.09)

13.44
(10.21)

0.477

5
5

3
1

1
2

1
2

-

5
5

1
3

2
1

2
1
-

5
5

3
1

0
3

1
2

Table 30 presents the baseline means and standard deviations for respiratory, acoustic, auditoryperceptual, aerodynamic, and self-assessment measures. The values are provided for the total
sample of participants who received the intervention, as well as for each intervention group
separately. Values were compared across groups with a one-way ANOVA and the results
confirmed that no significant differences were present between the groups. Results from the
Shapiro-Wilk test indicated normal distributions for all variables except for FEV1/FVC (p=0.006),
FEV1/FVC% (p=0.009), NHR /a/ (p=0.01), and APQ /a/ (p=0.03).
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Table 30. Comparison of Respiratory and Voice Outcomes at Baseline Between Groups (one-way ANOVA)

Outcome
Measure
MIP (cmH20)
Females
Males
MEP (cmH20)
Females
Males
FVC (L)
Females
Males
FVC (%)
Females
Males
FEV1 (L)
Females
Males
FEV1 (%)
Females
Males
FEV1/FVC
Females
Males
FEV1/FVC (%)
Females
Males
SPL speech(dB)

Total sample
Mean (SD)
79.70 (22.33)
70 (18.28)
89.40 (23.50)
118.5 (38.59)
86.00 (13.06)
151.00 (23.22)
3.01 (0.76)
2.53 (0.31)
3.48 (0.80)
83.5 (17.16)
84.20 (16.35)
82.80 (19.85)
2.15 (0.67)
1.80 (0.21)
2.51 (0.81)
80.20 (20.26)
79.60 (16.24)
80.80 (25.67)
0.71 (0.07)
0.71 (0.03)
0.70 (0.11)
94.6 (8.81)
94.40 (2.70)
94.80 (12.93)
72.00 (5.22)

IMST
Mean (SD)
88.50 (26.15)

EMST
Mean (SD)
75.33 (27.43)

VFE
Mean (SD)
72.33 (14.15)

p-value

109.75
(46.55)

128.67 (44.06)

120.00 (34.60)

0.847

2.97 (0.98)

2.78 (0.79)

3.28 (0.60)

0.770

83.00 (15.85)

70.67 (17.62)

97.00 (10.82)

0.174

2.17 (0.79)

1.88 (0.87)

2.39 (0.39)

0.704

79.50 (14.82)

64.00 (24.88)

97.33 (8.02)

0.122

0.73 (0.03)

0.65 (0.13)

0.73 (0.03)

0.355

95.75 (3.10)

87.67 (14.30)

100.00 (3.46)

0.291a

71.33 (8.12)

70.00 (1.56)

74.90 (1.25)

0.544

CPPS /a/
CPPS reading(dB)
NHR /a/
APQ /a/ (%)
Overall severity
Females
Males
Mean airflow (L)
Subglottal
pressure (cmH20)
Aerodynamic
resistance
(cmH20/l/s)
VHI-10
GFI

21.72 (2.72)
16.52 (1.52)
0.15 (0.06)
3.90 (1.81)
44.80 (22.73)
54.60 (19.60)
35.00 (23.21)
0.18 (0.10)
6.69 (2.73)

21.92 (1.05)
16.79 (1.28)
0.15 (0.02)
3.09 (0.97)
43.00 (28.58)

20.11 (1.26)
15.36 (1.93)
0.16 (0.12)
4.77 (3.16)
52.00 (30.41)

23.05 (4.84)
17.32 (1.05)
0.14 (0.02)
4.12 (0.89)
40.00 (7.55)

0.277a
0.286
0.812a
0.423a
0.832a

0.12 (0.05)
8.66 (3.26)

0.26 (0.09)
6.47 (1.44)

0.16 (0.13)
4.87 (1.88)

0.199
0.261

41.35 (21.48)

56.52 (15.69)

21.01 (8.15)

39.73 (23.94)

0.202

21.00 (6.41)
11.5 (3.44)

24.00 (6.06)
12.50 (3.11)

17.00 (5.57)
11.33 (3.79)

21.00 (6.41)
10.33 (4.51)

0.408b
0.775b

CPIB
Bowing Index

13.78 (6.28)
9.74 (2.90)

12.00 (6.08)
9.27 (1.92)

15.00 (4.00)
8.05 (0.53)

14.33 (9.87)
12.06 (4.37)

0.754b
0.320a

aResult

bResult

of the Welch test (when the assumption of homogeneity of variances was not met)
from the Kruskal-Wallis test for ordinal data

0.644
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The following sections describe the pre- to post-intervention changes on the respiratory,
laryngeal, acoustic, auditory-perceptual, aerodynamic, and self-assessment measures. The
various tasks and outcome measures that were recorded prior to and following the 4-week
intervention period are summarized in Appendix I.
Results from the Interventions: Respiratory Measures
Prior to treatment, all participants except for one presented with a MIP and a MEP value above
the lower limit of normal (LLN), as calculated with Enright’s reference equations (Enright,
Kronmal, Manolio, et al., 1994). One participant in the IMST group (subject 16) presented with a
MEP value lower than the LLN.

Table 31 presents the pre- and post-treatment values for each participant for MIP and MEP. Two
out of four participants in the IMST group improved their MIP, with a change greater than the
SEM (as calculated in Aim 1) and with large effect sizes (SMD=0.87 and 0.94). One participant in
the EMST group and one participant in the VFE group also improved their MIP with large and very
large effect sizes (SMD=0.96 and 1.23, respectively). Two out of three participants in the EMST
group improved their MEP with moderate to large effect sizes (SMD=0.66 and 1.11). In both cases,
the change was greater than the minimum difference (MD) calculated for this outcome measure
in Aim 1 (31.49 cmH20 for females and 15.22 cmH20 for males). One participant in the IMST group
also improved their MEP with a change above MD, although the SMD was small (SMD=0.38). Two
participants in the VFE group also improved their MEP considerably, with moderate to large effect
sizes (SMD=0.62 and 0.98).

Table 33 presents the group effect sizes and the ANOVA results for respiratory outcomes.
Interestingly, the VFE group increased both their MIP and MEP with moderate effect sizes
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(dw=0.60 and dw=0.68, respectively). An increase in MIP, although slightly smaller, was also found
in the IMST group, with an effect size of dw=0.46. The smallest increase in MIP was observed in
the EMST group (dw=0.30). As for MEP, the largest increase was observed in the EMST group as
expected (dw=0.98), followed by the VFE group (dw=0.68) and lastly the IMST group (dw=0.29). A
significant main time effect was found for MEP (p=0.012). A larger sample size may have allowed
for detection of a time by group interaction effect.

Table 32 presents the pre- and post-treatment changes in raw and percent predicted pulmonary
function values. No meaningful improvement in pulmonary function was noted for any of the
participants following the intervention. In all three groups, the effect sizes for pulmonary function
measures were small (below SMD=0.29). In addition, one participant in the IMST group
(participant 16) presented with negative SMDs for all pulmonary function parameters (ranging
from |SMD|=0.50 to 0.79), indicating a decrease in FVC, FEV1, and FEV1/FVC (raw and percent
predicted values). One participant in the EMST group (participant 10) presented with large
negative SMDs for the change in raw value and percent predicted value of FEV1/FVC (|SMD|=1.43
and 1.59, respectively). These two participants presented with particularly low pulmonary
function values at baseline for FVC and FEV1, ranging between 37% and 64% of predicted values.

Group effect sizes and results from the two-way ANOVA confirmed the lack of change in
pulmonary function measures in all three group. No main effect or interaction effect were found
for any of the pulmonary variables. In addition, group effect sizes were small for all groups and all
variables (Table 33).
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Table 31. Change in Respiratory Muscle Strength (Single-Subject Results)

ID

Group
Pre

2
9
12
16
10
13
20
14
17
18

IMST
IMST
IMST
IMST
EMST
EMST
EMST
VFE
VFE
VFE

97
119
81
57
60
59
107
56
80
81

MIP (cmH20)
Post
Change SMD2
78
156
106
55
57
89
100
82
82
93

-19
37**
25*
-2
-3
30*
-7
26*
2
12*

-0.38
0.87
0.94
0.11
-0.04
0.96
-0.72
1.23
0.43
0.25

Pre
96
176
100
67
126
86
174
81
132
147

MEP (cmH20)
Post
Change SMD2
100
221
102
61
180
143
176
109
169
161

4
45**
2
-6
54**
57**
2
28**
37*
14

0.39
0.38
-0.36
-0.17
0.66
1.11
0.09
0.62
0.98
0.38

*Change greater than SEM
**Change greater than MD
MIP=maximum inspiratory pressure; MEP=maximum expiratory pressure; SMD2=standard mean difference (two baseline and two follow-up data points were
available)

157
Table 32. Change in Pulmonary Function (Single-Subject Results)

ID

Group

2

IMST

9

IMST

12

IMST

16

IMST

10

EMST

13

EMST

20

EMST

14

VFE

17

VFE

18

VFE

FVC
Raw values (L)
Percent predicted values (%)
Pre
Post
Change SMD
2.97
102
4.35
87
2.12
79
2.44
64
2.20
51
2.46
76
3.68
85
2.64
100
3.36
85
3.83
106

3.03
105
4.08
82
2.17
82
2.06
54
2.38
56
2.37
75
3.51
81
2.67
102
3.30
84
3.75
104

0.06
3
-0.27
-5
0.05
3
-0.38
-10
0.18
5
-0.09
-1
-0.17
-4
0.03
2
-0.06
-1
-0.08
-2

0.08
0.17
-0.36
-0.29
0.07
0.17
-0.5
-0.58
0.24
0.29
-0.12
-0.06
-0.21
-0.20
0.04
0.12
-0.08
-0.06
-0.11
-0.12

FEV1
Raw values (L)
Percent predicted values (%)
Pre Post Change SMD

FEV1/FVC
Raw values (L)
Percent predicted values (%)
Pre
Post Change SMD

2.05
95
3.32
87
1.54
75
1.78
61
1.15
37
1.66
69
2.84
86
1.95
98
2.55
89
2.67
105

0.69
93
0.76
100
0.73
94
0.73
96
0.52
72
0.67
91
0.77
100
0.74
98
0.76
104
0.70
98

2.12
98
3.09
81
1.53
76
1.39
48
1.00
32
1.63
68
2.73
82
1.93
99
2.48
87
2.64
104

0.07
3
-0.23
-6
-0.01
-0.39
-13
-0.15
-5
-0.03
-1
-0.11
-4
-0.02
1
-0.07
-2
-0.03
-1

0.10
0.15
-0.34
-0.30
-0.01
0.05
-0.58
-0.64
-0.22
-0.25
-0.04
-0.05
-0.14
-0.16
-0.03
0.05
-0.10
-0.10
-0.04
-0.05

FVC=forced vital capacity; FEV1=forced expiratory volume in one second; SMD=standard mean difference

0.70
95
0.76
100
0.71
92
0.68
89
0.42
48
0.69
93
0.78
101
0.72
96
0.75
103
0.70
99

0.01
2
0
0
-0.02
-2
-0.05
-7
-0.10
-24
0.02
2
0.01
1
-0.02
-2
-0.01
-1
0
1

0.14
0.23
0
0
-0.29
-0.23
-0.71
-0.79
-1.43
-1.59
0.29
0.23
0.09
0.08
-0.29
-0.23
-0.14
-0.11
0
0.11
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Table 33. Two-Way ANOVA Results for Respiratory Measures (Group Results)

Outcome
Measure

IMST

EMST

VFE

Pre
(SD)
88.50
(26.15)

Post
(SD)
98.75
(43.49)

Diff.
ES (d)
10.25
dw=0.46
db=-0.14

Pre
(SD)
75.33
(27.43)

Post
(SD)
82.00
(22.34)

Diff.
ES (d)
6.67
dw=0.30
db=-0.30

Pre
(SD)
72.33
(14.15)

Post
(SD)
85.67
(6.35)

Diff
ES (d)
13.34
dw=0.60

MEP (cmH20)

109.75
(46.55)

121.00
(69.29)

128.67
(44.06)

166.33
(20.31)

146.33
(32.58)

26.33
dw=0.68

2.97
(0.98)

2.84
(0.94)

2.78
(0.79)

2.75
(0.66)

3.28
(0.60)

3.24
(0.54)

0.04
dw=0.05

FVC (%)

83.00
(15.85)

80.75
(20.87)

70.67
(17.62)

70.67
(13.05)

97.00
(10.82)

96.67
(11.02)

-0.33
dw=-0.02

FEV1 (L)

2.17
(0.79)

2.03
(0.77)

1.88
(0.87)

1.79
(0.88)

2.39
(0.39)

2.35
(0.37)

-0.04
dw=-0.06

FEV1 (%)

79.50
(14.82)

75.75
(20.76)

64.00
(24.88)

60.67
(25.79)

97.33
(8.02)

96.67
(8.74)

-0.66
dw=-0.03

FEV1/FEV

0.73
(0.03)

0.71
(0.03)

0.65
(0.13)

0.63
(0.19)

0.73
(0.03)

0.72
(0.03)

-0.01
dw=-0.14

FEV1/FVC (%)

95.75
(3.10)

94.00
(4.69)

87.67
(14.30)

84.00
(22.87)

37.66
dw=0.98
db=0.29
-0.03
dw=-0.04
db=-0.09
0.00
dw=0
db=0.02
-0.09
dw=-0.13
db=-0.07
-3.33
dw=-0.16
db=-0.13
-0.02
dw=-0.29
db=-0.14
-3.67
dw=-0.42
db=-0.34

120.00
(34.60)

FVC (L)

11.25
dw=0.29
db=-0.39
-0.13
dw=-0.17
db=-0.22
-2.25
dw=-0.13
db=-0.11
-0.14
dw=-0.21
db=-0.15
-3.75
dw=-0.19
db=-0.15
-0.02
dw=-0.29
db=-0.14
-1.75
dw=-0.20
db=-0.12

100.00
(3.46)

99.33
(3.51)

-0.67
dw=-0.08

MIP (cmH20)

**Significant at an alpha level of 0.05

F (p-value)
Time effect
Time*group
Group effect
2.288 (0.174)
0.077 (0.927)
0.400 (0.684)
11.512 (0.012)**
1.142 (0.372)
0.447 (0.657)
1.337 (0.285)
0.402 (0.684)
0.310 (0.743)
0.294 (0.605)
0.214 (0.813)
2.124 (0.190)
4.161 (0.081)
0.427 (0.668)
0.416 (0.675)
2.665 (0.147)
0.366 (0.706)
2.691 (0.136)
1.598 (0.247)
0.086 (0.919)
0.944 (0.434)
1.345 (0.284)
0.232 (0.799)
1.397 (0.309)

ES=effect size; dw=Cohen’s d within group; db=Cohen’s d between groups; SD=standard deviation; MIP=maximum inspiratory pressure; MEP=maximum expiratory
pressure; FVC=forced vital capacity; FEV1=forced expiratory volume in one second
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Results from the Interventions: Laryngeal Features
Table 34 displays the change in bowing index for each of the participants. All but two participants
for whom pre- and post-intervention data was available presented with a decrease in bowing. For
the participants who did improve, effect sizes ranged from |SMD|=0.26 to |SMD|=3.07. Group
analyses revealed that the largest mean reductions for bowing index occurred in the VFE group
(|dw|=1.19) and in the EMST group (|dw|=0.68) (Table 35). Importantly, participant 17 in the VFE
group improved considerably more than the others and strongly influenced the resulting group
effect size.

Table 34. Change in Bowing Index (Single-Subject Results)

ID

Group

2

IMST

Bowing Index
Pre
Post
Change
SMD
9.60
-

9

IMST

11.27

12

IMST

9.57

11.40

16

IMST

6.66

6.67

10

EMST

8.63

7.15

13

EMST

7.92

5.53

20

EMST

7.60

5.54

14

VFE

10.38

9.64

17

VFE

17.03

8.12

18

VFE

8.78

8.04

-

SMD=standard mean difference

1.83
0.63
0.01
0.00
-1.48
-0.51
-2.39
-0.82
-2.06
-0.71
-0.74
-0.26
-8.9
-3.07
-0.75
-0.26
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Regarding laryngeal features, all participants had concave vocal fold edges and a predominantly
open phase, both at baseline and after treatment. At baseline, five participants had a spindleshaped glottal gap, two had a posterior gap, one had an anterior gap, one had complete closure,
and one had unavailable data. No participant had a complete closure at post-treatment. No
participant had non-vibrating segments.

Table 36 presents the following VALI features: vibration amplitude, mucosal wave amplitude,
supraglottic activity, phase symmetry, and regularity of vibration. All but two participants had a
vibration amplitude within a normal range (between 40% and 60%) at baseline. Participants 14
and 17 presented with an increased vibration amplitude (80%) for at least one vocal fold pretreatment. These participants were both in the VFE group and both reduced their amplitude of
vibration to a more normal value following the intervention. They also both reduced their mucosal
wave amplitude on at least one vocal fold. Participant 16 (IMST group) had a reduced mucosal
wave amplitude at baseline which increased following treatment, while participant 20 (EMST
group) had an enhanced mucosal wave amplitude which did not change following treatment.
Subject 13 (EMST group) increased their mucosal wave on one vocal fold and decreased on the
other fold. Other participants had a normal mucosal wave at baseline or unavailable data.
All participants presented with a certain amount of supraglottic activity (hyperfunction), either
anteroposterior or mediolateral or both, at baseline. In the IMST group, two participants
decreased their hyperfunction while one participant increased and one had unavailable posttreatment data. In the EMST group, one participant slightly increased, one slightly decreased, and
one did not change. In the VFE group, two participants decreased and one increased. In summary,
the IMST and the VFE group had similar results regarding change in supraglottic activity, while the
EMST group had the least amount of change.
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Regarding phase symmetry, one participant in each of the intervention groups improved following
treatment. The greatest improvements (+30% and +20%) were found in the IMST and the VFE
group, respectively. However, this could be explained by the lower phase symmetry values at
baseline, which may have left more room for improvement. As for regularity of vibration, the two
participants with the lowest baseline values (40% and 60%) improved considerably following the
intervention (in the IMST and EMST group, respectively).
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Table 35. Two-Way ANOVA Results for Bowing Index (Group Results)

Outcome
Measure

Bowing Index

IMST

Pre
(SD)
8.11
(2.06)

Post
(SD)
9.03
(3.35)

EMST

Diff.
ES (d)
0.92
dw=0.32
db=1.51

Pre
(SD)
8.05
(0.53)

Post
(SD)
6.07
(0.93)

VFE

Diff.
ES (d)
-1.98
dw=-0.68
db=0.51

ES=effect size; dw=Cohen’s d within groups; db=Cohen’s d between groups; SD=standard deviation

Pre
(SD)
12.06
(4.37)

Post
(SD)
8.60
(0.90)

F (p-value)
Time effect
Time*group
Group effect
Diff
ES (d)
-3.46
dw=-1.19

1.884 (0.228)
1.247 (0.364)
2.338 (0.192)
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Table 36. Change in Laryngeal Features (Single-Subject Results)

ID

Group

2

IMST

9

IMST

12

IMST

16

IMST

10

EMST

13

EMST

20

EMST

14

VFE

17

VFE

18

VFE

Amplitude (%)
Mucosal wave (%)
Supgraglottic activity
Symmetry (%)
Right
Right
Anteroposterior
Left
Left
Mediolateral
Pre Post Change Pre
Post Change Pre
Post Change Pre
Post
40
40
60
60
40
40
60
60
60
40
60
60
60
80
80
80
60
40

40
40
60
60
20
40
60
60
40
40
60
60
40
40
40
60
-

0
-20
0
+20
0
-60
-60
-

40
60
60
40
20
20
60
60
80
40
80
80
60
80
80
80
80
80

40
40
60
40
80
60
80
60
80
80
80
20
60
60
80
-

-20
+40
+20
+20
0
-40
-20
-

0
1
1
1
3
4
2
4
2
3
0
1
2
2
1
2
2
4
2
3

2
1
2
3
0
3
1
3
0
2
2
2
0
1
1
2
5
3

Regularity (%)
Pre

Post

+2

60

90

+30

90

90

0

-

100

-

-

90

-

-

-2

-

90

-

-

90

-

-3

80

70

-10

40

90

+50

-1

80

90

+10

60

100

+40

+1

70

50

-20

70

50

-20

0

90

90

0

90

90

0

-2

90

50

-40

90

90

0

-3

50

70

+20

90

70

-20

+3

30

-

-

90

-

-
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Results from the Interventions: Acoustic and Auditory-Perceptual Judgement of Voice Quality
Measures
Table 37 presents the pre- and post-treatment acoustic measures for each participant. All
participants showed a clinically meaningful improvement in at least one of the acoustic measures,
except for one participant in the IMST group, one participantin the EMST group, and one
participant in the VFE group, who didn’t show any meaningful improvement.

Two participants in the IMST group increased their SPL during running speech with a moderate or
large effect size (SMD=0.75 and 1.00). Another participant in the IMST group decreased their SPL,
which was elevated at pre-treatment (from 82.4 dB to 80.3 dB; |SMD|=0.69). No meaningful
changes in SPL were found for participants in the other intervention groups.

All participants increased (improved) their CPPS during reading to some extent, except for one
participant in the EMST group (participant 20). These results were also reflected in the ANOVA
results, which revealed a significant time effect (p=0.023). Although no time by group interaction
were found, effect sizes were the greatest for the IMST (dw=0.82) and the EMST (dw=0.93) groups.
As for the VFE group, the pre- to post-treatment effect size was small (dw=0.28) and the mean
difference was below the SEM. When the RMST groups were compared to the VFE group, the
effect sizes were both medium although slightly superior for the EMST group (db=0.54 for IMST
and db=0.66 for EMST). Group effect sizes and ANOVA results are displayed in Table 38.

As for measures of voice quality during a sustained /a/, one participant in the IMST group
improved meaningfully for CPPS and APQ, and another one improved for NHR and APQ. Effect
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sizes were moderate to large (|SMD|=0.58 to 0.81). In the EMST group, only one participant had
a meaningful improvement on the sustained vowel: participant 13 improved their APQ and NHR,
with very large effect sizes (|SMD|=1.59 and 3.67). This participant had perturbation measures
considerably above normal values prior to treatment, which may have left more room for
improvement and could explain the large effect sizes following the intervention. In the VFE group,
one participant improved CPPS and APQ with large and very large effect sizes ((|SMD|=1.58 and
1.01), and one participant improved only APQ, with a moderate effect size (|SMD|=0.69). The
two-way ANOVA and the group effect sizes revealed no differences between the groups for CPPS
/a/ and NHR /a/. Moreover, the only meaningful effect size (|dw|=0.72) was found within the VFE
group, which improved on the APQ measure from pre- to post-treatment.

Table 39 presents the pre- and post-treatment values for perceptual judgment of overall severity,
as rated on the CAPE-V form. The four participants in the IMST group had a decrease
(improvement) in overall severity of voice quality, to different extents. Two of these participants
had a decrease (improvement) beyond the MD calculated for this outcome (21.79 for females and
15.92 for males), which also corresponded to very large effect sizes (|SDM|=2.07 and 1.68). All
participants in the EMST group also experienced a decrease (improvement) in overall severity.
This decrease was important (beyond the MD) in one participant, with a moderate effect size
(|SMD|=0.66). A similar scenario was observed in the VFE group, with one participant improving
beyond the MD and with a large effect size (|SMD|= 1.03). In summary, improvements in overall
severity of voice quality occurred in all three intervention groups, with at least one participant per
group improving in a clinically meaningful way. These results were confirmed by the results from
the ANOVA, which revealed a significant time effect. Although no significant time by group
interaction was found, larger pre-treatment to post-treatment effect sizes were found in the IMST
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group (|dw|=0.97), followed by the EMST group (|dw|=0.60), and lastly the VFE group (|dw|=0.29).
When compared to the VFE group, the IMST group had the largest effect size (|db|=0.67 versus
|db|=0.31 for the EMST group). Group effect sizes and ANOVA results are displayed in Table 38.
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Table 37. Change in Acoustic Measures (Single-Subject Results)

ID

Group

2

IMST

9

IMST

12

IMST

16

IMST

10

EMST

13

EMST

20

EMST

14

VFE

17

VFE

18

VFE

SPL speech (dB)
Pre Post Change
SMD2
62.9 70.9
8**
1.00
70.6 67.9
-2.7*
-0.45
69.4 73.6
4.2*
0.75
82.4 80.3
-2.1
-0.69
71 73.1
2.1
0.31
68.2 70.3
2.1
0.23
70.8 70.2
-0.6
-0.03
73.9 72.8
-1.1
-0.25
74.5 75.5
1
0.19
76.3 78.1
1.8
0.32

CPPS /a/ (dB)
Post
Change
SMD2
21.98 23.19
1.21
0.18
23.29 21.48
-1.81*
-1.00
21.65 22.17
0.53
0.35
20.77 22.17
1.4
0.58
18.85 20.32
1.47
0.26
20.10 19.93
-0.18
0.70
21.38 22.278
0.90
0.37
17.48 22.17 4.70**
1.58
26.06 26.85
0.80
0.45
25.63 23.58
-2.05*
-0.85

Pre

CPPS reading (dB)
Post
Change
SMD2
15.71 16.57
0.86*
0.33
15.82 16.38
0.57
0.33
17.22 20.01
2.79**
1.32
18.41 19.15
0.74*
0.06
14.58 16.07
1.49*
0.98
13.93 16.95 3.019**
1.53
17.55 17.306
-0.25
-0.41
17.64 18.29
0.65*
0.18
16.15 16.29
0.14
0.34
18.17 18.65
0.49
0.22

Pre

Pre
0.15
0.15
0.16
0.12
0.11
0.30
0.08
0.15
0.13
0.12

NHR /a/
Post
Change
SMD2
0.13
-0.02
0.12
0.15
0
0.47
0.12
-0.04
-0.66
0.10
-0.02
-0.46
0.09
-0.02
0.12
0.22
-0.09
-3.67
0.138 0.061
1.01
0.13
-0.02
-0.13
0.14
0.01
-0.01
0.12
0
0.10

APQ /a/ (%)
Post Change
SMD2
3.75 3.95
0.20
0.21
2.04 3.58
1.54
1.72
4.06 2.43
-1.63
-0.81
2.50 1.69
-0.81
-0.62
3.53 2.63
-0.90
-0.23
8.36 7.71
-0.65
-1.59
2.41 2.04
-0.37
-0.12
4.66 2.32
-2.34
-1.01
4.60 3.01
-1.60
-0.69
3.09 3.09
0
-0.05

Pre

*Change greater than SEM
**Change greater than MD
(SEM and MD were not available for NHR and APQ)
SPL=sound pressure level; CPPS=smoothed cepstral peak prominence; NHR=noise-to-harmonic ratio; APQ=amplitude perturbation quotient; SMD2=standard mean
difference (two baseline and two follow-up data points were available
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Table 38. Two-Way ANOVA Results for Vocal Quality Measures (Group Results)

Outcome
Measure

IMST

SPL speech
(dB)

Pre
(SD)
71.33
(8.12)

Post
(SD)
73.18
(5.29)

CPPS /a/
(dB)

21.92
(1.05)

22.25
(0.71)

CPPS reading
(dB)

16.79
(1.28)

18.03
(1.83)

NHR /a/

0.15
(0.02)

0.13
(0.02)

APQ /a/
(%)

3.09
(0.97)

2.91
(1.04)

Overall
Severity
(VAS
100mm)

43.00
(28.58)

21.00
(10.61)

EMST

Diff.
ES (d)
1.85
dw=0.35
db=0.25
0.33
dw=0.12
db=-0.30
1.24
dw=0.82
db=0.54
-0.02
dw=-0.33
db=-0.17
-0.18
dw=-0.10
db=0.62
-22
dw=-0.97
db=-0.67

Pre
(SD)
70.00
(1.56)

Post
(SD)
71.20
(1.65)

20.11
(1.26)

20.84
(1.26)

15.36
(1.93)

16.78
(0.64)

0.16
(0.12)

0.15
(0.06)

4.77
(3.16)

4.13
(3.12)

52.00
(30.41)

38.33
(30.50)

VFE

Diff.
ES (d)
1.20
dw=0.23
db=0.12
0.73
dw=0.27
db=-0.15
1.42
dw=0.93
db=0.66
-0.01
dw=-0.17
db=0
-0.64
dw=-0.35
db=0.37
-13.67
dw=-0.60
db=-0.31

F (p-value)
Time effect
Time*group
Group effect

Pre
(SD)
74.90
(1.25)

Post
(SD)
75.47
(2.65)

Diff
ES (d)
0.57
dw=0.11

23.05
(4.84)

24.20
(2.40)

1.15
dw=0.42

17.32
(1.05)

17.74
(1.27)

0.42
dw=0.28

0.14
(0.02)

0.13
(0.09)

-0.01
dw=-0.17

4.12
(0.89)

2.81
(0.42)

-1.31
dw=-0.72

40.00
(7.55)

33.33
(21.39)

-6.67
dw=-0.29

1.122 (0.325)
0.112 (0.896)
0.859 (0.464)
1.204 (0.309)
0.129 (0.881)
1.930 (0.215)
8.330 (0.023)**
0.691 (0.532)
1.187 (0.360)
1.041 (0.342)
0.075 (0.929)
0.157 (0.857)
4.027 (0.085)
0.903 (0.448)
0.593 (0.578)
5.578 (0.050)**
0.584 (0.583)
0.332 (0.728)

**Significant at an alpha level of 0.05
SPL=sound pressure level; CPPS=smoothed cepstral peak prominence; NHR=noise-to-harmonic ratio; APQ=amplitude perturbation quotient; VAS=visual analog scale;
ES=effect size, dw=Cohen’s d within groups; db=Cohen’s d between groups; SD=standard deviation
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Table 39. Change in Auditory-Perceptual Judgment of Overall Severity (Single-Subject Results)

ID

Group

2

IMST

9

IMST

12

IMST

16

IMST

10

EMST

13

EMST

20

EMST

14

VFE

17

VFE

18

VFE

Overall Severity
(VAS 100 mm)
Pre
Post
Change
SMD2
25
21
-4
-0.31
14
8
-6*
-0.24
76
21
-55**
-2.07
57
34
-23**
-1.68
72
69
-3
-0.37
67
38
-29**
-0.66
17
8
-9*
-0.39
48
52
4
0.26
33
10
-23**
-1.03
39
38
-1
0.09

*Change greater than SEM
**Change greater than MD
SMD2=standard mean difference (two baseline and two follow-up data points were available) VAS=visual analog scale
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Results from the Interventions: Aerodynamic Measures
Individual results for aerodynamic measures are presented in Table 40. In the IMST group, two
out of four participants increased their aerodynamic resistance with large to very large effect sizes
(SMD=0.90 and 1.46). In both cases, the increase was associated with a decrease in airflow
(|SMD|=0.50 and |SMD|=0.90, respectively) and not with an increase in subglottal pressure. A
decrease in subglottal pressure was in fact found in both participants, although the effect size was
only important in participant 9 (|SMD|=0.88). Although pre-treatment data was unavailable
regarding subglottal pressure and aerodynamic resistance for participant 12, the post-treatment
profile was the following: a low mean airflow rate, an adequate subglottal pressure, and a high
aerodynamic resistance. One participant in the IMST group (participant 16) had an abnormally
high subglottal pressure before the intervention, which decreased following treatment
(|SDM|=1.33), along with a small increase in mean airflow (SMD=0.30) and a considerable
decrease in aerodynamic resistance (|SDM|=1.40).

In the EMST group, no considerable changes were reported for participant 10, who presented
with an elevated glottal airflow rate at baseline and decreased aerodynamic resistance. Following
treatment, a small increase in subglottal pressure was noted (SMD=0.44), with only a negligible
increase in aerodynamic resistance (SDM=0.16). Mean airflow rate was slightly increased
following therapy (SMD=0.10). Although pre-therapy data was unavailable for participant 13
regarding subglottal pressure and aerodynamic resistance, post-therapy data suggests a similar
profile as participant 10: a slight increase in mean airflow rate (SDM=0.20) and a low aerodynamic
resistance at post-treatment. Participant 20 had a very high airflow at pre-treatment, which did
not decrease meaningfully after the intervention (|SMD|=0.10). In the same participant, an
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insignificant increase in subglottal pressure and in aerodynamic resistance occurred following
treatment (SMD=0.13 and 0.08, respectively).

Two out of three participants in the VFE group (participants 14 and 17) increased their
aerodynamic resistance, with large effect sizes (SMD=1.10 and 1.07, respectively). Participant 14
decreased their mean airflow rate (|SMD|=1.8) and maintained a somewhat stable subglottal
pressure (which was already within normal values), while participant 17 maintained a constant
airflow and increased their subglottal pressure (SMD=0.77), which was very low at baseline. The
third participant in the VFE group (participant 18) increased both airflow and subglottal pressure
(SMD=1.4 and 0.71, respectively). However, aerodynamic resistance decreased following the
intervention (|SMD|=1.73).

Results of the ANOVA (table 41) revealed a significant group effect for mean airflow during voicing
(p=0.039), and post hoc Tukey test indicated that the difference was between the IMST and EMST
groups (p=0.034). In fact, the EMST group had the greatest airflow value prior to the intervention
and increased slightly following the intervention, while the IMST group had the smallest airflow
and decreased following intervention, further widening the disparity between the groups. A
significant group effect was also found for aerodynamic resistance (p=0.003), and post hoc Tukey
test revealed that the differences were between IMST and EMST (p=0.002) between EMST and
VFE (p=0.042), and between IMST and VFE (p=0.030). The EMST group had the lowest
aerodynamic resistance at baseline and only had a slight increase following the intervention
(dw=0.12). The VFE group had the second largest resistance at baseline and also experienced only
a slight increase (dw=0.15). The IMST group had the largest resistance mean at baseline and also
experienced an increase (dw=0.32). Lastly, a significant time by group interaction was found for
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subglottic pressure (p=0.057). As shown in Figure 7, both EMST and VFE groups increased their
subglottal pressure (d=0.28 and d=0.41, respectively), while the IMST group had a mean decrease
in subglottal pressure (|d|=0.84).

Figure 7. Change in Group Means for Subglottal Pressure
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Table 40. Change in Aerodynamic Measures (Single Subject Results)

ID

Group

Mean airflow (L)
Post
Change
0.09
-0.05
0.05
-0.09

SMD
-0.50
-0.90

Subglottal pressure (cmH20)
Pre
Post
Change
SMD
7
6.16
-0.84
-0.30
6.56
4.15
-2.41
-0.88

Aerodynamic resistance (cmH20/l/s)
Pre
Post
Change SMD
49.07
68.48
19.41
0.90
45.96
77.41
31.45
1.46

2
9

IMST
IMST

Pre
0.14
0.14

12
16

IMST
IMST

0.05
0.16

0.06
0.19

0.01
0.03

0.10
0.30

12.41

7.84
8.79

-3.62

-1.33

74.52

121.77
44.41

-30.11

-1.40

10

EMST

0.27

0.28

0.01

0.10

7.48

8.68

1.2

0.44

26.77

30.15

3.38

0.16

13
20

EMST
EMST

0.17
0.34

0.19
0.33

0.02
-0.01

0.20
-0.10

5.45

5.37
5.80

0.35

0.13

15.25

27.61
17.07

1.82

0.08

14

VFE

0.31

0.13

-0.18

-1.8

7

6.26

-0.74

-0.27

22.05

45.73

23.68

1.10

17

VFE

0.11

0.10

-0.01

-0.1

3.42

5.53

2.11

0.77

30.17

53.12

22.95

1.07

18

VFE

0.06

0.20

0.14

1.4

4.19

6.14

1.95

0.71

66.97

29.83

-37.14

-1.73

SMD=standard mean difference
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Table 41. Two-Way ANOVA Results for Aerodynamic Measures (Group Results)

Outcome
Measure

Mean airflow
(L)
Subglottal
pressure
(cmH20)
Aerodynamic
resistance
(cmH20/l/s)

IMST

Pre
(SD)
0.12
(0.05)

Post
(SD)
0.10
(0.06)

8.66
(3.26)

6.37
(2.33)

56.52
(15.69)

63.43
(17.07)

EMST

Diff.
ES (d)
-0.02
dw=-0.20
db=0
-2.29
dw=-0.84
db=-1.25
6.91
dw=0.32
db=0.17

Pre
(SD)
0.26
(0.09)

Post
(SD)
0.27
(0.07)

6.47
(1.44)

7.24
(2.04)

21.01
(8.15)

23.61
(9.25)

VFE

Diff.
ES (d)
0.01
dw=0.10
db=0.30
0.77
dw=0.28
db=-0.12
2.60
dw=0.12
db=-0.03

*Significant at an alpha level of 0.1
**Significant at an alpha level of 0.05
ES=effect size; dw=Cohen’s d within groups; db=Cohen’s d between groups; SD=standard deviation

F (p-value)
Time main effect
Time*group
Group main effect

Pre
(SD)
0.16
(0.13)

Post
(SD)
0.14
(0.05)

Diff
ES (d)
-0.02
dw=-0.20

4.87
(1.88)

5.98
(0.39)

1.11
dw=0.41

39.73
(23.94)

42.89
(11.90)

3.16
dw=0.15

0.154 (0.707)
0.102 (0.904)
5.375 (0.039)**
0.076 (0.794)
5.362 (0.057)*
0.825 (0.490)
0.151 (0.714)
0.016 (0.984)
23.244 (0.003)**
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Results from the Interventions: Self-Assessment Measures
Individual results for the three self-assessment questionnaires are presented in Table 42.
All participants had a VHI-10 score above 11 prior to therapy, which is indicative of a meaningful
perceived voice handicap (Arffa et al., 2012). All participants in the IMST group improved
(decreased) their total VHI-10 score with moderate to large effect sizes ranging from
|SMD|=0.62 to |SMD|=2.34. In the EMST group, only one participant decreased their VHI-10
score, and the effect size was small (|SMD|=0.31). One participant in the EMST group worsened
(increased) their VHI-10 score by 10 points (SMD=1.56). In the VFE group, only one participant
improved their VHI-10 score (|SDM|=1.40).

Three out of four participants in the IMST group improved (decreased) their GFI score with large
effect sizes, ranging from |SMD|=1.16 to |SMD|=1.45. In the same group, one participant’s score
worsened (increased) by three points (SMD=0.87). For two participants in the EMST group, their
GFI score improved but with small to moderate effect sizes, ranging from |SMD|=0.29 to
|SMD|=0.58. In the VFE group, one participant had a meaningful improvement in GFI score
(|SMD|=1.45).

In the IMST group, all participants for who CPIB scores were available improved (increased) their
score with large to huge effect sizes, ranging from SMD=1.11 to SMD=3.18. In the EMST group,
one participant improved considerably (SMD=1.11), while another participant remained the same
and one got worse (SMD=-0.64). In the VFE group, two participants improved their CPIB scores,
with moderate to large effect sizes (SMD=0.64 and 0.80), while the other participant decreased
their CPIB score (SMD=-0.80).
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The group effect sizes confirmed that larger improvements occurred in the IMST group. In fact,
large to very large effect sizes were found in the IMST group on the three self-assessment
measures, ranging from |dw|=0.80 to 1.91. In opposition, only small effect sizes (or worsening of
scores) were found in the EMST group. In the VFE group, small effect sizes were found for the VHI10 and the CPIB questionnaires, and a medium effect size was found for the GFI questionnaire
(|dw|=0.58). The results from the ANOVA revealed a significant time by group interaction effect
for VHI-10 (p=0.070). In fact, while the IMST group made a considerable improvement (reduced
their mean VHI-10 score) (|dw|=1.40), the VFE group made a small improvement (|dw|=0.36) and
the EMST group demonstrated a decline as evidenced by an increase in their mean perceived
handicap at post-treatment (|dw|=0.47). See Table 43 and Figures 8, 9, and 10 for the ANOVA
results.

Correlations Between Improvements in Respiratory Muscle Strength and in Voice Outcomes
Tabl 44 displays the Spearman correlation coefficients between change in MIP and MEP and
change in voice measures. Only one significant correlation was found between improvements in
respiratory muscle strength and voice outcomes: a greater change in MIP was associated with a
greater change in aerodynamic resistance (r=0.64, p=0.048).
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Table 42. Change in Self-Assessment Measures (Single Subject Results)

ID
2
9
12
16
10
13
20
14
17
18

Group
IMST
IMST
IMST
IMST
EMST
EMST
EMST
VFE
VFE
VFE

Pre
28
15
26
27
23
12
16
20
14
29

Post
22
11
15
12
21
22
17
20
5
31

VHI-10
Change
-6
-4
-11
-15
-2
10
1
0
-9
2

SMD
-0.94
-0.62
-1.72
-2.34
-0.31
1.56
0.16
0
-1.40
0.31

Pre
11
10
12
17
14
13
7
10
6
15

Post
14
5
8
12
12
12
8
10
1
14

GFI
Change
3
-5
-4
-5
-2
-1
1
0
-5
-1

SMD
0.87
-1.45
-1.16
-1.45
-0.58
-0.29
0.29
0
-1.45
-0.29

Pre
15
5
16
11
15
19
19
21
3

Post
14
24
25
23
18
15
15
14
25
8

CPIB
Change
9
20
7
7
0
-4
-5
4
5

SMD
1.43
3.18
1.11
1.11
0
-0.64
-0.80
0.64
0.80

VHI-10=Voice Handicap Index-10; GFI=Glottal Function Index; CPIB=Communicative Participation Item Bank; SMD=standard mean difference
Table 43. Two-Way ANOVA Results for Self-Assessment Measures (Group Results)

Outcome
Measure

IMSeT
Pre
(SD)
24.00
(6.06)

Post
(SD)
15.00
(4.97)

GFI

12.50
(3.11)

9.75
(4.03)

CPIB

12.00
(6.08)

24.00
(1.00)

VHI-10

EMST
Diff.
ES (d)
-9.00
dw=-1.40
db=-1.04
-2.75
dw=-0.80
db=-0.22
12.00
dw=1.91
db=1.70

Pre
(SD)
17.00
(5.57)

Post
(SD)
20.00
(2.65)

11.33
(3.79)

10.67
(2.31)

15.00
(4.00)

16.00
(1.73)

VFE
Diff.
ES (d)
3.00
dw=0.47
db=0.83
-0.66
dw=-0.19
db=0.39
1.00
dw=0.16
db=-0.05

Pre
(SD)
21.00
(6.41)

Post
(SD)
18.67
(13.05)

Diff
ES (d)
-2.33
dw=-0.36

10.33
(4.51)

8.33
(6.66)

-2.00
dw=-0.58

14.33
(9.87)

15.67
(8.62)

1.34
dw=0.21

F (p-value)
Time main effect
Time*group
Group main effect
2.403 (0.165)
3.993 (0.070)*
0.034 (0.967)
3.533 (0.102)
0.413 (0.677)
0.208 (0.817)
5.586 (0.056)
3.193 (0.114)
0.268 (0.774)

*Significant at an alpha level of 0.1
VHI-10=Voice Handicap Index-10; GFI=Glottal Function Index; CPIB=Communicative Participation Item Bank; ES=effect size; dw=Cohen’s d within groups; db=Cohen’s d
between groups; SD=standard deviation
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Figure 8. Change in Group Means for Voice Handicap Index-10

Figure 9. Change in Group Means for Glottal Function Index

Figure 10. Change in Group Means for Communicative Participation Item Bank
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Table 44. Correlations Between Improvements in Respiratory Muscle Strength and in Voice Outcomes

MIP
(pvalue)
MEP
(pvalue)

SPL
speech
-0.35
(0.327)

CPPS
/a/
-0.47
(0.174)

CPPS
reading
0.19
(0.603)

NHR
/a/
-0.31
(0.385)

APQ
/a/
-0.10
(0.777)

Overall
severity
-0.13
(0.713)

Mean
airflow
-0.09
(0.815)

Subglottal
pressure
0.21
(0.556)

Aerodynamic VHI-10
resistance
0.64
0.22
(0.048)**
(0.533)

GFI

CPBI

-0.39
(0.260)

0.126
(0.748)

Bowing
index
0.12
(0.779)

0.07
(0.854)

-0.18
(0.626)

0.24
(0.510)

-0.19
(0.602)

0.05
(0.894)

0.16
(0.650)

-0.15
(0.686)

0.28
(0.434)

0.35
(0.318)

-0.09
(0.799)

-0.12
(0.763)

-0.66
(0.076)

**Significant at an alpha level of 0.05

0.50
(0.137)
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Results: Aim 3b
The objective of aim 3b was to assess whether baseline respiratory function and severity of vocal
fold atrophy impacted the response to the intervention in terms of change in voice-related
handicap. Results are presented below.
Respiratory Predictors for the IMST Group
The IMST group demonstrated the largest improvement in VHI-10 score (a mean reduction of 9
points on the questionnaire). To assess whether participants with a lower respiratory function
gained more from the IMST intervention, each respiratory variable was tested as a predictor for
improvement in VHI-10 score following therapy. Table 45 displays the results.

In the IMST group, baseline MIP was found to have a significant relationship with change in VHI10, with a beta-weight (b) of 0.98, an R-squared of 0.96, and a p-value of p=0.020 (Figure 11).
FEV1% had a b of 0.92, an R-squared of 0.85, and a p-value marginally significant (p=0.076)
(Figure 12). FVC% was found to be a potentially good predictor for change in VHI-10 in the IMST
group, with a b of 0.84 and an R-Squared of 0.71, although the p-value did not reach significance
(p= 0.158) (Figure 13). MEP was also found to be a potentially meaningful predictor, with a b of
0.82 and an R-squared of 0.67 (p=0.184) (Figure 14). Raw values of FVC and FEV1 also did not
reach significance (p=0.197 and p=0.239, respectively). The effect might have been too small to
reach significance with this very small sample size (n=4). Nonetheless, the direction of the
relationship was the same as for the other variables: a larger FVC and FEV1 were slightly
associated with a smaller decrease in VHI-10 score. The FEV1/FVC ratio (raw and predicted
percent), also did not reach statistical significance (p=0.930 for the raw value and p=0.675 for the
percent predicted value) and presented with the smallest b values (Table 45).
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Figure 11. Scatter plot and linear regression fitted-line for change in VHI-10 (y-axis) and MIP at baseline (x-axis). A
change towards the negative values is associated with a greater improvement.

Figure 12. Scatter plot and linear regression fitted-line for change in VHI-10 (y-axis) and FEV1% at baseline (x-axis). A
change towards the negative values is associated with a greater improvement.
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Figure 13. Scatter plot and linear regression fitted-line for change in VHI-10 (y-axis) and FVC% at baseline (x-axis). A
change towards the negative values is associated with a greater improvement.

Figure 14. Scatter plot and linear regression fitted-line for change in VHI-10 (y-axis) and MEP at baseline (x-axis). A
change towards the negative values is associated with a greater improvement.
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Table 45. Linear Regression Outcomes for Change in VHI-10 in the IMST Group

Variable

B

SE B

b

t

p

Model

RSquared

Adjusted
R-Squared

Intercept

-25.48

2.41

0

-10.58

0.009

49.89
(0.020**)

0.96

0.94

MIP

0.19

0.03

0.98

7.06

0.020**

Intercept

-33.61

7.31

-4.60

0.044

11.64
(0.076*)

0.85

0.78

FEV1%

0.31

0.09

0.92

3.41

0.076*

Intercept

-30.91

10.04

0

-3.08

0.091

4.89
(0.158)

0.71

0.56

FVC%

0.26

0.12

0.84

2.21

0.158

Intercept

-18.56

5.10

0

-3.64

0.068

3.99
(0.184)

0.67

0.50

MEP

0.09

0.04

0.82

2.00

0.180

Intercept

-21.03

6.57

0

-3.20

0.085

3.63
(0.197)

0.64

0.47

FVC

4.05

2.13

0.80

1.91

0.197

Intercept

-19.36

6.55

0

-2.96

0.098

2.75
(0.239)

0.58

0.37

FEV1

4.77

2.87

0.76

1.66

0.239

Intercept

-58.96

102.76

0

-0.57

0.624

0.24
(0.675)

0.11

-0.34

FEV1/FVC%

0.52

1.07

0.33

0.49

0.675

Intercept

-17.82

88.78

0

-0.20

0.860

0.01
(0.930)

0.005

-0.49

FEV1/FVC

12.12

121.97

0.07

0.10

0.930

F (p-value)

*Significant at an alpha level of 0.1 **Significant at an alpha level of 0.05
B=parameter estimate; SE B= standard error of B b=standardized parameter estimate (beta-weight);
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Respiratory Predictors for the Total Sample
To evaluate if respiratory measures were good predictors of treatment outcome regardless of the
intervention received (IMST, EMST, or VFE), relationships were also assessed within the total
sample. Because both IMST and EMST were strong predictors of the outcome (IMST predicted a
greater decrease in VHI-10 score and EMST a lesser decrease) (Table 46), they were both tested
as potential covariates with each respiratory variable. Age and gender were also tested in the
models and controlled for if necessary.

Table 46. Linear Regression Outcomes: Effect of Intervention Group on Change in VHI-10

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept

0.33

2.34

0

0.14

0.890

6.35
(0.036**)

0.44

0.37

IMST

-9.33

3.70

-0.67

-2.52

0.036**

Intercept

-6.14

2.30

0

-2.67

0.028

4.73
(0.061*)

0.37

0.29

EMST

9.14

4.20

0.61

2.18

0.061*

Intercept

-3.86

2.89

0

-1.33

0.219

0.08
(0.780)

0.01

-0.11

VFE

1.52

5.28

0.10

0.29

0.780

*Significant at an alpha level of 0.1
**Significant at an alpha level of 0.05

Two respiratory variables were found to be significant predictors for change in VHI-10, at an alpha
level of 0.05: FVC% (p=0.013) and FEV1% (p=0.049). The R-squared for both models was 0.75. MEP
was found to be marginally significant, at a 0.1 alpha level (p=0.076). Scatter plots for these three
variables are presented below (Figures 15 to 17) and show the direction of the relationship: higher
values of FVC%, FEV1%, and MEP at baseline were associated with less improvement in voice
handicap index after the intervention. Lower values of FVC%, FEV1% and MEP were associated
with greater improvement (more decrease in VHI-10 scores) following treatment.
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Figure 15. Scatter plot of the effect of FVC% at baseline (x-axis) on change in VHI-10 following treatment (y-axis), by
intervention group. A change towards the negative values is associated with a greater improvement.

Table 47. Linear Regression Results for Change in VHI-10 with FVC% as the Respiratory Predictor

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept -33.24

8.38

0

-3.97

0.005

10.68
(0.007**)

0.75

FVC%
EMST

0.09
3.29

0.72
0.98

3.29
4.48

0.013**
0.003**

Variable

B

0.30
14.72

0.68

**Significant at an alpha level of 0.05

Table 47 presents the linear regression results for FVC% as a predictor, when controlling for
potential covariates (in this case the only significant covariate was EMST). A higher FVC% at
baseline was associated with smaller improvement in VHI-10 following treatment. More
specifically, an increase of 3.3% in baseline FVC% was associated with one point less in VHI-10
improvement following treatment. In terms of SDs, an increase of one SD in baseline FVC%
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(17.16%) was associated with 0.72 SD less improvement in VHI-10 (corresponding to 5.22 points
on the questionnaire).

Figure 16. Scatter plot of the effect of FEV1% at baseline (x-axis) on change in VHI-10 following treatment (y-axis), by
intervention group. A change towards the negative values is associated with a greater improvement.

Table 48. Linear Regression Results for Change in VHI-10 with FEV1% as the Respiratory Predictor

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept -42.01

14.67

0

-2.86

0.029

6.02
(0.031**)

0.75

FEV1%
EMST
Age

0.09
3.72
0.20

0.62
0.93
0.25

2.47
3.76
1.18

0.049**
0.009**
0.281

Variable

B

0.22
14.00
0.23

0.63

**Significant at an alpha level of 0.05

Table 48 presents the linear regression results for FEV1% as a predictor, when controlling for
relevant covariates. A higher FEV1% at baseline was associated with smaller improvement in VHI10 following treatment. More specifically, an increase of 4.55% in baseline FEV1% was associated
with one point less in VHI-10 improvement following treatment. In terms of SDs, an increase of

187
one SD in baseline FEV1% (20.26%) was associated with 0.62 SD less improvement in VHI-10
(corresponding to 4.49 points on the questionnaire).

Figure 17. Scatter plot of the effect of MEP at baseline (x-axis) on change in VHI-10 following treatment (y-axis), by
intervention group. A change towards the negative values is associated with a greater improvement.

Table 49. Linear Regression Results for Change in VHI-10 with MEP as the Respiratory Predictor

SE B

b

t

p

Intercept -14.82

8.29

0

-1.79

0.124

MEP
IMST
Gender

0.10
3.78
7.89

1.14
-0.96
-1.26

2.14
-3.55
-2.20

0.076*
0.012**
0.070*

Variable

B

0.21
-13.42
-17.33

Model
F (p-value)
4.56
(0.055*)

RSquared
0.69

Adjusted
R-Squared
0.54

*Significant at an alpha level of 0.1

Table 49 presents the linear regression results for MEP as a predictor, when controlling for
relevant covariates. A higher MEP at baseline was associated with smaller improvement in VHI10 following treatment. More specifically, an increase of 4.76 cmH20 in baseline MEP was
associated with a one point less in VHI-10 improvement following treatment. In terms of SDs, an
increase of one SD in baseline MEP (38.59 cmH20) was associated 1.14 SD less improvement in
VHI-10 (corresponding to 8.25 points on the questionnaire).
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Although the other respiratory variables did not reach statistical significance, the results indicated
a relationship in the same direction. A greater sample size would be required to potentially reach
statistical significance for these variables (Tables 50 to 54).

Table 50. Linear Regression Results for Change in VHI-10 with FVC as the Respiratory Predictor

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept -8.61

8.88

0

-0.97

0.370

2.71
(0.138)

0.58

FVC
IMST
Gender

3.57
4.34
5.66

0.48
-0.86
-0.52

1.27
-2.78
-1.26

0.252
0.032
0.253

Variable

B

4.53
-12.05
-7.16

0.36

Table 51. Linear Regression Results for Change in VHI-10 with FEV1 as the Respiratory Predictor

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared RSquared

Intercept -51.31

20.34

0

-2.52

0.045

3.92
(0.0727*)

0.66

FEV1
EMST
Age

2.84
3.70
0.24

0.45
0.70
0.51

1.71
2.83
2.00

0.138
0.030
0.092

Variable

B

4.85
10.50
0.48

0.49

Table 52. Linear Regression Results for Change in VHI-10 with MIP as the Respiratory Predictor

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared R-Squared

Intercept -8.32

7.35

0

-1.13

0.301

3.18
(0.106)

0.61

MIP
IMST
Gender

0.12
5.12
5.31

0.58
-1.09
-0.56

1.54
-2.99
-1.46

0.175
0.024
0.194

Variable

B

0.19
-15.31
-7.76

0.42
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Table 53. Linear Regression Results for Change in VHI-10 with FEV1/FVC as the Respiratory Predictor

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared RSquared

Intercept

-65.92

38.87

0

-1.70

0.141

2.70
(0.139)

0.57

34.35
4.72
0.28

0.36
0.76
0.50

1.04
2.41
1.66

0.338
0.052
0.147

FEV1/FVC 35.78
EMST
11.39
Age
0.47

0.36

Table 54. Linear Regression Results for Change in VHI-10 with FEV1/FVC% as the Respiratory Predictor

Variable

B

SE B

b

t

p

Model
F (pvalue)

RAdjusted
Squared RSquared

Intercept

-65.13

35.01

0

-1.86

0.112

2.88
(0.125)

0.59

0.26
4.68
0.25

0.37
0.78
0.43

1.16
2.51
1.60

0.289
0.046
0.161

FEV1/FVC% 0.31
EMST
11.75
Age
0.41

0.38

Bowing Index as a Predictor
The influence of baseline bowing index on change in VHI-10 was also assessed with linear
regression. The results did not reach statistical significance, indicating that the effect of bowing
index on the response to the intervention was either not present or too small to be detected with
the limited sample size (p=0.246) (Table 55). In fact, meaningful improvements in VHI-10 scores
(at least 5 points) were obtained for a large range of baseline bowing index (6.66 to 17.03)
(Figure 18).

190

Figure 18. Scatter plot of the effect of bowing at baseline (x-axis) on change in VHI-10 following treatment (y-axis), by
intervention group. A change towards the negative values is associated with a greater improvement.

Table 55. Linear Regression Results for Change in VHI-10 with Bowing Index as a Predictor

Variable

B

SE B

b

t

p

Intercept

8.52

6.85

0

1.24

Bowing
Index
IMST

-0.81

0.64

-0.33

-1.26

0.254 4.21
(0.063*)
0.246

-9.97

3.61

-0.71

-2.76

0.028

Model
F (p-value)

RAdjusted
Squared R-Squared
0.55

0.42
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Controlling for Baseline Respiratory Measures
The effect of the intervention on change in VHI-10 score was assessed without controlling for
baseline respiratory function, and was then re-assessed while controlling for the respiratory
predictor that was the most significant influencer in the total sample: FVC%. Because a linear
relationship was found between FVC% and the difference in VHI-10 score, a univariate ANCOVA
was conducted with “change in VHI-10 score” as the dependent variable, “group” as the
independent variable, and FVC% as the covariate.

Table 56 presents the results from a univariate ANOVA (without controlling for FVC%) and post
hoc pairwise comparisons with Bonferroni correction. The group effect was marginally significant
(p=0.070), and partial eta squared for the variable “group" was 0.533, meaning that the
intervention group explained 53.3% of the variance in the outcome. Pairwise comparisons showed
a marginally significant difference between the EMST and the IMST groups (p=0.080). No
difference was found between the EMST and VFE groups, nor between the IMST and VFE groups.

Table 57 presents the results from the univariate ANCOVA when controlling for FVC%, as well as
pairwise comparisons between estimated marginal means, when FVC% was held constant at
83.50%. In this model, the effect for the variable “group” became statistically significant
(p=0.013), and the effect for FVC% at baseline was also significant at an alpha level of 0.05
(p=0.042). Partial eta squared for group increased when compared to the previous model (0.768
versus 0.533), meaning that controlling for baseline FVC% allowed for the detection of a greater
effect of the intervention group on the dependent outcome. Pairwise comparisons showed a
statistically significant difference between the EMST and the IMST groups (p=0.013). Moreover, a
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marginally significant difference was found between the EMST and the VFE groups (p=0.089). No
significant difference was found between the IMST and VFE groups.

Table 56. (a)ANOVA Results for the Effect of Intervention Group on Change in VHI-10 Without Controlling for Baseline
Respiratory Function (b) Multiple Comparisons Between Intervention Groups

Type III Sum
of Squares

Source
Corrected Model
Intercept
Group
Error
Total
Corrected Total

a

251.733
75.758
251.733
220.667
588.000
472.400

df
2
1
2
7
10
9

Mean Square
125.867
75.758
125.867
31.524

F

Sig.

3.993
2.403
3.993

0.070*
0.165
0.070*

Partial Eta
Squared
0.533
0.256
0.533

a.

95% Confidence Interval

Mean
Difference (I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

(I) Group

(J) Group

EMST

IMST

12.00

4.288

0.080*

-1.41

25.41

VFE

5.33

4.584

0.848

-9.00

19.67

EMST

-12.00

4.288

0.080*

-25.41

1.41

VFE

-6.67

4.288

0.492

-20.08

6.74

EMST

-5.33

4.584

0.848

-19.67

9.00

IMST

6.67

4.288

0.492

-6.74

20.08

IMST
VFE

b. Adjustment for multiple comparisons= Bonferroni
*Significant at an alpha level of 0.1
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Table 57. (a)ANOVA Results for the Effect of Intervention Group on Change in VHI-10 When Controlling for Baseline
Respiratory Function (b) Multiple Comparisons Between Intervention Groups, adjustment for multiple comparisons=
Bonferroni

Source

Type III Sum
of Squares

df

Mean Square

F

Sig.

Partial Eta
Squared

367.745a
143.153
116.012
346.013
104.655
588.000
472.400

3
1
1
2
6
10
9

122.582
143.153
116.012
173.007
17.443

7.028
8.207
6.651
9.919

0.022**
0.029**
0.042**
0.013**

0.778
0.578
0.526
0.768

Corrected Model
Intercept
FVC% baseline
Group
Error
Total
Corrected Total
a.

95% Confidence Interval for
Difference

Mean
Difference (IJ)

Std. Error

Sig.

Lower Bound

Upper Bound

(I) Group

(J) Group

EMST

IMST

15.312

3.439

0.013**

4.008

26.616

VFE

12.405

4.376

0.089*

-1.980

26.790

EMST

-15.312

3.439

0.013**

-26.616

-4.008

VFE

-2.907

3.507

1.000

-14.437

8.623

EMST

-12.405

4.376

0.089*

-26.790

1.980

2.907

3.507

1.000

-8.623

14.437

IMST
VFE

VFE

b. Adjustment for multiple comparisons= Bonferroni
*Significant at an alpha level of 0.1
**Significant at an alpha level of 0.05

Chapter 5: Discussion
Discussion Aim 1
Which outcomes present with the strongest intra-subject reliability in a sample of
patients with presbyphonia.

Out of the 29 variables assessed, only eight presented with sufficient intra-subject reliability for
both females and males. These variables were: SPL during reading, CPPS /a/, CPPS during
reading, NHR /a/, APQ /a/, MIP, MEP, and perceptual judgment of overall severity.

Respiratory Muscle Strength
A reliability study (Romer & McConnell, 2004) revealed excellent agreement ratios for MIP and
MEP. The authors explain these results by the fact that the participants in their experiment were
thoroughly familiarized with the procedure a priori and that the measurements were all taken by
the same investigator, therefore reducing secondary variance. Reducing bias is also likely to
increase sensitivity to change of these measures, which have also proven to be strong. In fact,
various studies have obtained statistically significant improvements in MIP and MEP after
interventions targeting respiratory muscle strength (Souza et al., 2014). Our results also showed
strong intra-subject reliability for MIP and MEP, both in males and females.
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Measures of Intensity and Fundamental Frequency
Measures of SPL and F0 during reading as well as F0 during speech showed a significant trial effect,
indicative of systematic error. This might have been caused by the fact that loudness and pitch
were not controlled for during the assessment tasks. These measures are therefore not reliable
enough to inform on pre- to post-treatment changes, despite presenting with excellent ICCs.
These observations are consistent with Lee et al.’s (1999) results, which showed that participants
for who frequency was not controlled produced significantly different F0 from one trial to
another, 28 days apart. The same study showed that other acoustic and aerodynamic measures’
reliability were not affected by these changes in F0, when intensity remained constant. However,
not controlling for intensity led to the most inconsistencies across trials for jitter (at low pitch),
and for airflow rate and MPT (at high pitch) (Linda Lee et al., 1999). In fact, Huang et al. (1995)
showed that measures of voice quality, including jitter, shimmer, and normalized noise energy,
varied significantly with different intensity levels (D. Z. Huang, Minifie, Kasuya, & Lin, 1995).

In patients with dysphonia, the question of controlling for frequency and intensity is more
complex than in vocally healthy participants, because they are part of the patients’ clinical picture
and may represent parameters that the therapy is aiming at modifying. This is especially true in
patients with presbyphonia, who can present with reduced intensity and altered fundamental
frequency. Controlling for these variables may improve the results of intra-subject variability but
it may also obscure the positive effects of voice therapy on these variables and potentially on
other voice measures. This hypothesis was also suggested by Awan and colleagues (2013) in their
reliability study on aerodynamic measures, in which intensity and fundamental frequency were
not controlled. The authors explained that, even though stronger intra-subject reliability values
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may have been obtained, the validity of the measurements would have been reduced by masking
the true phonatory behaviors (Awan et al., 2013; Higgins et al., 1994). For this reason, they
suggested that the measurements be taken at comfortable loudness and pitch. A potential
solution for systematic error could be to conduct multiple trials at baseline and at follow-up and
to average those measures in order to obtain a more stable measurement while allowing
participants to phonate at comfortable intensity and frequency.

Measures of Voice Quality
Acoustic measures have been criticized by various authors on the basis of a lack of reliability and
sensitivity to change (Carding et al., 2009; Leong et al., 2013). A study revealed a poor reliability
for jitter, shimmer, and NHR in dysphonic participants (ICCs=0.46, 0.40, and 0.33,
respectively)(Carding et al., 2004). In the same study, ICCs were higher for normal voices
(ICCs=0.73, 0.55, and 0.68, respectively). Leong et al. (2013) also found a good reliability for some
perturbation measures in a sample of vocally healthy participants, when computed over 10
repeated trials. However, the measures were only reliable in male participants (ICC=0.91 for jitter;
ICC=0.69 for relative average perturbation; ICC=0.71 for STD F0). Shimmer presented with ICCs
lower than 0.60 in both males and females (Leong et al., 2013).

In our study, two measures of pitch perturbation (jitter and PPQ for sustained /i/) were also found
to be reliable only in males. On the other hand, shimmer for sustained /a/ was reliable only in
females. The only time-based vocal quality measures that showed acceptable reliability (ICC³0.60)
for both genders were NHR and APQ for the vowel /a/.
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The voice samples did not include any type III voice signals, which are too aperiodic to allow the
acoustic software to compute perturbation measures. However, it is likely that type II voice signals
were present. These voice signals can be analyzed by the computer but they present with
considerable aperiodicity that can reduce the reliability of perturbation measures such as jitter
and shimmer (Carding et al., 2004). This is a limitation inherent to the analysis of dysphonic voices
with traditional acoustic voice measures.

As a response to critics regarding traditional acoustic measures, efforts to develop a more robust
measure of voice quality have led to the development of cepstral peak prominence (CPP)
measures. There is a growing body of evidence demonstrating that cepstral measures (frequencybased) are more appropriate than traditional acoustic measures (time-based) for analyzing
connected speech, which makes them more ecologically valid (Maryn et al., 2009). Time-based
measures rely on the periodic signal and thus their accuracy for severely dysphonic voices is not
optimal (Gillespie et al., 2014). On the other hand, frequency-based measures inform on the
dominance of F0 over superfluous noise in the signal and do not depend on the periodicity of the
waveform (Gillespie et al., 2014). In a meta-analysis on acoustic measurement of voice quality,
CPPS was the only acoustic measure to show acceptable concurrent validity with perceived overall
severity in both sustained vowel and speech (Maryn et al., 2009). Lastly, with computer software
for cepstral measure analyses becoming more accessible, ASHA advocates for the inclusion of
cepstral measures in the acoustic analysis of voice quality (Awan et al., 2013). In our study, CPPS
during sustained /a/ and during reading displayed a good reliability, with no significant difference
between genders and no significant time effect.
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Maximum Phonation Time
MPT demonstrated a poor reliability based on the ICC and the elevated values of CV and MD. In
fact, a MD of 18 seconds would have to be obtained in order to ensure a true treatment effect,
which is clinically unrealistic. Lee et al. found that MPT varied significantly across two trials (28
days apart) in the group in which intensity was not controlled (Linda Lee et al., 1999). Johnson
and Goldfine (2016) also found a significant trial effect when measuring MPT three times during
a single session. The second trial was in average two seconds longer than the first and third trials,
and the authors hypothesized that variations were likely due to changes in laryngeal efficiency
considering that phonatory volume (amount of air expelled during the task) remained constant
across trials (Johnson & Goldfine, 2016). Despite this systematic variation, the authors did find a
strong ICC for MPT (ICC=0.86), which is consistent with Awan et al.’s (2013) findings (ICC=0.87).
However, in these two studies, trials were recorded on the same day (Johnson & Goldfine, 2016)
or at a one-week interval (Awan et al., 2013), and both experiments were conducted on vocally
healthy participants. Patients with presbyphonia are likely to present with more variability, thus
inflating the error term and reducing the ICC. This could explain why MPT had poor reliability in
our study.

Reliability in Presbyphonia
There are a lot of discrepancies in the literature surrounding the intra-subject reliability of
objective voice measures. This could be due to the differences in population samples and in
instrumentation across studies. This highlights the importance of assessing the outcome
measures’ reliability specific to a study before conducting pre- to post-treatment analyses on
those variables. More importantly, a majority of reliability studies have been conducted on young
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and vocally healthy participants (Awan et al., 2013; Linda Lee et al., 1999; Leong et al., 2013) and
therefore their results are not necessarily applicable to dysphonic populations. In fact, in can be
expected that disordered voiced will present with a higher biological variability when compared
to normal voices, thus leading to lower ICCs (Carding et al., 2004; Leong et al., 2013). In addition,
as previously stated, time-based acoustic measurements’ reliability decreases with more
aperiodic signals, which is likely to be the case for many dysphonic voices (Leong et al., 2013).

In a paper on MPT, Johnson and Goldfine (2016) suggested that documenting variability from one
trial to another may provide relevant information on a patient’s abilities, especially when it comes
to elderly individuals. In fact, older voices show more oscillation instability, as shown in shortterm perturbations (increased jitter and shimmer), and long-term perturbations (variations in
intonation contours when a utterance is repeated) (Baken, 2005). Baken (2005) hypothesized that
an increased “biomechanical nonlinearity” of the vocal folds (the fact that a certain amount of
stretch does not lead to a proportional amount of stress/tension) could be the main cause for the
perceptual characteristics of the aging voice. The author demonstrated, with a mathematical
model, that an increase in nonlinearity indeed led to increases in jitter and shimmer, as well as to
changes in glottal closure and transglottal airflow (Baken, 2005). A decreased voice stability, and
therefore increased variability, may therefore be an important characteristic of older voices and
it should be taken into account when using voice outcomes to measure pre- post-therapy
changes. An increased stability of the voice could be deemed a sign of improvement, and future
studies could consider taking repeated post-therapy measurements (even on the same day) to
assess the stability of the voice as an outcome measure.
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Limitations for Aim 1
Many parameters can be controlled in order to obtain better intra-subject reliability outcomes.
For example, previous studies have controlled for room temperature (Leong et al., 2013), time of
the day (Leong et al., 2013), and intensity and frequency of the voice samples (Linda Lee et al.,
1999). Although the need for a controlled assessment environment is crucial to be able to detect
the true effect of a treatment, many biological factors are difficult to control and are part of the
voice’s inherent variability. The goal of therapy is to yield an improvement that will be noticeable
despite the variability due to factors such as time of the day, hydration level, or fatigue/sleep
time. In the context of this study, in which the goal was to determine which outcomes are the
most sensitive to detect a significant change in voice in a specific sample of participants,
controlling for less parameters served a purpose of ecological validity. The SEMs and MDs that
were computed are therefore conservative in the sense that they take into account variability that
can arise from these uncontrolled parameters.

When using reliability measures to estimate sample size for a study, it has been suggested that
the number trials be representative of the duration of the study (Hopkins, 2000). In the present
study, the interval of time between the first and the second assessment varied between five and
62 days and averaged 21 days. Therefore, it is possible that the expected error in measurement
that could occur between baseline and follow-up was underestimated by measuring intra-subject
reliability at an average of a three-week interval instead of four.

201

Discussion Aim 2
What is the respiratory function of patients with presbyphonia and how is it correlated to
voice measures in this population?

The objectives of this aim were to 1) describe the voice and respiratory profile of a sample of
treatment-seeking presbyphonic individuals, and 2) examine if relationships could be drawn
between respiratory function and phonation in these participants.

Baseline Respiratory Function in Patients with Presbyphonia
Pulmonary function and respiratory muscle strength decrease as a function of aging, and a
decreased respiratory function is therefore part of the clinical picture of presbyphonia. However,
the extent to which it is related to poor voice outcomes remains unclear. The first question that
arises is: do treatment-seeking presbyphonic patients have poorer respiratory function than the
general elderly population?

One third of the participants in the studied sample had FVC and FEV1 values below 80% of the
predicted values, which is often used as the definition of abnormal (Rabe et al., 2007). FVC and
FEV1 are known to decrease as a function of age (Janssens et al., 1999; Kim & Sapienza, 2005), and
in some individuals the aging process may be more advanced and compounded by disease
processes, leading to lower percent predicted values and potentially to a decreased FEV1/FVC
ratio. Five of the participants in the sample presented with a FEV1/FVC ratio below the 0.70
threshold that defines obstructive pathology as suggested by the Global Initiative for Chronic
Obstructive Lung Disease (GOLD)(Rabe et al., 2007). However, this ratio tends to decrease with
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age, and lower limits of normal (LLN) between 0.56 and 0.64 were found in a cohort of elderly
individuals (Enright, Kronmal, Manolio, et al., 1994). One participant had a FEV1/FVC ratio below
0.64 in our sample.

Regarding respiratory muscle strength, four participants had either a MIP or a MEP or both below
the LLN as calculated with Enright et al.’s (1994) reference equations. When compared to
individuals from the Cardiovascular Health Study (CHS) cohort, comprising MIP and MEP data for
5,201 and 756 functional individuals over 65 years old, respectively, our participants with
presbyphonia presented with a further decline in MEP (Enright, Kronmal, Manolio, et al., 1994).
In fact, 18% of the presbyphonic males (two participants) and 20% of the presbyphonic females
(two participants) fell below the LLN, while only 11% of the males and 6.1% of the females fell
below LLN in the CHS cohort. In addition, the mean MEP for former and never smokers in the CHS
cohort was 141 cmH20, which is considerably higher than the mean MEP from our sample of
presbyphonic patients, 118.19 cmH20. On the other hand, no atypical decline in MIP was
observed: 9% of the males (one participant) and 0% of the females had a MIP below LLN,
compared to 8.8% of the males and 6.9% of the females having a MIP below LLN in the CHS cohort.
The mean MIP for former and never smokers in the CHS cohort was 66 cmH20, compared to 82.67
cmH20 in the presbyphonic sample (Enright, Kronmal, Manolio, et al., 1994).

In older individuals, inspiratory pressures are better preserved than expiratory pressures (Hoit &
Hixon, 1987; Huber & Spruill, 2008). This can be explained by the loss of elastic recoil of the lungs,
the decreased compliance of the ribcage, and by the atrophy process that has been shown to
affect the expiratory muscles to a greater extent than the inspiratory muscles (Janssens et al.,
1999; Lalley, 2013). In addition, the small airways tend to close at a higher volume during
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expiratory effort, further reducing expiratory pressures (Lalley, 2013). However, this expected
decrease in MEP is taken into account in the reference equations for respiratory muscle strength
for elderly individuals. The fact that a higher percentage of participants in our sample had a MEP
below LLN when compared to a general cohort of elderly participants potentially suggests a
decrease in expiratory pressures greater than what would normally be expected based on
normative values.

In summary, our sample of presbyphonic patient seemed to present values of FVC, FEV1, and MEP
that are lower than what would be expected from normal aging. The hypothesis that a greater
deficit in respiratory function may explain why some older people present with a “pathological”
presbyphonia, while others are not bothered by their voice remains plausible and warrants
further investigation (Crawley et al., 2018).

Baseline Voice Function in Patients with Presbyphonia

Laryngeal Features
Our sample of presbyphonic participants was representative of patients with presbyphonia with
regards to laryngeal parameters that are considered as hallmarks of the disorder. Results for
bowing index were similar to those obtained by Kaneko et al. (2015) in a sample of 16 participants
with age-related vocal fold atrophy. This was expected since the mean age was similar and the
bowing index is thought to be an indicator of age-related changes in the vocal folds. The presence
of bowing is consistent with the fact that 95% of our sample had concave vocal fold edges.
Moreover, all participants except for three had an incomplete glottal closure, and the most
common type of gap was a spindle gap, which is characteristic of presbyphonia (Pontes et al.,
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2006). In addition, all participants presented with a certain amount of supraglottic hyperfunction,
either anteroposterior or mediolateral, or both. This is consistent with Yamauchi et al.’s (2015)
finding that patients with vocal fold atrophy tend to present with greater supraglottic activity
when compared to vocally healthy speakers.
Regarding amplitude of vibration and mucosal wave amplitude, values below 40% or above 60%
were considered to be abnormal based on clinical experience. Approximately 25% of the
participants had an amplitude of vibration above 60% for at least one of the vocal folds. On the
other hand, more than 50% of the sample had abnormal results regarding mucosal wave
amplitude. Four participants had a reduced mucosal wave amplitude (below 40% on at least one
vocal fold) and eight participants had an increased mucosal wave amplitude (above 60% on at
least one vocal fold). As it will be discussed in the following sections, age-related changes in the
vocal fold layers and in the TA muscle affect the pliability of the tissue can lead to increased
amplitude of vibration and mucosal wave amplitude. On the other hand, compensatory
mechanisms can limit the amplitude of vibration as well as the lateral movement of the mucosal
wave. In addition, Yamauchi et al. (2015) found decreased amplitude of vibration in females with
vocal fold atrophy and suggested that a poor respiratory function could lead to a decreased
subglottal pressure and limit the excursion of the vocal folds .
Consistent with the literature, phase symmetry was found to be decreased in our sample (Pontes
et al., 2006; Yamauchi et al., 2015). This can be explained by the degenerative changes in the vocal
folds’ lamina propria and muscle affecting the tension, mass, and viscoelasticity of the vocal folds
and leading to an asymmetric vibration (Yamauchi et al., 2015). This can also lead to an aperiodic
vibration. The regularity of the vibration could further be affected by the unstable respiratory
support due to age-related changes in the respiratory system.
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Acoustic Measures
Normative values of voice quality in elderly speakers are sparse. Two studies have provided
normative data for both APQ and NHR during a sustained /a/ specifically in older inviduals
(Gorham-Rowan & Laures-Gore, 2006; Xue & Deliyski, 2001). The mean for NHR was 0.19 in Xue
and Deliyski’s (2001) study and 0.14 in Gorham-Rowan and Laures-Gore’s (2006) study, when
combining data for males and females. As for APQ, the former study had a mean of 4.04%, while
the latter had a mean of 2.63%. These discrepancies could partly be related to the fact that the
former study had an age mean higher by approximately five years when compared to the latter,
which could explain the more severe perturbation values. Our participant sample had a mean age
in between (72 years old), but the values for NHR and APQ were closer and even higher to those
of the older speakers, indicating a more severe perturbation in the acoustic signal (Xue & Deliyski,
2001).

Although norms specifically for older speakers were not found for CPPS, some studies have
provided information on values that can be expected from vocally healthy versus dysphonic adult
speakers. Based on a reading sample, Sauder et al. (2017) obtained a mean value of 20.11 dB
(SD=1.27 dB) in 70 non-dysphonic speakers and 17.49 dB (SD=1.52 dB) in 100 subjects with
heterogeneous voice disorders. Based on these results, our sample had a mean CPPS
representative of dysphonic speakers for the reading task (mean CPPS=16.29 dB, SD=1.46 dB).
Watts et al. obtained a mean CPPS of 20.07 dB (SD=3.33 dB) for a reading task and 22.86 dB
(SD=4.07 dB) for a sustained vowel, when combining dysphonic and non-dysphonic subjects. Our
results showed lower values, especially for the reading task, which is indicative of more dysphonic
voices. On the other hand, our results are not consistent with those reported by Phadke et al.
(2018), who obtained a mean CPPS of 13.8 dB (SD=2.1 dB) for a sustained vowel and 10.4 dB
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(SD=1.5 dB) for comfortable speech in 84 female teachers with no voice complaints. Since a higher
CPPS value is indicative of a better voice quality, it is not clear why we obtained higher values in
our presbyphonic sample. Although we followed the procedures described by Phadke et al. (2018)
obtain CPPS values, it is possible that other differences in methodologies could explain these
discrepancies.

Normative values for SPL are challenging to obtain because many factors influence this measure,
such as the distance at which the measure is taken and the level of background noise. A previous
study revealed a mean of 77.7 dB during a reading and speaking task in older speakers.
(Sundarrajan, Huber, & Sivasankar, 2017). The mean SPL obtained in our sample of presbyphonic
participants was much lower (71.7 dB, SD=4.5 dB). Of note, the microphone in our experiment
was placed at a slightly greater distance (14 cm) when compared to Sundarrajan et al.’s study (6
cm), which could partly account for the difference. Our results are closer to those obtained by
Baker et al. (2001), who found a mean SPL of 71.44 dB in five older individuals, compared to 76.23
dB in younger participants, for a syllable repetition task. This could be explained by the fact that
some participants in Baker et al.’s study also presented with vocal fold bowing and incomplete
glottal closure. The authors, who also found reduced EMG amplitudes for the TA and LCA muscles
in the older participants, explained that a reduced loudness in older speakers could be partly
attributable to muscle atrophy and peripheral denervation, as well as to a reduced neural drive
to the laryngeal motoneurons (Baker et al., 2001).

Auditory-Perceptual Measures
Heman-Ackhah et al. (2003) provided normative data for perceptual ratings of overall severity in
a large sample of dysphonic and non-dysphonic voices. Although ratings in that study were not
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based on the CAPE-V, the raters used a VAS of 100 mm to assess the parameter of
dysphonia/normality, similarly to the CAPE-V methodology. The results indicated a 10th percentile
at 10 mm, which the authors considered as the cut-off value for a dysphonic voice (Heman-Ackah
et al., 2003). This is also consistent with Angadi et al. (2018), who considered 10 mm on the CAPEV to be the clinical threshold for normality. Based on this cut-off, only one participant out of 21
(5% of our total sample) presented with a perceptually normal voice in our sample. Overall
severity for the other 20 participants varied between 14 mm and 89 mm on the CAPE-V scale.

Aerodynamic Measures
Zraick et al. (2012) provided normative data by age group for all aerodynamic measures assessed
with the Phonatory Aerodynamic System (PAS): subglottal pressure in females with perceptually
normal voices ranged between 3.79 and 18.39 cmH20 (mean=7.78 cmH20, SD=4.23 cmH20). None
of the females in our presbyphonic sample exceeded this range, and the mean was similar.
Normative values for subglottal pressure in males were less variable and ranged between 2.02
and 9.46 cmH20 (mean=6.31 cmH20, SD=1.94 cmH20) (Zraick et al., 2012). Two participants in our
sample exceeded this range, and the mean for males was slightly higher. This could be explained
by a higher phonation threshold pressure in the presence of either a large glottal gap or a
significant amount of supraglottic activity, which are both hallmarks of presbyphonia. As for mean
airflow during voicing, Zraick et al. (2012) reported a range between 0.02 and 0.33 L/s in females
(mean=0.13 L/s, SD=0.07 L/s) and a range between 0.01 and 0.83 L/s in males (mean=0.15 L/s,
SD=0.18 L/s). In our presbyphonic sample, none of the females exceeded this normative range,
but the mean was slightly higher. Similarly, none of the presbyphonic males exceeded the range,
but the mean and median were much higher, indicating that more participants had a mean airflow
rate in the upper range, which is expected from patients with vocal fold atrophy, who often

208
present with incomplete glottal closure. Normative data for aerodynamic resistance also shows a
high inter-subject variability. Values for older females varied between 18 and 211.60 cmH20/L/s
(mean=79.05 cmH20/L/s, SD=52.05 cmH20/L/s); and values for older males varied between 4.18
and 900.09 cmH20/L/s (mean=137.31 cmH20/L/s, SD=221.50 cmH20/L/s)(Zraick et al., 2012). None
of the participants in our presbyphonic sample were outside of these ranges, but the means for
females and for males were both lower than the normative values.
Even though the normative data described above were computed on individuals with perceptually
normal voices, the resulting ranges were very large. This is indicative of high inter-subject
variability for these measures, even in normal speakers. This emphasizes the importance of
conducting a multidimensional assessment in order to better interpret aerodynamic parameters,
their impact on other voice outcomes, and if the measures are indicative of abnormal physiology.

Self-Assessment Measures
Arrfa et al. (2012) calculated normative values for the VHI-10 and the results indicated that a score
above 11 is indicative of a voice-related handicap. In our sample, only three participants had a
score below 11 at baseline, meaning that 86% of the participants were perceiving a meaningful
voice-related handicap. A GFI score higher than 4 was determined as the cut-off value to
differentiate normal and abnormal voices (Bach et al., 2005). 100% of the presbyphonic
participants in our study had a GFI score greater than this threshold. This is expected considering
that this questionnaire is sensitive to deficits specifically experienced by patients with glottal
insufficiency, as seen in presbyphonic patients. Lastly, the Communicative Participation Item Bank
(CPIB) is a fairly new measure designed to assess the construct of communicative participation
across various communication disorders and situations (Baylor et al., 2013). Although few studies
are available for comparison, the form allows for a conversion to a standard T-score with a mean
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of 50 and a standard deviation of 10, based on the calibration sample (701 participants with four
different types of communication disorders) (Baylor et al.). Base on the T-score, three
presbyphonic participants in our sample presented with a score above one SD from the calibration
mean and three participants had a score below one SD from the calibration mean. The rest of the
participants had a score close to the mean, indicating that the sample was not too different from
a larger sample of patients with different types of communication disorders (more specifically:
multiple sclerosis, Parkinson’s disease, amyotrophic lateral sclerosis and head and neck cancer)
(Baylor et al.).

Clusters 1 and 3: The Impact of Age
The cluster analysis led to the formation of three clusters with distinct respiratory and voice
characteristics. The formation of clusters 1 and 3 seem to have been greatly influenced by age:
while cluster 1 was comprised of older individuals, with lower raw respiratory values, cluster 3
was comprised of younger individuals, with higher raw respiratory values. Moreover, despite very
different raw respiratory means, clusters 1 and 3 had similar standard respiratory means,
indicating similar respiratory health. Cluster 1 could therefore be referred to as the “healthy older
cluster”, and cluster 3 as the “healthy younger cluster”, based on percent predicted values of
respiratory function. Cluster 3 was comprised exclusively of males, which also explains the higher
raw respiratory values.

The older cluster had the lowest mean for the integrity factor, while the younger cluster had the
greatest mean. The integrity factor is a weighted measure including bowing index (multiplied by 1) and phase symmetry as rated on the VALI assessment form. Cluster 1 had the lowest
aerodynamic factor (a weighted measure of subglottal pressure and glottal airflow) while cluster
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3 had the highest one. Results from the correlations showed that the raw respiratory factor, the
integrity factor, and the aerodynamic factor were significantly inversely correlated with age and
therefore confirm the role of age in shaping these older and younger “healthy” clusters. Awan et
al. (2006), who found correlations between vital capacity and some measures of vocal function,
highlighted that these results do not necessarily imply a causal relationship, but may merely
reflect a simultaneous decline in both the laryngeal and respiratory system with aging. This seems
to be a plausible explanation regarding the results for the integrity and aerodynamic factors in
clusters 1 and 3. Because age was normally distributed in the sample, with a wide range from 56
to 91 years old, its impact on these voice parameters was easily detectable in the cluster and
correlation analyses.

The fact that age was correlated with the integrity factor was expected and reflects the effect of
age-related changes in the larynx. In fact, a loss of fibers in the TA muscle has been reported in
older vocal folds (Kersing & Jennekens, 2004; Malmgren et al., 1999), which is thought to be partly
related to cell injury and death and a regeneration and re-innervation process that is insufficient
to compensate for the loss of fibers as aging occurs (Malmgren, Lovice, & Kaufman, 2000). Agerelated changes do not only affect the TA muscle, but also the composition of the layers of tissue
surrounding it. For example, older vocal folds were found to contain a decreased number of cells
forming the epithelium, resulting in a reduced thickness when compared to younger vocal folds
(Goncalves et al., 2016). These changes lead to atrophied vocal folds, which in turn is reflected in
the bowing index. The fact that the parameter of phase symmetry varied closely with bowing
index suggests that it represents another indicator of the severity of laryngeal changes.
Specifically, changes in the structure of the vocal folds affect its vibration with increased
asymmetry as bowing increases.
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Cluster 2: The Impact of an Impaired Respiratory Function
Cluster 2 had a mean age in between clusters 1 and 3 and a greater deficit in both respiratory
factors as well as in some of the voice factors. This suggests that some voice factors were not
influenced by age but may have been influenced by a lower respiratory function. Although cluster
2 was predominantly comprised of women, it is unlikely that gender drove the formation of this
cluster, considering that women in the total sample had higher or similar standard respiratory
values when compared to males, and that cluster 2 has the lowest standard respiratory factor.
Therefore, it can be hypothesized that participants in cluster 2 present with specific respiratory
and voice characteristics that tend to vary together. These relationships are elucidated in the
following sections, and are schematized in Figures 19 and 20.

On Resistance and Hyperfunction
A linear relationship approaching significance was found between FVC and FEV1 and resistance,
and therefore a lower respiratory function could explain why cluster 2 also had the highest mean
for the resistance factor. An increase of one standard deviation in FEV1 (0.84 L) or in FVC (1.07 L)
was associated with a decrease in aerodynamic resistance of 0.39 standard deviation, which
corresponds to approximately 12 cmH20/l/s. This is very close to the difference in resistance that
was observed between a group of individuals with presbyphonia and a group of age and gender
matched subjects without presbyphonia in Angadi et al.’s (2018) study, thus suggesting a clinically
meaningful relationship.

Participants who present with a reduced amount of air available for phonation are potentially
increasing their laryngeal airway resistance (Rlaw) for airflow conservation purposes (Zhang,
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2016c). Increasing Rlaw and reducing glottal airflow prevents them from reaching their expiratory
reserve volume too quickly, where natural expiratory pressures are low and muscular respiratory
requirements are high (Zhang, 2016c). Participants with a lower respiratory function were
therefore potentially compensating for a decreased FVC by making laryngeal adjustments to
remain at a higher lung volume and make use of natural expiratory pressures to decrease
respiratory effort. Increasing Rlaw could also allow speakers to build up subglottal pressure with
less expiratory effort. Solomon et al. found that Rlaw increased linearly during a maximum
phonation task in some participants, as lung volume decreased (Solomon, Garlitz, & Milbrath,
2000). SPL was controlled during the experiment, requiring subjects to make adjustments to
maintain the same loudness even at low lung volume. Increasing resistance allows speakers to
maintain adequate subglottal pressure with less airflow and therefore with less expiratory effort
(Zhang, 2015). However, compromising glottal airflow is not characteristic of comfortable speech,
during which speakers usually maintain a constant airflow (Iwata, Von Leden, & Williams, 1972;
Solomon et al., 2000; Zhang, 2016c). This strategy may nonetheless be employed by patients who
present with a decreased respiratory drive and who have difficulty building up sufficient subglottal
pressure for speech. While increasing Rlaw may help build up subglottal pressure, an elevated Rlaw
also generates the need for a greater subglottal pressure in order to overcome the increased
phonation threshold pressure and initiate or maintain vocal fold vibration (Higgins & Saxman,
1991; Zhang, 2015). In this case, patients may also attempt to augment their expiratory effort in
addition to maintaining a low glottal airflow, which can lead to an imbalance between subglottal
pressure and glottal airflow and further increase resistance and laryngeal effort.

Increasing resistance therefore seems to, at least partly, serve the purpose of compensating for a
decreased respiratory function. The paradox in the case of patients with presbyphonia is that they
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also present with age-related changes affecting the vocal folds’ molecular composition and their
ability to fully close and generate adequate resistance to airflow is diminished (Hammond et al.,
2000). Involvement of the supraglottic structures has been observed in subjects with
presbyphonia as a compensation for this loss in resistance (Higgins & Saxman, 1991). This could
explain why hyperfunction was not correlated with respiratory function, since it was used by many
subjects as a compensation for laryngeal deficits and in an attempt to normalize resistance,
regardless of their respiratory status. However, subjects who presented with the highest
resistance values all presented with a clinicially significant amount of hyperfunction. Although a
correlation between the hyperfunction and handicap factors was present, the relationship
between resistance and handicap was much stronger. In other words, hyperfunction does not
necessarily cause a meaningful increase in handicap unless it is associated with an excessive
aerodynamic resistance and therefore in the presence of a significant imbalance between
subglottal pressure and glottal airflow. Even so, a smaller ventricular gap has been found to be
associated with a decrease in phonatory efficiency because of its effect on transglottal pressure
(Alipour & Scherer, 2012; Kniesburges et al., 2017), and therefore more research is needed to fully
understand the positive and negative effects of supraglottic activity in patients with
presbyphonia.
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On Pliability
The pliability factor was comprised of the following VALI parameters: amplitude of vibration (right
and left vocal folds), amplitude of mucosal wave (right and left vocal folds), and regularity of
vibration. It had a strong relationship with the resistance factor: a greater resistance was
associated with a reduced pliability. This finding is not surprising, considering that a higher
resistance, which was accompanied by hyperfunction, is likely to restrain vocal fold vibration and
mucosal wave movement. In fact, a study by Alipour and Scherer (2012) on excised larynges
showed that medialization and motion of the false vocal folds generates positive air pressure
exerting a vertical force on the true vocal folds, potentially inhibiting lateral movement of the
tissue. This is also prone to affect their periodicity, which could explain why the parameter of
regularity of vibration was associated with vibration and mucosal wave amplitude in the factor
analysis, despite it being an indicator of severity similarly to bowing index and phase symmetry.
Some presbyphonic individuals may also attempt to compensate for an atrophied TA by relying
on cricothyroid muscle (CT) activation (Zhang, 2019), which increases the anteroposterior
stiffness of the true vocal folds and might also reduce their pliability. On the other hand, a
severely decreased resistance is associated with flaccid vocal folds and an abnormally increased
vibration and mucosal wave amplitudes. This is caused by age-related changes in the tissue of the
vocal folds, affecting their viscoelastic properties (Hammond et al., 2000). However, the pliability
factor was not correlated with age nor with the integrity factor despite being affected by the same
age-related changes in vocal fold tissue and TA muscle. This may be because of the compensation
strategies (CT activation and supraglottic hyperfunction), which can increase aerodynamic
resistance and reduce tissue pliability despite important vocal fold atrophy.
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Cluster 2, which included subjects with the lowest respiratory function, had a substantially smaller
mean on the pliability factor when compared to the two other clusters. Moreover, MEP was found
to be a good respiratory predictor for the pliability factor: a larger MEP was associated with a
greater pliability. These findings could be caused by the fact that a greater expiratory pressure
1) reduces the need to increase resistance as a compensation for insufficient respiratory capacity,
which would in turn restrain pliability, and 2) induces a greater lateral movement of the vocal
folds (greater vibration and mucosal wave amplitude) if resistance is held constant (Zhang, 2015).

While a significantly reduced pliability is not desirable for phonation and can be a symptom of
insufficient airflow or excessive laryngeal stiffness or tension, a markedly large vibration and
mucosal wave amplitude is most likely to be associated with a lack of vocal fold resistance, a
predominantly open phase, and a large glottal airflow. As is was demonstrated in a computational
model, an increase in subglottal pressure without a sufficient increase in glottal resistance further
pushes the vocal folds apart, increases mean glottal airflow rate and glottal area amplitude
(Zhang, 2015). This is particularly relevant in the case of presbyphonic patients, for who increasing
resistance of the true vocal folds is sometimes physiologically unachievable because of the
degeneration of the TA muscle (Kersing & Jennekens, 2004; Malmgren et al., 1999), but also
because other changes in the vocal fold tissue. For example, collagen networks, although
quantitatively increased, are disorganized and not fulfilling their role as well as in younger vocal
folds, therefore leading to a decreased tissue resistance (Hammond et al., 2000).

In summary, a decreased respiratory function leads to increased resistance as a compensation
strategy, which in turn can limit vibration and mucosal wave amplitudes and hinder regularity of
vibration. On the other hand, an imbalance between the respiratory drive and the ability of the
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vocal folds to provide sufficient resistance against it may lead to abnormally large vibration and
mucosal wave amplitudes, especially in vocal folds that are already more pliable because of agerelated changes. A balance between true vocal fold resistance and respiratory effort needs to be
achieved for an efficient phonation, which can represent a challenge in patients with
presbyphonia who are likely to present with impairments in both the laryngeal and the respiratory
system.

On Handicap
In addition to having lower means for the respiratory and pliability factors, as well as higher means
for the resistance and hyperfunction factors, cluster 2 had the highest handicap value. The
handicap factor was a weighted measure of three disease-specific self-assessment
questionnaires: VHI-10, GFI, and CPIB. Thus, subjects with a lower respiratory function also had a
higher perceived voice handicap. These results are in line with previous research revealing that
female teachers with a lower FVC also had a higher Voice Fatigue Index factor (Hunter, Maxfield,
& Graetzer, 2019). However, only raw values were found to be predictors of vocal fatigue in
Hunter et al.’s (2019) study, while standardized values were better predictors in our sample. This
could be because of the different subject samples: Hunter et al.’s experiment was conducted on
otherwise healthy teachers, who would be expected to present with a healthy respiratory
function. Percent predicted values may therefore not have presented with sufficient variation
within the sample to detect a relationship with vocal fatigue. Alternatively, variations in raw
spirometry values, driven by factors such as height, age, and weight, allowed for the detection of
a relationship between raw pulmonary function and vocal fatigue (Hunter et al., 2019). On the
other hand, a significant proportion of the participants in our study with presbyphonia presented
with a decreased respiratory health, with one third of the participants having FVC% and FEV1%
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values below 80% of the predicted value, which revealed that a reduced respiratory health was
associated with a greater vocal handicap, in this sample.

Standardized respiratory values were stronger predictors of perceived vocal handicap than raw
respiratory values. Raw values, representative of the amount of air available and the strength of
the respiratory muscles, may impact handicap through its direct effect on phonation physiology
(on resistance, hyperfunction, and pliability). On the other hand, standardized respiratory values
inform on the health of the respiratory system, which may impact perceived handicap through
both a physiological pathway and a general impairment pathway. For example, individuals with
poor respiratory health may already experience impairment from shortness of breath (SOB),
which can be exacerbated when speaking. This is likely to be the case in patients with
presbyphonia, who present with incomplete glottal closure and are susceptible to run out of air
quickly when speaking. SOB caused by the decline in respiratory function is likely to aggravate the
discomfort associated with vocal atrophy and could lead to more avoidance behaviors when it
comes to communication situations, making the individual less functional in that they are less
inclined to participate. Many questions on the voice-related self-assessment questionnaires
pertain to participation, as it is a crucial aspect of health-related quality of life (McDougall, Wright,
& Rosenbaum, 2010). To use the International Classification of Functioning, Disability and Health’s
(ICF) terminology (International Classification of Functioning, Disability and Health, 2001),
because the impairment affects many body functions and structures (which in addition are interrelated), the resulting participation restrictions are more important .

Individuals who are generally less healthy may also live the burden of their voice disorder more
negatively because of personality traits. A study by Kubzansky et al. (2002) using longitudinal data
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demonstrated that a “pessimistic explanatory style” (the way an individual reacts to events in
their life) was associated with a faster decline in FEV1 and FVC over time. Alternatively, an
optimistic explanatory style was associated with better pulmonary health and a slower decline in
FEV1 and FVC over time (Kubzansky et al., 2002). The relationships were strong and were even
comparable to the effect of smoking on lung function. Optimism is thought to have direct
physiological effects on health (McEwen & Stellar, 1993), but can also influence health via indirect
psychological and social pathways such as through a good support networks as well as proactive
and healthy habits (Kubzansky et al., 2002). Although not assessed in our study, these
characteristics could have influenced the participants’ perception of their voice disorder: more
optimistic subjects may experience less handicap when compared to their more pessimistic
counterparts, in addition to having a better respiratory function.

Figure 19 is a handicap-focused model and summarizes the relationships between respiratory and
voice function and how they impact perceived voice handicap in patients with presbyphonia,
based on the studied sample. Wider arrows indicate stronger relationships, based on the
Spearman correlation coefficients.
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Figure 19. Voice handicap-focused model of the effect of respiratory function in presbyphonia. Wider arrows indicate
stronger relationships, based on Spearman correlation coefficients (r).

Voice Quality
The two factors related to voice quality (perturbation and speech) were not included in the
handicap model. In fact, no relationship was found between voice quality and perceived handicap
in the studied sample, suggesting that the sound of the voice does not functionally affect patients
with presbyphonia as much as the physical demands required to produce voice. This is despite
measures of perturbation and noise being increased when compared to norms for young and
middle-aged adults, and similar to other values reported for older individuals (Xue & Deliyski,
2001).

Respiratory function was not found to be a predictor for voice quality in our sample, which was
only correlated with the integrity factor: a decreased integrity of the vocal folds was associated
with more perturbation in a sustained vowel (smaller NHR and APQ values). This could explain
why the older cluster (cluster 1), which had the lowest integrity value, also had the highest
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perturbation value. Surprisingly, cluster 1 also had the highest mean speech factor. This was not
expected, considering the inverse correlation between the speech and perturbation factors. The
speech factor included SPL during conversation and CPPS during reading, and was therefore a
measure of loudness and quality of speech during functional tasks. As it could be expected, a
higher perturbation during the sustained vowel was correlated with a reduced voice quality and
loudness during more complex tasks such as reading and speaking.

As shown in Figure 20, the aerodynamic factor (comprised of subglottal pressure and glottal
airflow) was positively correlated with the integrity factor. However, it is very likely that this
relationship was mainly driven by age, as both of these factors had an inverse correlation with
age. The model also shows that age was correlated with respiratory function (raw values), which
was expected. However, respiratory function did not impact voice factors in this model. The fact
that respiratory function was not correlated with the aerodynamic factor is somewhat surprising,
considering that subglottal pressure is in large part determined by the alveolar lung pressure
(Zhang, 2016b). However, patients with a decreased respiratory function may still be able to
achieve normal levels of subglottal pressure, but at the cost of great respiratory and/or laryngeal
effort and potentially in an inconsistent manner. Another surprising result, in our small sample, is
the fact that neither the respiratory factors or the aerodynamic factor were correlated with the
speech factor, encompassing SPL during speech. The reason for this could also reside in the use
of compensatory strategies, potentially allowing patients to achieve a conversational loudness
without adequate airflow and respiratory drive, by increasing their laryngeal airway resistance. In
fact, at low subglottal pressure, an increase in vocal fold resistance leads to a higher maximum
flow declination rate (MFDR), which is a predictor of intensity (Zhang, 2016a, 2016b).
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Figure 20. Voice quality-focused model of the effect of age in presbyphonia. Wider arrows indicate a stronger
relationship, based on Spearman correlation coefficients (r).

Limitations for Aim 2
Factor and cluster analyses are usually conducted on large sample sizes, which was not the case
in this study. Although these methodologies were helpful in extracting meaningful information
from the multiple outcome measures, their results would be more robust with a much larger
sample size. The small sample size could also explain why some of the relationships between
respiratory and voice outcomes were not found to be significant despite having the same
directionality as other significant results. Only the relationships with the largest effect sizes
reached significance, which was to be expected in a pilot study. In order to detect smaller effect
sizes, a future study with more participants should be conducted.

Another limitation from this study resides in the fact that different voice outcomes were recorded
during different assessment tasks, and phonation physiology is likely to differ from one task to
another. For example, laryngeal parameters were rated based on a sustained /i/ during
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videostroboscopy, while aerodynamic variables were recorded during syllable repetition. Not only
are these tasks different from each other, but they are also different from phonation during
running speech. To solve this issue, a future study could attempt to measure all voice outcomes
during a single task, although this would represent a significant methodological challenge.
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Discussion Aim 3a
What is the effect of respiratory muscle strength training on respiratory and voice
outcomes in patients with presbyphonia?
The rationale behind adding respiratory muscle training to voice therapy was that improving
respiratory function would lead to improved voice outcomes. However, the mechanism behind
this hypothesis remains unclear because of a lack of studies on respiratory exercises and voice
outcomes. A recent literature review conducted by our research team concluded that, in order to
better our understanding of the mechanism of action, future studies should 1) isolate respiratory
training as the independent variable of the study, 2) report a comprehensive array of voice and
respiratory outcomes, 3) assess the relationship between changes in respiratory and voice
function, and 4) compare the effect of “voice therapy only” to “voice therapy + respiratory
training” (Desjardins & Bonilha, 2019). The present study followed these recommendations and
the results are discussed below.

Effect on Respiratory Measures
One of the limitations of the literature when assessing the effect of respiratory exercises on voice
was that, in many studies, few or no respiratory outcomes were assessed. Therefore, even if
change in phonation was observed, it was unclear whether it had been caused by a change in
respiratory function (Desjardins & Bonilha, 2019). Just like phonation, respiration is multidimensional and can be assessed with various measures. In this study, measures of maximal effort
were recorded, including maximal respiratory muscle strength (MIP and MEP) and pulmonary
function tests (FVC, FEV1, and FEV1/FVC). Raw measures as well as LLN and percent predicted
values were considered.
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A mean increase in both MIP and MEP was observed in the three intervention groups. As
expected, the EMST group had the largest increase in MEP, and this is consistent with current
evidence supporting that EMST induces significant changes in MEP (Desjardins & Bonilha, 2019).
The IMST group increased their MIP, but interestingly the effect size was slightly less than for the
VFE group. Various studies have confirmed the efficiency of IMST for improving MIP (Beaumont,
Forget, Couturaud, & Reychler, 2018; Lotters et al., 2002; Mueller, 2013; Ray, 2018; Silva et al.,
2013). However, two subjects in the IMST group from our study did not have a meaningful
improvement in MIP, which could potentially be explained by a ceiling effect. In fact, one of the
subjects who did not improve was a recreational swimmer with a baseline MIP much higher than
the predicted value for their age, gender, and weight. On the other hand, the other subject who
did not improve had a baseline MIP very close to the LLN and had had a recent injury to the
ribcage, which may have limited the gains from IMST.
Improvements in MIP and MEP in the VFE group were likely caused by training effects, since
respiratory muscle strength measures were taken prior to and after each therapy session.
Measurement error could also partly explain these results, although the increase was larger than
the SEM in two out of three subjects for both MIP and MEP. It is also possible that, for some
participants, VFE exerted a sufficient load on the respiratory muscles to induce a significant
increase in strength. This could also explain the increase in MIP for some subjects in the EMST
group, and the increase in MEP for some subjects in the IMST group, although these could also be
the result of the RMST . In fact, previous studies have reported changes in MIP following EMST
and changes in MEP following IMST and there is therefore some evidence for cross-training effects
(Duruturk, Acar, & Dogrul, 2018; Gosselink, Kovacs, Ketelaer, Carton, & Decramer, 2000; Ray,
2018; Vorona et al., 2018).
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No improvement in pulmonary function measures (raw values or predicted percent values) were
observed in any of the intervention groups. This is consistent with many studies in the respiratory
literature having found no improvement in spirometry measures after a RMST intervention (Cerny
et al., 1997; Mota et al., 2007; Tsai et al., 2016; Weiner, Magadle, Beckerman, Weiner, & BerarYanay, 2003). Unless the decreased FVC was a result of respiratory muscle weakness, a change in
pulmonary function would not necessarily be expected despite an increase in MIP and/or MEP.
As for FEV1, another explanation could reside in the fact that, beyond a certain alveolar pressure
at a given volume, maximal flow rate is mainly determined by the elastic recoil from the lungs and
therefore an increase in MEP may not affect flow rate. This justification was suggested by a group
of authors (Chiara, Martin, Davenport, & Bolser, 2006) who found limited improvements in FVC
and FEV1 in subjects with multiple sclerosis, despite enhanced MEP following an EMST
intervention.

Effect on Laryngeal Structures and Function
The majority of participants experienced a reduction in the amount of bowing of the vocal folds
following the intervention, except for two participants, both in the IMST group (participant 12 and
16). Interestingly, these subjects also presented with the lowest compliance (76% and 77% of daily
home practice completed). The largest effect sizes in terms of bowing reduction was found in the
VFE group. Altogether, these results suggest that VFE does help counteract the atrophy of the TA
muscle, and that more benefits regarding vocal fold atrophy can be gained from spending more
time doing the voice exercises. However, as it will be discussed in the following sections, merely
improving the integrity of the vocal folds with VFEs may not be sufficient to reduce the burden of
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presbyphonia and enhance communicative participation in all patients, and the addition of RMST
(more specifically IMST), seems to provide benefits beyond those achieved with VFEs only.
Although no significant effects for bowing index were found based on the ANVOA results, a large
effect size was noted in the VFE group, and a greater sample size may have revealed a significant
time by group interaction effect. Nonetheless, this lack of significance is consistent with Kaneko
et al.’s (2015) results, who reported no change in bowing index following a VFE intervention in 16
patients with vocal fold atrophy, despite improvement in various other voice measures. The
authors hypothesized that vocal function might have been improved despite a change in bowing
due to enhanced coordination between the respiratory and the laryngeal systems (Kaneko et al.,
2015). As a matter of fact, improved coordination is one of the objectives of the VFEs, and as it
will be explained later, may be further achieved by performing IMST prior to the voice exercises.
This could also elucidate why the IMST group presented with the largest improvements on selfassessment outcomes despite having the smallest decrease in bowing index.

The VFEs also helped normalize vibration and mucosal wave amplitude in two participants in the
VFE group, while at the same time reducing supraglottic activity. These results are consistent with
the greater aerodynamic resistance obtained for these participants. Two participants in the IMST
group also decreased their hyperfunction, as well as one participant in the EMST group. The
decrease in bowing index and in supraglottic activity could help clarify why some participants in
the IMST and in the VFE groups improved their perceived handicap despite an increase in
aerodynamic resistance. In fact, it was shown in Aim 2 that a high resistance was strongly
associated with a higher perceived handicap. The handicap-focused model (Figure 19) also
showed that hyperfunction was a predictor, to some extent, for both resistance and handicap.
Results from this aim suggest that voice therapy helps reduce hyperfunction and rebalances
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resistance so that it is provided by an enhanced approximation of the true vocal folds and not
mainly through compensatory strategies. However, these benefits were not observed in the EMST
group, in which no subjects were able to increase their resistance with a meaningful effect size,
despite a reduction in bowing observed for all three participants. This could be due to the inability
of the vocal folds to resist the increased subglottal pressures triggered by the EMST intervention,
which could also be described as a lack of coordination between the respiratory and laryngeal
systems.
Effect on Acoustic Measures and Auditory-Perceptual Judgements of Voice Quality
No meaningful change in SPL was observed in the EMST or the VFE groups. This could be explained
by a lack of effect of the intervention on intensity, or in the case of the VFE group, by the fact that
participants presented with a small deviation from normal at baseline. On the other hand,
participants in the IMST group presented with larger deviations from normal and consequently
there was greater room for improvement. Only participants in the IMST group achieved moderate
to large effect sizes and raw changes above the SEM for this outcome measure. Participants 2 and
12 increased their SPL, while subject 16 decreased meaningfully. The changes occurred in
opposite directions and this could explain why no significant result was found in the ANOVA when
means were compared, despite the fact that these participants experienced a change towards a
normalized SPL value.
SPL and subglottal pressure are closely related, since an increase in subglottal pressure is the main
strategy used by healthy speakers to increase loudness of the voice (Zhang, 2016a). However, a
computational study by Zhang showed that, at low subglottal pressures, laryngeal adjustments
improving vocal fold resistance enhance vocal fold contact which in turn induces a higher MFDR
and an increase in intensity (Zhang, 2016a, 2016b). This could explain why subject 2, in the IMST
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group, who decreased their subglottal pressure but increased their aerodynamic resistance, was
able to increase conversational SPL.
Although a reduced intensity is a common complaint of patients with presbyphonia, an inability
to produce a soft vocal quality can also be an issue in this population and can occur because of
two reasons. Firstly, a large glottal gap increases the subglottal pressure required to initiate and
sustain phonation. Patients with severe glottal atrophy may therefore not be able to produce
voice at low subglottal pressures and intensity. Alternatively, patients who compensate with
excessive supraglottic activity are also increasing their phonation threshold pressure and reducing
their ability to produce a soft voice (Zhang, 2015). A reduction in subglottal pressure and in SPL,
if these were abnormally elevated at baseline as it was the case for participant 16 in the IMST
group, can therefore be indicative of an improved balance between the respiratory and laryngeal
systems.

Auditory-perceptual judgments of overall severity confirmed that subjects in the IMST group were
potentially able to achieve a better phonato-respiratory coordination. In fact, single-subject and
group effect sizes showed that the largest improvements occurred in the IMST group, followed by
the EMST group, and lastly the VFE group. Regarding CPPS during reading, subjects in the VFE
group did not improve, while one subject in the IMST group and two subjects in the EMST group
made sizable improvements. Large group effect sizes and raw improvements above SEM were
noted in the IMST and the EMST groups for this variable, which was not the case for the VFE group.
One of the objectives of RMST was to provide subjects with more air available for speech, since
sufficient airflow and subglottal pressure are necessary to sustain the vibration of the vocal folds.
The hypothesis was that training the inspiratory muscles would allow to increase the inspiratory
volume and to have a better control of the airflow, and that training the expiratory muscles would
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allow to make a better use of the expiratory reserve volume (ERV). Subjects in both respiratory
training groups increased their vocal quality during conversation and reading to a greater extent
that subjects in the VFE, which could suggest that they had more air available to sustain a
sufficient subglottal pressure and therefore a healthier vibration and greater voice quality during
those tasks. In addition, the lack of improvement in perceived handicap in the EMST group suggest
that participants in this group may have been using suboptimal strategies in terms of respiratory
effort, as it will be discussed later.

Different results were obtained regarding the voice quality of a sustained vowel. The only
meaningful difference between the groups was the larger pre- to post-treatment effect size found
in the VFE group for the APQ measure. Participants in the VFE group spent more time practicing
sustained sounds and therefore it is fitting that they were able to improve the vocal quality of the
sustained /a/ slightly more than the other groups. Studies having assessed the effect of RMST on
vocal quality are very sparse and therefore few comparisons can be made. Johansson et al. tested
an EMST intervention on five subjects with multiple sclerosis and reported that three out of the
five subjects experienced a decrease in coefficient of variation of F0 during a sustained vowel task,
with effect sizes ranging from d=-0.7 to d=-0.12 (Johansson, 2012). Pereira et al. (2015) found no
significant improvement in jitter, shimmer, GNE, and noise following an EMST intervention in
teachers with and without voice disorders, and even found a significant increase in shimmer in
the EMST group. However, in that experiment, EMST was not combined with voice exercises in.
As it was discussed previously, augmenting subglottal pressure without making any laryngeal
adjustments results in an increase in glottal airflow and consequently in turbulence and noise
(Zhang, 2015). This further highlights the importance of combining voice exercises with
respiratory training.
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Measures of vocal quality during speech and reading are more ecologically valid than those
obtained from a sustained vowel task, and this is especially relevant for presbyphonic patients. In
fact, Huber (2008) found that the effects of aging on the voice were more obvious when utterance
length increased. For example, lung volume excursion was greater in older adults when compared
to younger adults in longer utterances, but not in shorter ones. This implies that long utterances
tax the respiratory system to a greater extent and older speakers have to provide more effort in
order to compensate for changes in both the laryngeal and respiratory systems. Assessing vocal
quality during conversation and reading tasks is therefore crucial in understanding the impact of
the intervention on age-related deficits. This provides a potential explanation as to why greater
improvements in overall severity and CPPS reading were found in the RMST groups, while these
differences were not observed in the sustained vowel task.

Effect on Aerodynamic Measures
Aerodynamic measures are crucial in understanding the mechanistic effect of RMST interventions
because they are the result of both respiratory and phonatory activities. However, they have to
be interpreted carefully and while considering the whole clinical picture of the patient because
an increase or a decrease in those measures do not necessarily imply that a meaningful
improvement occurred.

Participants in the IMST group decreased their subglottal pressure following the intervention. This
reduction was accompanied by a reduction in glottal airflow in two of the participants, who also
considerably increased their aerodynamic resistance. Participant 16, in the IMST group, had a
different response to the intervention: the decrease in subglottal pressure was accompanied by
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a slight increase in glottal airflow and a decrease in aerodynamic resistance. This could be
explained by the reduction in supraglottic activity, which was elevated at baseline and probably
causing the abnormally elevated subglottal pressure observed at baseline by increasing the
required phonation threshold pressure. Many patients with vocal fold atrophy engage
supraglottic structures to reduce airflow and help build-up subglottal pressure, as discussed in
Aim 2. Although this theoretically increases aerodynamic resistance, the resistance is provided
mostly by compensatory mechanisms and not by a healthy vocal fold closure. In the case of
participant 16, a longer intervention duration may have induced better results: once
hyperfunction is reduced, the respiratory and the laryngeal system have to readjust their
coordinated activity until an optimal balance between resistance, glottal airflow, and subglottal
pressure is achieved.

In fact, the vocal folds modulate the flow of air that is directed towards them and respond to it by
adjusting their resistance in order to maintain a glottal airflow that is adequate for phonation
(Zhang, 2015). As subglottal pressure increases, a proportional increase in vocal fold
approximation and/or stiffness needs to occur to maintain a small glottal airflow (Zhang, 2015). If
subglottal pressure is unpredictable or too strong, the atrophied vocal folds may not be able to
maintain their resistance against it and glottal airflow will likely be elevated. Optimal airflow
conservation therefore relies on the balance between subglottal pressure and glottal resistance
(Zhang, 2015). Training the inspiratory muscles is relevant in finding this balance because it
promotes good airflow control: the inspiratory muscles have to be engaged during the expiratory
phase of speech to control the natural expiratory pressures. The resulting subglottal pressure is
more stable and can be more easily modulated by the vocal folds. Nonetheless, in the presence
of substantial atrophy, a certain amount of supraglottic activity may be necessary to maintain a
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reasonable airflow rate and to avoid excessive expiratory effort needed to produce a target
subglottal pressure.

Participants in the EMST group slightly increased their subglottal pressure, but none of them
reduced their airflow, nor had a meaningful increase in aerodynamic resistance, despite having
baseline values below normal. It is possible that EMST helps increase subglottal pressure but also
induces a slight increase in airflow because the vocal folds’ valving function is impaired and cannot
respond adequately to the intensified subglottal pressure. When subglottal pressure is increased
against insufficient glottal resistance, two scenarios can occur: either the vocal folds are being
further blown apart, resulting in a larger glottal airflow rate; or the larynx compensates with
excessive hyperfunction. As it was mentioned above, a certain amount of supraglottic activity can
be beneficial in reducing glottal airflow; however, excessive laryngeal hyperfunction can be a
“defense mechanism” for erratic, and potentially elevated subglottal pressures (Rubin,
Macdonald, & Blake, 2011) and can cause vocal fatigue and discomfort, in addition to hindering
vocal fold vibration (Kniesburges et al., 2017).

This highlights the importance of voice exercises in this population: to strengthen the laryngeal
muscles and help increase the ability of the true vocal folds to provide adequate resistance against
subglottal pressure, while at the same time allowing to reduce supraglottic activity. There are two
ways to augment vocal fold resistance: by enhancing vocal fold approximation, and by
augmenting their antero-posterior stiffness (Zhang, 2015). Vocal fold approximation is regulated
by the combined action of the lateral cricoarytenoid (LCA) and the inter-arytenoid (IA) muscles.
In addition, the involvement of the thyroarytenoid (TA) muscle is necessary to achieve complete
closure of the membranous vocal folds (Chhetri et al., 2012; Yin & Zhang, 2014). Enhancing
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resistance by increasing vocal fold approximation is an effective strategy at low to medium
subglottal pressures. At higher subglottal pressures, increasing stiffness becomes more efficient,
and relies on the activation of the cricothyroid (CT) muscle (Zhang, 2015). Patients with
presbyphonia tend to compensate for the atrophy of the TA muscle by relying mainly on CT muscle
activation, which is not effective for providing adequate resistance and to control F0 in the lower
register (Zhang, 2019). Building up the strength of the TA muscle and potentially reducing its
atrophy is therefore important for enhancing vocal fold approximation and improving airflow
modulation and F0 control. In fact, two of the participants who received only voice therapy
increased their laryngeal resistance with large effect sizes. One of these subjects also increased
their subglottal pressure and maintain a constant airflow, while the other participant maintained
a somewhat constant subglottal pressure and reduced their airflow to a more normal value.
Nonetheless, results from self-assessement measures suggest that adding IMST to voice exercises
could lead to greater benefits for patients with presbyphonia, as it will be discussed in the next
section.

Effect on Self-Assessment Measures
Despite the improvement observed in voice quality during conversation and reading, participants
in the EMST group did not improve their self-assessment scores meaningfully. Importantly, an
increase in VHI-10 scores, indicating an increased in perceived handicap, was observed for this
group, with a medium effect size. On the other hand, the IMST group made meaningful
improvement on all self-assessment questionnaires, with large to very large effect sizes. Although
some improvement was also observed in the VFE group, improvements in the IMST group were
much larger.
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EMST promotes the use of the abdominal muscles to compress the air out of the lungs with
greater force. As previously mentioned, the resulting increase in subglottal pressure is likely to be
accompanied by an increase in glottal airflow if resistance of the vocal folds is not proportionally
increased (Zhang, 2015). As a result, the speaker runs out of air quickly and has to further
compress the ribcage to use the air from the expiratory reserve volume and maintain sufficient
airflow and subglottal pressure for phonation. Preliminary findings from this study suggest that
this may not be the preferable strategy to improve voice-related quality of life in this patient
population. It could be hypothesized that increasing subglottal pressure and phonation duration
by relying on the expiratory muscles comes at a great cost effort-wise, especially if the glottal gap
remains significant. Subglottal pressure tends to decrease as lung volume decreases, as a result
of reduced recoil pressure (Iwarsson, Thomasson, & Sundberg, 1998). The expiratory effort
needed to maintain sufficient subglottal pressure below the resting expiratory level is even more
important because the natural pressures become negative and need to be overcome by muscular
effort (Huber, 2008). Despite training of the expiratory muscles, the required effort may be too
great for older speaker in whom expiratory pressures are already decreased due to age-related
changes in the respiratory system, more so than inspiratory pressures (Enright, Kronmal, Higgins,
Schenker, & Haponik, 1994). Additionally, if the expiratory effort necessary to produce voice is
not being maintained to successfully meet voice demands, more effort from the laryngeal muscles
will be required in order to compensate.

It may be that a respiratory training capitalizing on the inspiratory strength, which is already
better preserved in this population, is more effective in achieving an optimal balance between
respiratory and laryngeal effort during phonation.
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Activating the inspiratory muscles during the expiratory phase of speech allows the speaker to
maintain the natural recoil pressures at a higher level for a longer period of time, which provides
necessary airflow and subglottal pressure without requiring much effort from the expiratory or
laryngeal muscles. It is also possible that participants were able to initiate phonation at a higher
lung volume, to take advantage of greater recoil pressures. This strategy is already used by older
speakers, who initiate speech at a higher lung volume when compared to younger adults, to
compensate for reduced expiratory pressures (Huber, 2008; Huber & Spruill, 2008). As it was
shown in Aim 2, participants with a lower respiratory function tend to increase their laryngeal
airway resistance to slow down the decrease in lung volume and maintain higher natural
expiratory pressure. However, this compensation was associated with laryngeal hyperfunction
and with higher perceived handicap. Even though FVC was not increased following IMST, subjects
may have learned to make a greater use of their inspiratory capacity, thus optimizing their
phonatory volume. Having more air available to provide adequate airflow and subglottal pressure
for phonation has been associated with decreased vocal fatigue (Hunter et al., 2019). In fact, more
subjects in the IMST group improved on the questionnaire items related to vocal fatigue and
discomfort, when compared to the EMST and the VFE groups: “I feel as though I have to strain to
produce voice”; “Throat discomfort or pain after using your voice”; “Vocal fatigue (voice
weakened as you talked)”.

In addition, the greater airflow and airflow control resulting from a stronger activation of the
inspiratory muscles may have allowed the subjects to extend utterance lengths between breaths,
without increasing laryngeal effort. In studies comparing older and young speakers, older adults
were found to expend a greater percentage of the vital capacity per syllable and to produce less
syllables per breath group when compared to younger adults (Huber, 2008; Huber & Spruill,
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2008). A more effective inspiration prior to speaking, as well as a better use of the inspiratory
muscles during phonation, may have reduced the number of pauses needed for breathing, which
could in turn could have decreased the sensation of shortness of breath. Interestingly, no item
from the administered self-assessment questionnaires addressed shortness of breath. The full
version of the VHI does comprise the item “I run out of air when I talk” (Jacobson et al., 1997),
however it is not present in the short version, which was used in the present study (Arffa et al.,
2012). The CPIB questionnaire assesses different communication situations, some of which
involve the production of more complex and thus longer utterances. More subjects in the IMST
group improved on those items when compared to the other groups: “Having a long conversation
with someone you know about a book, movie, show or sports event”; “Giving someone detailed
information”; and “Trying to persuade a friend or family member to see a different point of view”.
A greater proportion of subjects in the IMST group also improved on the items “Communicating
when you need to say something quickly” and “Getting your turn in a fast-moving conversation”.
This could be related to an enhanced efficiency of the inspiratory muscles to take quick and yet
efficient inspirations between utterances.

Correlations Between Changes in Respiratory and Voice Function
No correlations were found between improvements in MIP and MEP and improvements in voice
outcomes, except for aerodynamic resistance which was positively correlated with change in MIP.
Moreover, two subjects in the IMST group did not have a meaningful improvement in MIP, but
did improve their voice and voice-related quality of life, more so than subjects in other groups.
One reason for these findings may reside in the fact that spirometry and muscle strength
measurements are maximal effort tasks, while phonation is not a maximal effort task. An
improvement in maximal measures of respiration may not be required to witness improvements
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in phonation mechanics. The participants were instructed to performed the respiratory training
immediately prior to the voice exercises. We hypothesize that IMST may have prompted the
engagement of the inspiratory muscles during the VFEs, and that an improvement in respiratory
function rather than in maximal strength may be at the source of the changes in voice quality,
aerodynamics, and voice-related quality of life. Similarly, even if FVC during spirometry did not
improve, inspiratory volume prior to phonation may have been increased with IMST, thus
providing more air during speech.

Limitations for Aim 3a
The hypothesis that lung volume initiation may have been increased could not be verified,
because kinematic measures were not assessed in this study, which constitutes a limitation.
Although integrity of the respiratory system, as measured by maximal effort tests, has been
shown to impact voice outcomes (Aim 2), its functional aspects should also be considered and
would help further elucidate the mechanisms of action through which IMST improves voice
outcomes.

The very small sample size represents a significant limitation. The assumption of equality of
variances and of normal distribution of the residuals were not always met, and therefore the
results of the ANOVA may be less reliable. This is why interpretation of the results also relied on
single-subject analyses as well, as well as on effect size computations. This is all the more
important considering that comparisons of group means do not take into account the whole
clinical picture of the participants. For example, when assessing aerodynamic measures and
laryngeal parameters, both a decrease or an increase in the outcome may be desirable, based on
the baseline status and the whole clinical picture of the patient.
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Intra-subject variability is an important factor to consider, especially in patients with
presbyphonia who already tend to present with an increased intra-individuals variability in voice
measures. If the importance of the raw change in one outcome was not confirmed by a
meaningful effect size, which was based on two baseline and two follow-up measurements (when
available), it indicates a lack of stability in the improvement. A future study could take multiple
baseline and follow-up measurement to increase the robustness of single-subject findings, and to
assess the stability of the improvements following the intervention. Moreover, it is possible that
a longer intervention duration could have yielded more stable results.
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Discussion: Aim 3b
How do baseline measures of respiratory function influence the effects of RMST in patients
with presbyphonia?
Results from Aim 2 confirmed that the state of the respiratory system (pulmonary function and
respiratory muscle strength) does have an impact on phonation physiology and on perceived voice
handicap. In fact, a lower respiratory function was associated with more functional handicap
related to phonation. Additionally, results from Aim 3a revealed that adding respiratory exercises,
more specifically IMST, to voice exercises led to greater improvements in voice outcomes,
especially in self-assessment measures. However, it was still unclear if respiratory exercises
should be recommended for all patients with presbyphonia, or only for patients who present with
a decreased respiratory function.
Results from Aim 3b revealed that, although the state of the respiratory system at baseline did
impact the response to the intervention, this was true for all intervention groups and not only for
those including respiratory exercises. Moreover, all participants in the IMST group improved on
self-assessment measures, suggesting that patients with and without reduced respiratory
function may benefit from respiratory training. The results are discussed in detail in the following
sections.

Impact of Baseline Respiratory Function
The respiratory variables that had the largest effect on the response to the intervention, as
measured by the change in VHI-10 score, were: FVC%, FEV1%, and MEP. Additionally, MIP was
found to be an important predictor within the IMST group. Although preliminary, these findings
support the hypothesis that baseline respiratory function influences the response to voice
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therapy. More specifically, a lower baseline respiratory function was associated with a greater
improvement in VHI-10 following the intervention.

This is consistent with the results from Aim 2, which showed that a lower respiratory function
tends to be associated with a higher perceived voice handicap, potentially because of a higher
laryngeal effort to compensate for the decreased respiratory support, and/or a feeling of
shortness of breath when speaking. However, the reason why lower respiratory values predicted
improvements in voice handicap is not obvious, considering that 1) none of the interventions
induced changes in pulmonary function, and 2) improvements in respiratory muscle strength were
not correlated with improvements in perceived vocal handicap. It is possible that participants
with a greater respiratory deficit were less likely to make an optimal use of their respiratory
support during phonation, and that the intervention improved the functional use of their
respiratory system without necessarily improving maximal values as measured by MIP, MEP, FVC,
and FEV1. In other words, an impaired respiratory system could lead to a suboptimal respiratory
support, which leaves more room for improvement from respiratory training. On the other hand,
if a patient is already making an optimal use of their respiratory support, they may have less room
for improvement and this could translate into less change in VHI-10 score.

Interestingly, respiratory variables were also found to be important predictors for change in VHI10 in the total sample, when controlling for the intervention received. It is already acknowledged
that certain voice exercises target both the respiratory and the laryngeal system, and especially
the coordination between the two. VFEs are one of those, as they have been described as a series
of specific exercises targeting strength, endurance, flexibility and stability of the laryngeal and
respiratory systems as well as the balance between muscular effort and airflow (Stemple et al.,
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1994; Tay et al., 2012). When performing VFEs, subjects are instructed to hold certain notes for
increased time durations, while producing sounds that promote a healthy vocal fold vibration. In
participants who presented with decreased respiratory function, these exercises may be sufficient
to promote a more efficient use of respiratory support during phonation, leading to greater
improvements when compared to patients presenting with better baseline respiratory function.

Importance of Controlling for Baseline Respiratory Status
The VFE group had the highest mean on two of the respiratory predictors (FVC% and FEV1%),
while the EMST group had the lowest mean on these same variables. Even if not statistically
significant, these differences could be clinically meaningful in a sense that they have the potential
to affect the response to treatment. A univariate analysis of covariance tested the differences
between the mean change in VHI-10 across the three groups, while controlling for baseline FVC%.
The results were then compared to those obtained when baseline respiratory function was not
taken into account. When adjusting the means to control for FVC%, the difference between the
IMST and the EMST group was amplified (the IMST group improved significantly more than the
EMST group) and the difference between the EMST and the VFE group was also amplified (the
VFE group improved more than the EMST group, and the difference was marginally significant).
The EMST group would have been expected to make the greatest improvements based on the
low baseline FVC%, which was not the case. In fact, the EMST group had by far the least
improvement in VHI-10 score following the intervention. On the other hand, the difference
between the IMST and the VFE group was reduced, meaning that when adjusting for baseline
FVC%, the two groups had a similar decrease in VHI-10.
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Voice therapy studies rarely incorporate respiratory outcomes. Of the 23 studies that assessed
the effect of a respiratory intervention on voice outcomes, only 12 of them measured at least one
respiratory outcome (Desjardins & Bonilha, 2019). Of those, four studies included exclusively
respiratory muscle strength measures (Chiara et al., 2007; Johansson, 2012; Ray, 2018; Roy et al.,
2003), two studies included exclusively spirometry measures (Choi, 2016; Ramig et al., 1995),
three studies included exclusively kinematic or other types of respiratory measures (Collyer,
Kenny, & Archer, 2009, 2011; Schaeffer, 2017), and three studies included a combination of
respiratory measures (Cerny et al., 1997; Darling-White & Huber, 2017; Mueller, 2013).

Results from Aim 3b demonstrated that baseline respiratory function impacts the response to
voice therapy, with or without respiratory exercises. In the voice field, a lot of research has been
directed towards finding the best outcomes to measure treatment effect on voice. It is well
acknowledged that voice is multidimensional and that a variety of outcomes is crucial in obtaining
a complete clinical picture. However, respiratory function has not been included in the
recommended assessment protocol despite playing a major role in voice production.
Aerodynamic measures such as mean glottal airflow, subglottal pressure, and aerodynamic
resistance are the result of laryngeal and respiratory function (Vaca et al., 2017). While they
provide essential information on the combined activity of these systems, they do not provide
information on the status of the respiratory system and how it could impact the response to the
intervention. Including respiratory function measures in voice studies could help reduce
unexplained variance and could help researchers and clinicians gain a better understanding of the
mechanisms of action of the studied interventions, especially in populations at risk of presenting
with heterogeneous profiles of respiratory healthy such as patients with presbyphonia.
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Is There a Need for Impairment-Specific Interventions?
Findings from this study do not support the premise that only patients with an impaired
respiratory function are likely to benefit from an intervention loading the respiratory system. Even
though the difference between the IMST and the VFE group was substantially reduced when
controlling for baseline FVC%, there was an increase in standard deviations for VHI-10 in the VFE
group (SD=6.41 at pre-treatment and SD=13.05 at post-treatment). This increase was not
observed in the IMST group, for which the VHI-10 standard deviation decreased from 6.06 to 4.97
after therapy. This indicates that the inter-subject variability was reduced in the IMST group. In
fact, every participant in the IMST group responded positively to the intervention, even though
subjects with a lower respiratory function experienced the greatest improvement. Even
participant 2, who presented with a FVC% of 100%, had a decrease of 6 points on the VHI-10,
which has been considered a clinically meaningful improvement (J. Gartner-Schmidt & Rosen,
2011). On the other hand, the two participants in the VFE group who presented with a FVC% of
100% or more experienced no improvement at all in VHI-10 score. Therefore, the effect of VFEs
may be limited in patients with a less severe respiratory baseline condition potentially, because
of a ceiling effect. A more intense intervention such as IMST may “raise the ceiling” and further
improve respiratory support, which might not be possible only with VFEs. Future studies are
needed in order to gain a better understanding of the effects of VFEs and IMST in presbyphonic
patients with various baseline respiratory profiles.

In summary, regardless of the baseline respiratory function, the IMST intervention yielded the
best and least variable response. This is also in line with the results from Ziegler et al. (2014), who
found that the intervention involving a greater load of the respiratory system (PhoRTE) led to
greater self-reported improvements in the studied sample. Although interventions involving only
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voice exercises may lead to meaningful self-reported improvements with a longer treatment
duration (E. E. H. Berg, E.; Klein, A.; Johns, M. M., 3rd, 2008; Kaneko et al., 2015; Sauder et al.,
2010), results from our study suggest that using an intervention involving a greater load on the
respiratory system leads to better self-reported improvements, for some patients, even with a
short treatment duration (four weeks). In sum, results from this study and from the literature
indicate that an intervention involving a greater load on the respiratory system may allow patients
to achieve optimal results quicker, and potentially reduce the need for surgical interventions.

It is also possible that less severe patients seeking treatment for voice difficulties represent a
subset of patients with an increased awareness of their voice problem and greater expectations.
In this case, a surgical intervention may or may not yield the desired results for these patients.
For example, participant 18, in the VFE group, presented with a well preserved respiratory
function in comparison to the rest of the sample, and with a bowing index below the median,
indicating a mild severity profile. This participant was an active recreational singer very aware of
their voice difficulties and concerned about their ability to perform upcoming concerts. This
participant was susceptible of presenting with high expectations regarding therapy outcomes.
Following four weeks of VFEs, perceived handicap increased by two points on the VHI-10 and the
participant decided to undergo a surgical intervention. An IMST intervention, combined with
counseling aiming at adjusting the expectations of the participant, may have yielded more optimal
results. In fact, Gartner-Schmidt and Rosen’s (2011) results revealed that the rate of success for
patients undergoing surgery after an unsuccessful voice therapy trial was only 17%. In the authors’
discussion of this result, they indicated that unrealistic expectations from the patients may be a
major cause, and emphasized the importance of counseling prior to a surgical intervention to
readjust expectations.
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Impact of Baseline Laryngeal Status
The impact of baseline laryngeal status on the response to behavioral voice therapy in patients
with presbyphonia is not well known and yet is crucial in making clinical decisions. A surgical
option is usually recommended for patients with severe atrophy (as shown by increased bowing
of the vocal fold and prominence of the vocal fold processes), because of the assumption that
these patients are less likely to benefit from behavioral voice therapy. The findings from this study
do not support this assumption. In fact, baseline bowing index was not found to be a significant
predictor for the change in VHI-10 following behavioral therapy. This is consistent with the results
from Tanner et al. (2010), who studied the response to treatment in two monozygotic twins with
severe age-related vocal fold bowing. Limited functional improvements were observed following
surgical management, as reported by the subjects. Moreover, while mid-membranous closure
was improved, a significant posterior gap remained following the procedure. On the other hand,
subsequent voice therapy led to an improved mid-membranous and posterior closure, as well as
improvements on the VHI scores, especially for one of the twins. In addition, Lu et al. (1998)
reported that patients with vocal fold bowing experienced limited benefits from thyroplasty type
1: while glottal gap was improved postoperatively, most of the other voice outcomes remained
unchanged. In the light of their results, Tanner et al. (2010) suggested that behavioral voice
therapy should be considered as the primary approach regardless of the severity of the laryngeal
changes. Our findings also support this recommendation, considering that a clinically meaningful
decrease in VHI-10 score was noted for patients with a wide range of bowing index scores and
that a greater baseline severity was not predictive of less functional improvement following
behavioral voice therapy.
The reason why bowing index was not a good predictor for change in VHI-10 following treatment
could reside in the fact that, although it is a measure of baseline laryngeal severity, it is not
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sufficiently informative of the patient’s general clinical picture. Baseline laryngeal severity is a
complex construct to measure, especially in patients with glottic insufficiency who use many
compensation strategies to counteract the lack of glottic closure. While some of these strategies
may help normalize the sound, they may also tax the laryngeal and respiratory systems and lead
to increased effort and vocal fatigue (Zhang, 2019). As it was demonstrated in Aim 2, the integrity
factor (comprised of bowing index and phase symmetry), was not included in the handicap-driven
model because it didn’t play a significant role on perceived handicap. Factors that were related
to handicap (directly or indirectly) were: respiratory, pliability, resistance, and hyperfunction.
These factors are related to phonation physiology. On the other hand, bowing index is related to
vocal fold anatomy and structure, and although it does have an impact on physiology, many other
factors come into play and should be considered when attempting to predict a patient’s
responsiveness to voice therapy.

Limitations for Aim 3b
Because of the small sample size, we were limited in the choice of statistical approaches for this
aim. A future study with a larger sample size could allow researchers to dichotomize the outcome
and to compute the odds ratio of improving on the VHI-10 score, based on the baseline respiratory
function. Moreover, a larger sample size would allow for the identification of the best predictors
within each of the intervention group separately.
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Conclusions and Directions for Future Studies
Respiratory function was found to impact voice via two main pathways: through its physiological
effect on voice and through its impact on general health and impairment. The raw respiratory
strength and amount of air available for phonation were found to be predictors of physiological
voice outcomes: a lower respiratory function was associated with an increased aerodynamic
resistance accompanied by hyperfunction and reduced amplitude of vibration, mucosal wave
amplitude and regularity of vibration. Standardized measures of respiratory function had a direct
impact on perceived handicap, indicating that poor respiratory health may exacerbate the burden
of the voice disorder. Respiratory function did not have an impact on voice quality, which was
mostly influenced by the severity of vocal fold atrophy.
In line with those results, we also found that a lower baseline respiratory function was predictive
of a greater improvement in self-reported outcomes following behavioral voice therapy. Those
results do not imply that only patients with respiratory impairments would benefit from a
respiratory intervention, considering that voice therapy including IMST led to the greatest
improvements in VHI-10, even when adjusting for baseline respiratory function. The mechanism
of improvement could be explained by a better subglottal pressure control, as well as more air
available for phonation.
On the other hand, subjects who received EMST had the least improvement, potentially because
of an imbalance between the resulting respiratory drive and the ability of the vocal folds to
provide adequate resistance to modulate the airflow. Nonetheless, future studies could explore
the effect of starting with IMST and VFE and then adding EMST to the training protocol once an
optimal phonato-respiratory coordination has been established. Future studies should also assess
the relationships between respiratory and voice measures in other voice disorders, such as muscle
tension dysphonia, as well as the impact of IMST in these patients.
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Appendix I: Pre- and Post-Intervention Tasks and Outcome Measures
Assessment Category
Respiratory Assessments

Tasks
Spirometry testing
Respiratory muscle pressure testing

Outcome Measures
FVC, FEV1, and FEV1/FVC (raw and percent
predicted values
MIP and MEP

Laryngeal Features

Visual examination of the larynx with Bowing index
videostrosbocopy
Laryngeal parameters from the VALI form

Acoustic and Auditory-Perceptual
Assessments

Sustained /a/ at comfortable pitch and NHR, APQ,CPPS, overall severity (CAPE-V)
loudness for approximately 5 seconds
Read the 6 sentences from the CAPE-V
Natural speech for approximately one minute

Aerodynamic Assessment

Syllable repetition with the PAS

Self-Assessments

VHI-10, GFI, and CPIB

CPPS during reading, overall severity (CAPE-V)
Mean SPL during conversation, overall
severity (CAPE-V)
Subglottal pressure, mean airflow during
voicing, and aerodynamic resistance
Scores from the VHI-10, GFI, and CPIB
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Appendix II: Individual Results for Respiratory Measures
Participant

MIP

1

69

2
(interstitial
disease)
3 (mild
asthma)
4

97

5 (CREST
syndrome)
6

144

7

113

8

49

9

119

10

60

11

71

12

81

13

59

14

56

16

57

17

80

18

81

19

21

20

107

21

114

22

59

121
133

45

Predicted
(LLN)
54.94
(22.94)
49.70
(17.70)

MEP

65.35
(33.35)
97.72
(56.72)
108.08
(67.08)
73.85
(41.85)
80.81
(39.81)
43.23
(11.23)
103.18
(62.18)
83.67
(42.67)
49.42
(17.42)
62.96
(30.96)
52.49
(20.49)
57.19
(25.19)
79.17
(47.17)
86.92
(45.92)
73.07
(32.07)
82.64
(41.64)
94.25
(53.25)
95.47
(54.47)
73.66
(32.66)

121

114
96

163
117
89
160
85
176
126
90
100
86
81
67
132
147
89
174
186
83

Predicted
(LLN)
109.95
(57.95)
96.24
(44.24)

FVC%

FEV1%

FEV1/FVC

FEV1/FVC%

113

107

0.71

95

102

95

0.69

93

137.22
(85.22)
210.45
(139.45)
231.80
(160.80)
159.18
(107.18)
169.75
(98.75)
79.06
(27.06)
221.4
(150.4)
175.75
(104.75)
95.50
(43.50)
131.08
(79.08)
103.46
(51.46)
115.84
(63.84)
172.88
(120.88)
181.95
(110.95)
151.3
(80.3)
173.25
(102.25)
201.2
(130.2)
203
(132)
152.95
(81.95)

68

61

0.68

89

120

131

0.83

109

85

76

0.69

90

68

75

0.84

109

108

106

0.71

97

136

143

0.76

106

87

87

0.76

100

51

37

0.52

72

115

115

0.75

101

79

75

0.73

94

76

69

0.67

91

100

98

0.74

98

64

61

0.73

96

85

89

0.76

104

106

105

0.70

98

42

44

0.74

103

85

86

0.77

100

111

108

0.73

97

85

88

0.73

103

